1	RESEARCH	NN	O	research	nn	2	SENT_1	[p1l1751t81r1917b102],
2	LETTERS	NNS	O	letter	_	0	SENT_1	[p1l1926t81r2067b102],

1	Research	NNP	O	Research	nn	2	SENT_2	[p1l109t179r330b215],
2	letters	NNS	O	letter	_	0	SENT_2	[p1l345t179r495b215],

1	Polymorphism	NN	O	polymorphism	_	0	SENT_3	[p1l91t346r457b398],
2	of	IN	O	of	_	0	SENT_3	[p1l480t346r529b388],
3	the	DT	O	the	det	5	SENT_3	[p1l547t347r632b388],
4	thymidylate	NN	O	thymidylate	nn	5	SENT_3	[p1l652t346r961b398],
5	synthase	NN	O	synthase	prep_of	1	SENT_3	[p1l982t347r1219b398],
6	gene	NN	O	gene	dep	1	SENT_3	[p1l1240t352r1367b398],
7	and	CC	O	and	_	0	SENT_3	[p1l1389t347r1481b388],
8	outcome	NN	O	outcome	dep	1	SENT_3	[p1l1504t348r1733b388],
9	of	IN	O	of	_	0	SENT_3	[p1l1755t346r1804b388],
10	acute	JJ	O	acute	amod	12	SENT_3	[p1l1823t348r1971b388],
11	lymphoblastic	JJ	O	lymphoblastic	amod	12	SENT_3	[p1l14t442r839b557],
12	leukaemia	NN	O	leukaemia	prep_of	6	SENT_3	[p1l893t442r1502b536],

1	M	NN	O	m	nn	2	SENT_4	[p1l9t647r67b699],
2	Krajinovic	NN	O	krajinovic	nsubjpass	17	SENT_4	[p1l95t648r427b712],
3	,	,	O	,	_	0	SENT_4	[p1l95t648r427b712],
4	I	PRP	O	I	appos	2	SENT_4	[p1l461t648r476b699],
5	Costea	NNP	O	Costea	dep	4	SENT_4	[p1l504t646r738b710],
6	,	,	O	,	_	0	SENT_4	[p1l504t646r738b710],
7	S	NNP	O	S	nn	10	SENT_4	[p1l769t646r809b700],
8	Chiasson	NNP	PERSON	Chiasson	nn	10	SENT_4	[p1l839t646r1130b700],
9	lnterindividual	JJ	O	lnterindividual	amod	10	SENT_4	[p1l11t787r492b841],
10	variability	NN	O	variability	appos	5	SENT_4	[p1l532t787r868b853],
11	in	IN	O	in	_	0	SENT_4	[p1l908t787r962b840],
12	response	NN	O	response	prep_in	10	SENT_4	[p1l1005t800r1311b853],
13	to	TO	O	to	_	0	SENT_4	[p1l1348t789r1417b841],
14	methotrexate	NN	O	methotrexate	prep_to	12	SENT_4	[p1l1458t787r1921b841],
15	could	MD	O	could	aux	17	SENT_4	[p1l1961t787r2142b841],
16	be	VB	O	be	auxpass	17	SENT_4	[p1l10t879r87b933],
17	caused	VBN	O	cause	_	0	SENT_4	[p1l170t879r411b933],
18	by	IN	O	by	_	0	SENT_4	[p1l498t879r571b945],
19	variable	JJ	O	variable	amod	20	SENT_4	[p1l652t879r919b933],
20	concentrations	NNS	O	concentration	agent	17	SENT_4	[p1l1003t879r1517b933],
21	of	IN	O	of	_	0	SENT_4	[p1l1601t879r1665b933],
22	thymidylate	NN	O	thymidylate	nn	23	SENT_4	[p1l1743t879r2144b945],
23	synthase	NN	O	synthase	prep_of	20	SENT_4	[p1l7t973r334b1039],
24	.	.	O	.	_	0	SENT_4	[p1l7t973r334b1039],

1	We	PRP	O	we	nsubj	2	SENT_5	[p1l370t973r478b1026],
2	investigated	VBD	O	investigate	_	0	SENT_5	[p1l514t972r933b1039],
3	the	DT	O	the	det	5	SENT_5	[p1l967t973r1078b1026],
4	possible	JJ	O	possible	amod	5	SENT_5	[p1l1114t972r1392b1038],
5	association	NN	O	association	dobj	2	SENT_5	[p1l1426t972r1818b1026],
6	between	IN	O	between	_	0	SENT_5	[p1l1855t973r2142b1026],
7	a	DT	O	a	det	9	SENT_5	[p1l8t1079r45b1120],
8	tandem-repeat	JJ	O	tandem-repeat	amod	9	SENT_5	[p1l87t1066r585b1132],
9	polymorphism	NN	O	polymorphism	prep_between	5	SENT_5	[p1l630t1066r1098b1132],
10	in	IN	O	in	_	0	SENT_5	[p1l1145t1066r1199b1119],
11	the	DT	O	the	det	14	SENT_5	[p1l1242t1066r1352b1120],
12	thymidylate	NN	O	thymidylate	nn	14	SENT_5	[p1l1393t1066r1794b1132],
13	synthase	NN	O	synthase	nn	14	SENT_5	[p1l1836t1066r2143b1132],
14	promoter	NN	O	promoter	prep_in	2	SENT_5	[p1l10t1160r336b1224],
15	,	,	O	,	_	0	SENT_5	[p1l10t1160r336b1224],
16	of	IN	O	of	_	0	SENT_5	[p1l407t1158r471b1212],
17	which	WDT	O	which	rel	22	SENT_5	[p1l534t1158r732b1212],
18	a	DT	O	a	det	20	SENT_5	[p1l802t1171r838b1212],
19	triple	JJ	O	triple	amod	20	SENT_5	[p1l905t1158r1082b1224],
20	repeat	NN	O	repeat	nsubjpass	22	SENT_5	[p1l1152t1160r1369b1224],
21	is	VBZ	O	be	auxpass	22	SENT_5	[p1l1439t1158r1491b1212],
22	associated	VBN	O	associate	rcmod	14	SENT_5	[p1l1559t1158r1930b1212],
23	with	IN	O	with	_	0	SENT_5	[p1l1998t1158r2142b1212],
24	increased	VBN	O	increase	amod	25	SENT_5	[p1l10t1251r338b1305],
25	expression	NN	O	expression	prep_with	22	SENT_5	[p1l377t1251r745b1317],
26	of	IN	O	of	_	0	SENT_5	[p1l785t1251r849b1305],
27	thymidylate	NN	O	thymidylate	nn	28	SENT_5	[p1l882t1251r1283b1318],
28	synthase	NN	O	synthase	prep_of	25	SENT_5	[p1l1320t1252r1647b1318],
29	,	,	O	,	_	0	SENT_5	[p1l1320t1252r1647b1318],
30	and	CC	O	and	_	0	SENT_5	[p1l1689t1252r1808b1305],
31	outcome	NN	O	outcome	prep_with	22	SENT_5	[p1l1847t1253r2143b1305],
32	of	IN	O	of	_	0	SENT_5	[p1l8t1345r73b1399],
33	acute	JJ	O	acute	amod	35	SENT_5	[p1l119t1347r310b1399],
34	lymphoblastic	JJ	O	lymphoblastic	amod	35	SENT_5	[p1l362t1345r834b1411],
35	leukaemia	NN	O	leukaemia	prep_of	31	SENT_5	[p1l886t1345r1234b1399],
36	in	IN	O	in	_	0	SENT_5	[p1l1286t1345r1340b1398],
37	205	CD	NUMBER	205	num	38	SENT_5	[p1l1392t1345r1525b1399],
38	children	NNS	O	child	prep_in	35	SENT_5	[p1l1575t1345r1844b1399],
39	treated	VBN	O	treat	partmod	38	SENT_5	[p1l1894t1345r2142b1399],
40	with	IN	O	with	_	0	SENT_5	[p1l7t1437r151b1491],
41	methotrexate	NN	O	methotrexate	prep_with	39	SENT_5	[p1l197t1437r681b1491],
42	.	.	O	.	_	0	SENT_5	[p1l197t1437r681b1491],

1	We	PRP	O	we	nsubj	2	SENT_6	[p1l725t1437r832b1491],
2	obtained	VBD	O	obtain	_	0	SENT_6	[p1l875t1437r1169b1491],
3	DNA	NN	O	dna	nn	4	SENT_6	[p1l1216t1437r1361b1490],
4	samples	NNS	O	sample	dobj	2	SENT_6	[p1l1401t1437r1683b1503],
5	from	IN	O	from	_	0	SENT_6	[p1l1725t1437r1875b1491],
6	buccal	JJ	O	buccal	amod	8	SENT_6	[p1l1922t1437r2142b1491],
7	epithelial	JJ	O	epithelial	amod	8	SENT_6	[p1l8t1530r322b1596],
8	cells	NNS	O	cell	prep_from	2	SENT_6	[p1l350t1531r528b1596],
9	,	,	O	,	_	0	SENT_6	[p1l350t1531r528b1596],
10	peripheral	JJ	O	peripheral	amod	11	SENT_6	[p1l559t1530r894b1596],
11	blood	NN	O	blood	prep_from	2	SENT_6	[p1l925t1531r1125b1596],
12	,	,	O	,	_	0	SENT_6	[p1l925t1531r1125b1596],
13	or	CC	O	or	_	0	SENT_6	[p1l1154t1544r1219b1584],
14	bone	NN	O	bone	nn	15	SENT_6	[p1l1246t1531r1406b1585],
15	marrow	NN	O	marrow	prep_from	2	SENT_6	[p1l1433t1544r1685b1584],
16	in	IN	O	in	_	0	SENT_6	[p1l1711t1530r1765b1584],
17	remission	NN	O	remission	prep_in	2	SENT_6	[p1l1794t1530r2141b1596],
18	,	,	O	,	_	0	SENT_6	[p1l1794t1530r2141b1596],
19	and	CC	O	and	_	0	SENT_6	[p1l8t1624r127b1678],
20	analysed	VBD	O	analyse	conj_and	2	SENT_6	[p1l223t1624r521b1690],
21	them	PRP	O	they	dobj	20	SENT_6	[p1l615t1624r786b1678],
22	for	IN	O	for	_	0	SENT_6	[p1l880t1624r970b1678],
23	the	DT	O	the	det	24	SENT_6	[p1l1061t1624r1171b1678],
24	polymorphism	NN	O	polymorphism	prep_for	20	SENT_6	[p1l1267t1624r1735b1690],
25	by	IN	O	by	_	0	SENT_6	[p1l1833t1624r1906b1690],
26	PCR	NN	O	pcr	nn	27	SENT_6	[p1l2001t1624r2143b1678],
27	amplification	NN	O	amplification	prep_by	20	SENT_6	[p1l8t1716r472b1782],
28	.	.	O	.	_	0	SENT_6	[p1l8t1716r472b1782],

1	Individuals	NNS	O	individual	nsubj	9	SENT_7	[p1l509t1716r870b1770],
2	who	WP	O	who	nsubj	4	SENT_7	[p1l900t1716r1037b1770],
3	were	VBD	O	be	cop	4	SENT_7	[p1l1067t1729r1230b1770],
4	homozygous	JJ	O	homozygous	rcmod	1	SENT_7	[p1l1263t1716r1679b1783],
5	for	IN	O	for	_	0	SENT_7	[p1l1709t1716r1799b1770],
6	the	DT	O	the	det	8	SENT_7	[p1l1827t1716r1937b1770],
7	triple	JJ	O	triple	amod	8	SENT_7	[p1l1966t1716r2144b1782],
8	repeat	NN	O	repeat	prep_for	4	SENT_7	[p1l10t1811r227b1875],
9	had	VBD	O	have	dep	18	SENT_7	[p1l259t1810r376b1863],
10	a	DT	O	a	det	12	SENT_7	[p1l409t1823r445b1863],
11	poorer	JJR	O	poorer	amod	12	SENT_7	[p1l479t1823r693b1875],
12	outlook	NN	O	outlook	dobj	9	SENT_7	[p1l723t1810r980b1863],
13	than	IN	O	than	_	0	SENT_7	[p1l1007t1810r1157b1863],
14	those	DT	O	those	prep_than	12	SENT_7	[p1l1188t1810r1378b1863],
15	with	IN	O	with	_	0	SENT_7	[p1l1407t1809r1551b1863],
16	other	JJ	O	other	amod	17	SENT_7	[p1l1584t1810r1762b1863],
17	genotypes	NNS	O	genotype	prep_with	14	SENT_7	[p1l1790t1811r2143b1876],
18	(	VBP	O	(	_	0	SENT_7	[p1l9t1903r196b1969],
19	odds	NNS	O	odds	dobj	18	SENT_7	[p1l9t1903r196b1969],
20	ratio	NN	O	ratio	nsubj	18	SENT_7	[p1l245t1903r398b1957],
21	4-1	CD	NUMBER	4-1	num	20	SENT_7	[p1l444t1903r575b1968],
22	,	,	O	,	_	0	SENT_7	[p1l444t1903r575b1968],
23	95	CD	PERCENT	95	number	24	SENT_7	[p1l625t1903r766b1957],
24	%	NN	PERCENT	%	amod	25	SENT_7	[p1l625t1903r766b1957],
25	Cl	NN	O	cl	appos	20	SENT_7	[p1l812t1903r878b1957],
26	1-9-9-O	NN	O	1-9-9-o	nn	31	SENT_7	[p1l928t1903r1213b1968],
27	,	,	O	,	_	0	SENT_7	[p1l928t1903r1213b1968],
28	p	NN	O	p	nn	31	SENT_7	[p1l1264t1903r1604b1969],
29	=	JJ	O	=	amod	31	SENT_7	[p1l1264t1903r1604b1969],
30	0-O01	NN	O	0-o01	nn	31	SENT_7	[p1l1264t1903r1604b1969],
31	)	NN	O	)	dep	25	SENT_7	[p1l1264t1903r1604b1969],
32	.	.	O	.	_	0	SENT_7	[p1l1264t1903r1604b1969],

1	Genotyping	NN	O	genotyping	nsubj	6	SENT_8	[p1l1653t1903r2040b1969],
2	of	IN	O	of	_	0	SENT_8	[p1l2083t1903r2147b1957],
3	thymidylate	NN	O	thymidylate	nn	4	SENT_8	[p1l7t1995r408b2061],
4	synthase	NN	O	synthase	prep_of	1	SENT_8	[p1l440t1995r747b2061],
5	might	MD	O	might	aux	6	SENT_8	[p1l782t1995r974b2062],
6	make	VB	O	make	_	0	SENT_8	[p1l1009t1995r1192b2049],
7	it	PRP	O	it	nsubj	8	SENT_8	[p1l1228t1995r1272b2049],
8	possible	JJ	O	possible	xcomp	6	SENT_8	[p1l1307t1995r1586b2061],
9	to	TO	O	to	_	0	SENT_8	[p1l1618t1997r1686b2049],
10	individualise	NN	O	individualise	nn	11	SENT_8	[p1l1722t1995r2143b2049],
11	treatment	NN	O	treatment	prep_to	8	SENT_8	[p1l7t2090r348b2142],
12	for	IN	O	for	_	0	SENT_8	[p1l375t2088r465b2142],
13	patients	NNS	O	patient	prep_for	11	SENT_8	[p1l494t2088r772b2154],
14	with	IN	O	with	_	0	SENT_8	[p1l798t2088r942b2142],
15	acute	JJ	O	acute	amod	17	SENT_8	[p1l972t2090r1164b2142],
16	lymphoblastic	JJ	O	lymphoblastic	amod	17	SENT_8	[p1l1194t2088r1666b2155],
17	leukaemia	NN	O	leukaemia	prep_with	13	SENT_8	[p1l1697t2088r2066b2142],
18	.	.	O	.	_	0	SENT_8	[p1l1697t2088r2066b2142],

1	Lancet	NNP	O	Lancet	_	0	SENT_9	[p1l10t2238r244b2293],
2	2002	CD	DATE	2002	num	1	SENT_9	[p1l272t2236r482b2303],
3	;	:	O	;	_	0	SENT_9	[p1l272t2236r482b2303],
4	359	CD	NUMBER	359	dep	1	SENT_9	[p1l516t2236r681b2293],
5	:	:	O	:	_	0	SENT_9	[p1l516t2236r681b2293],
6	1033-34	CD	NUMBER	1033-34	num	9	SENT_9	[p1l718t2236r1044b2293],
7	Thymidylate	NNP	O	Thymidylate	nn	9	SENT_9	[p1l7t2336r462b2408],
8	synthase	NN	O	synthase	nn	9	SENT_9	[p1l619t2336r918b2408],
9	catalyses	NNS	O	catalysis	dep	4	SENT_9	[p1l1075t2336r1382b2408],
10	conversion	NN	O	conversion	nsubj	15	SENT_9	[p1l1539t2336r1923b2394],
11	of	IN	O	of	_	0	SENT_9	[p1l2078t2336r2153b2393],
12	deoxyuridylate	JJ	O	deoxyuridylate	amod	13	SENT_9	[p1l9t2428r534b2500],
13	monophosphate	NN	O	monophosphate	prep_of	10	SENT_9	[p1l645t2428r1219b2500],
14	to	TO	O	to	aux	15	SENT_9	[p1l1331t2441r1398b2486],
15	deoxythymidylate	VB	O	deoxythymidylate	infmod	9	SENT_9	[p1l1512t2428r2143b2500],
16	monophosphate	NN	O	monophosphate	dobj	15	SENT_9	[p1l8t2520r602b2593],
17	.	.	O	.	_	0	SENT_9	[p1l8t2520r602b2593],

1	Inhibition	NN	O	inhibition	nsubj	5	SENT_10	[p1l678t2520r1034b2578],
2	of	IN	O	of	_	0	SENT_10	[p1l1106t2519r1181b2578],
3	this	DT	O	this	det	4	SENT_10	[p1l1241t2520r1366b2578],
4	enzyme	NN	O	enzyme	prep_of	1	SENT_10	[p1l1440t2538r1705b2592],
5	results	VBZ	O	result	_	0	SENT_10	[p1l1777t2520r2006b2578],
6	in	IN	O	in	_	0	SENT_10	[p1l2078t2520r2144b2577],
7	deoxythymidine	NN	O	deoxythymidine	nn	9	SENT_10	[p1l9t2613r580b2685],
8	triphosphate	NN	O	triphosphate	nn	9	SENT_10	[p1l621t2613r1068b2685],
9	depletion	NN	O	depletion	prep_in	5	SENT_10	[p1l1111t2613r1465b2685],
10	,	,	O	,	_	0	SENT_10	[p1l1111t2613r1465b2685],
11	and	CC	O	and	_	0	SENT_10	[p1l1510t2613r1638b2671],
12	subsequently	RB	O	subsequently	advmod	5	SENT_10	[p1l1680t2613r2145b2685],
13	in	IN	O	in	_	0	SENT_10	[p1l8t2705r75b2762],
14	chromosome	NN	O	chromosome	nn	15	SENT_10	[p1l148t2705r607b2763],
15	breaks	NNS	O	break	prep_in	5	SENT_10	[p1l678t2705r906b2763],
16	and	CC	O	and	_	0	SENT_10	[p1l981t2705r1110b2763],
17	cell	NN	O	cell	nn	18	SENT_10	[p1l1183t2705r1301b2763],
18	death	NN	O	death	conj_and	9	SENT_10	[p1l1374t2705r1614b2763],
19	.	.	O	.	_	0	SENT_10	[p1l1374t2705r1614b2763],

1	‘	NN	O	‘	nn	3	SENT_11	[p1l1374t2705r1614b2763],
2	Thymidylate	NN	O	thymidylate	nn	3	SENT_11	[p1l1688t2705r2143b2777],
3	synthase	NN	O	synthase	nsubj	7	SENT_11	[p1l9t2797r309b2869],
4	is	VBZ	O	be	cop	7	SENT_11	[p1l350t2797r400b2855],
5	an	DT	O	a	det	7	SENT_11	[p1l443t2816r524b2855],
6	essential	JJ	O	essential	amod	7	SENT_11	[p1l565t2797r864b2855],
7	enzyme	NN	O	enzyme	_	0	SENT_11	[p1l905t2815r1171b2869],
8	in	IN	O	in	_	0	SENT_11	[p1l1211t2797r1278b2854],
9	proliferating	VBG	O	proliferate	amod	10	SENT_11	[p1l1316t2796r1759b2870],
10	cells	NNS	O	cell	prep_in	7	SENT_11	[p1l1799t2797r1971b2867],
11	,	,	O	,	_	0	SENT_11	[p1l1799t2797r1971b2867],
12	and	CC	O	and	_	0	SENT_11	[p1l2015t2797r2144b2855],
13	thus	RB	O	thus	advmod	17	SENT_11	[p1l8t2890r157b2948],
14	is	VBZ	O	be	cop	17	SENT_11	[p1l203t2890r253b2947],
15	an	DT	O	a	det	17	SENT_11	[p1l299t2909r381b2948],
16	important	JJ	O	important	amod	17	SENT_11	[p1l425t2890r780b2962],
17	target	NN	O	target	conj_and	7	SENT_11	[p1l823t2903r1027b2962],
18	for	IN	O	for	_	0	SENT_11	[p1l1070t2890r1170b2947],
19	Various	JJ	O	various	amod	21	SENT_11	[p1l1210t2890r1465b2948],
20	anticancer	JJ	O	anticancer	amod	21	SENT_11	[p1l1512t2890r1881b2947],
21	drugs	NNS	O	drug	prep_for	17	SENT_11	[p1l1924t2890r2141b2962],
22	,	,	O	,	_	0	SENT_11	[p1l1924t2890r2141b2962],
23	including	VBG	O	include	_	0	SENT_11	[p1l8t2982r344b3054],
24	methotrexate	NN	O	methotrexate	nn	25	SENT_11	[p1l399t2982r870b3040],
25	g1utamates	NNS	O	g1utamate	prep_including	17	SENT_11	[p1l927t2982r1396b3054],
26	.	.	O	.	_	0	SENT_11	[p1l927t2982r1396b3054],
27	"	''	O	"	punct	7	SENT_11	[p1l927t2982r1396b3054],

1	2	CD	NUMBER	2	nsubjpass	25	SENT_12	[p1l927t2982r1396b3054],
2	A	DT	O	a	det	4	SENT_12	[p1l1451t2983r1509b3039],
3	major	JJ	O	major	amod	4	SENT_12	[p1l1564t2982r1772b3054],
4	cause	NN	O	cause	nsubj	14	SENT_12	[p1l1828t3001r2019b3040],
5	of	IN	O	of	_	0	SENT_12	[p1l2078t2982r2153b3040],
6	resistance	NN	O	resistance	prep_of	4	SENT_12	[p1l8t3074r355b3132],
7	to	TO	O	to	_	0	SENT_12	[p1l405t3087r472b3132],
8	drugs	NNS	O	drug	prep_to	6	SENT_12	[p1l525t3074r718b3146],
9	that	WDT	O	that	nsubj	10	SENT_12	[p1l769t3074r908b3132],
10	target	VBP	O	target	rcmod	8	SENT_12	[p1l956t3087r1160b3146],
11	this	DT	O	this	det	12	SENT_12	[p1l1208t3074r1333b3132],
12	enzyme	NN	O	enzyme	dobj	10	SENT_12	[p1l1385t3092r1651b3146],
13	is	VBZ	O	be	cop	14	SENT_12	[p1l1701t3074r1752b3132],
14	failure	NN	O	failure	rcmod	1	SENT_12	[p1l1802t3073r2027b3132],
15	of	IN	O	of	_	0	SENT_12	[p1l2078t3073r2153b3132],
16	inhibition	NN	O	inhibition	prep_of	14	SENT_12	[p1l8t3167r377b3236],
17	,	,	O	,	_	0	SENT_12	[p1l8t3167r377b3236],
18	and	CC	O	and	_	0	SENT_12	[p1l409t3167r538b3225],
19	expression	NN	O	expression	rcmod	1	SENT_12	[p1l566t3167r939b3239],
20	of	IN	O	of	_	0	SENT_12	[p1l967t3167r1042b3225],
21	thymidylate	NN	O	thymidylate	nn	22	SENT_12	[p1l1058t3167r1478b3239],
22	synthase	NN	O	synthase	prep_of	19	SENT_12	[p1l1507t3167r1807b3239],
23	has	VBZ	O	have	aux	25	SENT_12	[p1l1833t3167r1948b3225],
24	been	VBN	O	be	auxpass	25	SENT_12	[p1l1975t3167r2144b3225],
25	reported	VBN	O	report	_	0	SENT_12	[p1l8t3259r311b3331],
26	to	TO	O	to	aux	27	SENT_12	[p1l338t3272r406b3317],
27	predict	VB	O	predict	xcomp	25	SENT_12	[p1l434t3259r685b3331],
28	response	NN	O	response	dobj	27	SENT_12	[p1l712t3278r1021b3331],
29	to	TO	O	to	_	0	SENT_12	[p1l1049t3272r1116b3317],
30	cytotoxic	JJ	O	cytotoxic	amod	31	SENT_12	[p1l1147t3259r1468b3331],
31	treatment	NN	O	treatment	prep_to	27	SENT_12	[p1l1496t3260r1887b3317],
32	.	.	O	.	_	0	SENT_12	[p1l1496t3260r1887b3317],

1	‘	NN	O	‘	_	0	SENT_13	[p1l1496t3260r1887b3317],

1	A	DT	O	a	det	3	SENT_14	[p1l92t3352r150b3408],
2	tandem-repeat	JJ	O	tandem-repeat	amod	3	SENT_14	[p1l198t3351r721b3424],
3	sequence	NN	O	sequence	nsubjpass	6	SENT_14	[p1l772t3369r1096b3424],
4	has	VBZ	O	have	aux	6	SENT_14	[p1l1145t3351r1260b3409],
5	been	VBN	O	be	auxpass	6	SENT_14	[p1l1311t3351r1480b3409],
6	identified	VBN	O	identify	_	0	SENT_14	[p1l1530t3350r1868b3409],
7	in	IN	O	in	_	0	SENT_14	[p1l1918t3351r1985b3408],
8	the	DT	O	the	det	10	SENT_14	[p1l2034t3351r2143b3409],
9	promoter	NN	O	promoter	nn	10	SENT_14	[p1l7t3457r342b3516],
10	region	NN	O	region	prep_in	6	SENT_14	[p1l377t3444r600b3516],
11	of	IN	O	of	_	0	SENT_14	[p1l637t3444r712b3501],
12	the	DT	O	the	det	15	SENT_14	[p1l738t3444r847b3502],
13	thymidylate	NN	O	thymidylate	nn	15	SENT_14	[p1l883t3444r1303b3516],
14	synthase	NN	O	synthase	nn	15	SENT_14	[p1l1341t3444r1641b3516],
15	gene	NN	O	gene	prep_of	10	SENT_14	[p1l1678t3445r1888b3516],
16	?	.	O	?	_	0	SENT_14	[p1l1678t3445r1888b3516],

1	It	PRP	O	it	nsubjpass	3	SENT_15	[p1l1924t3445r1980b3501],
2	was	VBD	O	be	auxpass	3	SENT_15	[p1l2014t3463r2143b3502],
3	shown	VBN	O	show	_	0	SENT_15	[p1l9t3536r236b3594],
4	to	TO	O	to	aux	6	SENT_15	[p1l276t3549r343b3594],
5	be	VB	O	be	cop	6	SENT_15	[p1l384t3536r466b3594],
6	polymorphic	JJ	O	polymorphic	xcomp	3	SENT_15	[p1l506t3536r980b3608],
7	,	,	O	,	_	0	SENT_15	[p1l506t3536r980b3608],
8	containing	VBG	O	contain	xcomp	6	SENT_15	[p1l1025t3536r1402b3608],
9	either	CC	O	either	prep	8	SENT_15	[p1l1442t3536r1645b3594],
10	two	CD	NUMBER	two	nn	14	SENT_15	[p1l1682t3549r1810b3594],
11	or	CC	O	or	_	0	SENT_15	[p1l1854t3555r1926b3594],
12	three	CD	NUMBER	three	conj_or	10	SENT_15	[p1l1964t3536r2143b3594],
13	28-bp	JJ	O	28-bp	amod	14	SENT_15	[p1l10t3628r217b3700],
14	repeats	NNS	O	repeat	dep	9	SENT_15	[p1l292t3640r566b3700],
15	;	:	O	;	_	0	SENT_15	[p1l292t3640r566b3700],
16	the	DT	O	the	det	19	SENT_15	[p1l643t3628r751b3685],
17	three	CD	NUMBER	three	num	19	SENT_15	[p1l825t3628r1004b3685],
18	28-bp	JJ	O	28-bp	amod	19	SENT_15	[p1l1081t3628r1287b3700],
19	repeat	NN	O	repeat	nsubjpass	21	SENT_15	[p1l1363t3641r1583b3700],
20	is	VBZ	O	be	auxpass	21	SENT_15	[p1l1656t3628r1706b3685],
21	associated	VBN	O	associate	parataxis	3	SENT_15	[p1l1783t3628r2144b3685],
22	with	IN	O	with	_	0	SENT_15	[p1l7t3720r162b3778],
23	higher	JJR	O	higher	amod	24	SENT_15	[p1l207t3720r434b3792],
24	expression	NN	O	expression	prep_with	21	SENT_15	[p1l480t3720r853b3792],
25	of	IN	O	of	_	0	SENT_15	[p1l901t3720r976b3777],
26	thymidylate	NN	O	thymidylate	nn	27	SENT_15	[p1l1013t3720r1433b3792],
27	synthase	NN	O	synthase	prep_of	24	SENT_15	[p1l1483t3720r1782b3792],
28	than	IN	O	than	_	0	SENT_15	[p1l1830t3720r1988b3777],
29	the	DT	O	the	det	32	SENT_15	[p1l2034t3720r2143b3778],
30	two	CD	NUMBER	two	num	32	SENT_15	[p2l8t30r135b75],
31	28-bp	JJ	O	28-bp	amod	32	SENT_15	[p2l198t17r405b89],
32	repeat	NN	O	repeat	prep_than	21	SENT_15	[p2l465t18r732b89],
33	?	.	O	?	_	0	SENT_15	[p2l465t18r732b89],

1	Since	IN	O	since	mark	7	SENT_16	[p2l795t17r984b75],
2	concentration	NN	O	concentration	nsubj	7	SENT_16	[p2l1046t17r1539b75],
3	of	IN	O	of	_	0	SENT_16	[p2l1599t17r1674b75],
4	thymidylate	NN	O	thymidylate	nn	5	SENT_16	[p2l1723t17r2143b89],
5	synthase	NN	O	synthase	prep_of	2	SENT_16	[p2l9t109r309b181],
6	could	MD	O	could	aux	7	SENT_16	[p2l385t109r580b167],
7	affect	VB	O	affect	advcl	25	SENT_16	[p2l654t108r847b167],
8	treatment	NN	O	treatment	nn	9	SENT_16	[p2l918t122r1267b167],
9	efficacy	NN	O	efficacy	dobj	7	SENT_16	[p2l1340t108r1627b181],
10	,	,	O	,	_	0	SENT_16	[p2l1340t108r1627b181],
11	drug-related	JJ	O	drug-related	amod	12	SENT_16	[p2l1704t109r2144b181],
12	toxicity	NN	O	toxicity	dobj	7	SENT_16	[p2l8t202r292b274],
13	,	,	O	,	_	0	SENT_16	[p2l8t202r292b274],
14	or	CC	O	or	_	0	SENT_16	[p2l398t221r471b259],
15	both	DT	O	both	dobj	7	SENT_16	[p2l569t202r753b271],
16	,	,	O	,	_	0	SENT_16	[p2l569t202r753b271],
17	testing	NN	O	testing	nsubj	25	SENT_16	[p2l857t202r1095b274],
18	for	IN	O	for	_	0	SENT_16	[p2l1194t202r1295b259],
19	this	DT	O	this	det	23	SENT_16	[p2l1394t202r1519b260],
20	tandem	JJ	O	tandem	amod	23	SENT_16	[p2l1622t202r2145b274],
21	—	NN	O	—	nn	23	SENT_16	[p2l1622t202r2145b274],
22	repeat	NN	O	repeat	nn	23	SENT_16	[p2l1622t202r2145b274],
23	polymorphism	NN	O	polymorphism	prep_for	17	SENT_16	[p2l7t294r525b366],
24	might	MD	O	might	aux	25	SENT_16	[p2l586t294r793b366],
25	predict	VB	O	predict	_	0	SENT_16	[p2l853t294r1105b366],
26	therapeutic	JJ	O	therapeutic	amod	27	SENT_16	[p2l1166t294r1568b366],
27	response	NN	O	response	dobj	25	SENT_16	[p2l1630t313r1960b366],
28	.	.	O	.	_	0	SENT_16	[p2l1630t313r1960b366],

1	We	PRP	O	we	nsubj	2	SENT_17	[p2l2025t295r2143b352],
2	investigated	VBD	O	investigate	_	0	SENT_17	[p2l8t386r433b457],
3	the	DT	O	the	det	4	SENT_17	[p2l487t386r595b443],
4	association	NN	O	association	dobj	2	SENT_17	[p2l653t386r1043b443],
5	between	IN	O	between	_	0	SENT_17	[p2l1096t386r1392b443],
6	this	DT	O	this	det	10	SENT_17	[p2l1446t386r1571b443],
7	polymorphism	NN	O	polymorphism	nn	10	SENT_17	[p2l1626t386r2144b458],
8	and	CC	O	and	_	0	SENT_17	[p2l10t478r139b536],
9	disease	NN	O	disease	nn	10	SENT_17	[p2l171t478r418b536],
10	outcome	NN	O	outcome	prep_between	4	SENT_17	[p2l452t491r759b536],
11	in	IN	O	in	_	0	SENT_17	[p2l790t478r857b535],
12	children	NNS	O	child	prep_in	2	SENT_17	[p2l889t478r1180b536],
13	treated	VBN	O	treat	partmod	12	SENT_17	[p2l1210t478r1458b536],
14	with	IN	O	with	_	0	SENT_17	[p2l1487t478r1643b536],
15	methotrexate	NN	O	methotrexate	prep_with	13	SENT_17	[p2l1673t478r2143b536],
16	for	IN	O	for	_	0	SENT_17	[p2l8t571r108b629],
17	acute	JJ	O	acute	amod	19	SENT_17	[p2l136t584r322b629],
18	lymphoblastic	JJ	O	lymphoblastic	amod	19	SENT_17	[p2l351t571r848b643],
19	leukaemia	NN	O	leukaemia	prep_for	15	SENT_17	[p2l877t571r1256b629],
20	.	.	O	.	_	0	SENT_17	[p2l877t571r1256b629],

1	205	CD	NUMBER	205	num	3	SENT_18	[p2l95t665r222b720],
2	French-Canadian	JJ	MISC	french-canadian	amod	3	SENT_18	[p2l257t663r889b720],
3	children	NNS	O	child	nsubjpass	12	SENT_18	[p2l921t663r1212b720],
4	with	IN	O	with	_	0	SENT_18	[p2l1240t663r1396b720],
5	acute	JJ	O	acute	amod	7	SENT_18	[p2l1427t676r1613b720],
6	lymphoblastic	JJ	O	lymphoblastic	amod	7	SENT_18	[p2l1645t663r2143b735],
7	leukaemia	NN	O	leukaemia	prep_with	3	SENT_18	[p2l8t756r367b814],
8	(	CD	NUMBER	(	num	10	SENT_18	[p2l450t756r669b827],
9	ALL	NN	O	all	nn	10	SENT_18	[p2l450t756r669b827],
10	)	NN	O	)	dep	7	SENT_18	[p2l450t756r669b827],
11	were	VBD	O	be	auxpass	12	SENT_18	[p2l751t775r916b814],
12	treated	VBN	O	treat	_	0	SENT_18	[p2l994t756r1242b814],
13	at	IN	O	at	_	0	SENT_18	[p2l1320t769r1383b814],
14	the	DT	O	the	det	20	SENT_18	[p2l1458t756r1567b814],
15	Sainte-Justine	NNP	LOCATION	Sainte-Justine	nn	20	SENT_18	[p2l1647t756r2143b826],
16	Hospital	NNP	LOCATION	Hospital	nn	20	SENT_18	[p2l9t848r333b920],
17	,	,	O	,	_	0	SENT_18	[p2l9t848r333b920],
18	Montreal	NNP	LOCATION	Montreal	appos	20	SENT_18	[p2l372t848r726b917],
19	,	,	O	,	_	0	SENT_18	[p2l372t848r726b917],
20	Canada	NNP	LOCATION	Canada	prep_at	12	SENT_18	[p2l767t848r1060b917],
21	,	,	O	,	_	0	SENT_18	[p2l767t848r1060b917],
22	between	IN	O	between	_	0	SENT_18	[p2l1098t848r1394b906],
23	1988	CD	DATE	1988	prep_between	20	SENT_18	[p2l1438t850r1605b906],
24	and	CC	DATE	and	_	0	SENT_18	[p2l1646t848r1774b906],
25	2000	CD	DATE	2000	conj_and	23	SENT_18	[p2l1812t851r2010b917],
26	;	:	O	;	_	0	SENT_18	[p2l1812t851r2010b917],
27	we	PRP	O	we	nsubj	28	SENT_18	[p2l2048t867r2143b906],
28	used	VBD	O	use	parataxis	12	SENT_18	[p2l8t940r171b997],
29	Dana-Farber	NNP	ORGANIZATION	Dana-Farber	nn	31	SENT_18	[p2l200t940r666b997],
30	Cancer	NNP	ORGANIZATION	Cancer	nn	31	SENT_18	[p2l696t940r951b997],
31	Institute	NNP	ORGANIZATION	Institute	dobj	28	SENT_18	[p2l978t940r1278b997],
32	(	CD	NUMBER	(	num	35	SENT_18	[p2l1313t940r1581b1011],
33	DFCI	NNP	ORGANIZATION	DFCI	nn	35	SENT_18	[p2l1313t940r1581b1011],
34	)	CD	NUMBER	)	num	35	SENT_18	[p2l1313t940r1581b1011],
35	protocols	NNS	O	protocol	dep	31	SENT_18	[p2l1614t940r1966b1012],
36	.	.	O	.	_	0	SENT_18	[p2l1614t940r1966b1012],

1	The	DT	O	the	det	3	SENT_19	[p2l1999t940r2143b997],
2	study	NN	O	study	nn	3	SENT_19	[p2l9t1032r201b1104],
3	population	NN	O	population	nsubj	4	SENT_19	[p2l233t1032r622b1104],
4	comprised	VBD	O	comprise	_	0	SENT_19	[p2l658t1032r1027b1104],
5	114	CD	NUMBER	114	num	6	SENT_19	[p2l1071t1034r1193b1089],
6	boys	NNS	O	boy	dobj	4	SENT_19	[p2l1228t1032r1388b1104],
7	and	CC	O	and	_	0	SENT_19	[p2l1427t1032r1556b1090],
8	91	CD	NUMBER	91	num	9	SENT_19	[p2l1593t1034r1669b1090],
9	girls	NNS	O	girl	dobj	4	SENT_19	[p2l1713t1032r1882b1104],
10	,	,	O	,	_	0	SENT_19	[p2l1713t1032r1882b1104],
11	with	IN	O	with	_	0	SENT_19	[p2l1919t1032r2074b1090],
12	a	DT	O	a	det	14	SENT_19	[p2l2110t1051r2144b1089],
13	median	JJ	O	median	amod	14	SENT_19	[p2l8t1124r272b1182],
14	age	NN	O	age	prep_with	4	SENT_19	[p2l331t1143r444b1196],
15	of	IN	O	of	_	0	SENT_19	[p2l505t1124r580b1182],
16	4-7	CD	NUMBER	4-7	num	17	SENT_19	[p2l629t1126r736b1181],
17	years	NNS	NUMBER	year	prep_of	14	SENT_19	[p2l796t1143r975b1196],
18	(	RB	O	(	advmod	19	SENT_19	[p2l1040t1124r1224b1196],
19	IQR	VBP	O	iqr	dep	17	SENT_19	[p2l1040t1124r1224b1196],
20	2-9-84	CD	DATE	2-9-84	num	21	SENT_19	[p2l1279t1124r1601b1195],
21	)	CD	NUMBER	)	dobj	19	SENT_19	[p2l1279t1124r1601b1195],
22	;	:	O	;	_	0	SENT_19	[p2l1279t1124r1601b1195],
23	179	CD	NUMBER	179	num	24	SENT_19	[p2l1670t1126r1791b1182],
24	children	NNS	O	child	nsubj	25	SENT_19	[p2l1854t1124r2144b1182],
25	had	VBD	O	have	conj_and	4	SENT_19	[p2l7t1217r137b1275],
26	B-cell	NN	MISC	b-cell	nn	27	SENT_19	[p2l203t1217r409b1274],
27	leukaemia	NN	O	leukaemia	dobj	25	SENT_19	[p2l474t1217r855b1286],
28	,	,	O	,	_	0	SENT_19	[p2l474t1217r855b1286],
29	22	CD	NUMBER	22	nsubj	30	SENT_19	[p2l925t1219r1008b1274],
30	had	VBD	O	have	ccomp	4	SENT_19	[p2l1074t1217r1205b1275],
31	T-cell	NN	O	t-cell	nn	32	SENT_19	[p2l1269t1217r1482b1274],
32	ALL	NN	O	all	dobj	30	SENT_19	[p2l1545t1218r1735b1286],
33	,	,	O	,	_	0	SENT_19	[p2l1545t1218r1735b1286],
34	and	CC	O	and	_	0	SENT_19	[p2l1805t1217r1934b1275],
35	four	CD	NUMBER	four	nsubj	36	SENT_19	[p2l1998t1216r2146b1274],
36	had	VBD	O	have	conj_and	4	SENT_19	[p2l7t1309r137b1367],
37	ALL	NN	O	all	dobj	36	SENT_19	[p2l177t1310r349b1366],
38	of	IN	O	of	_	0	SENT_19	[p2l388t1309r463b1367],
39	undeﬁned	JJ	O	undeﬁned	amod	40	SENT_19	[p2l495t1309r855b1367],
40	lineage	NN	O	lineage	prep_of	37	SENT_19	[p2l896t1309r1164b1381],
41	.	.	O	.	_	0	SENT_19	[p2l896t1309r1164b1381],

1	At	IN	O	at	_	0	SENT_20	[p2l1208t1310r1294b1367],
2	the	DT	O	the	det	3	SENT_20	[p2l1334t1309r1442b1367],
3	time	NN	O	time	prep_at	17	SENT_20	[p2l1484t1309r1640b1367],
4	of	IN	O	of	_	0	SENT_20	[p2l1684t1309r1759b1367],
5	diagnosis	NN	O	diagnosis	prep_of	3	SENT_20	[p2l1792t1309r2141b1381],
6	,	,	O	,	_	0	SENT_20	[p2l1792t1309r2141b1381],
7	white-blood-cell	JJ	O	white-blood-cell	amod	9	SENT_20	[p2l7t1401r591b1459],
8	(	NN	O	(	nn	9	SENT_20	[p2l632t1401r883b1472],
9	WBC	NN	ORGANIZATION	wbc	nsubj	17	SENT_20	[p2l632t1401r883b1472],
10	)	NN	O	)	nn	11	SENT_20	[p2l632t1401r883b1472],
11	count	NN	O	count	dep	9	SENT_20	[p2l925t1414r1127b1459],
12	was	VBD	O	be	cop	17	SENT_20	[p2l1159t1420r1287b1459],
13	greater	JJR	O	greater	mwe	14	SENT_20	[p2l1323t1414r1571b1473],
14	than	IN	O	than	quantmod	15	SENT_20	[p2l1603t1401r1761b1459],
15	50	CD	NUMBER	50	num	16	SENT_20	[p2l1798t1401r2147b1459],
16	>	JJR	O	>	npadvmod	17	SENT_20	[p2l1798t1401r2147b1459],
17	<	JJR	O	<	_	0	SENT_20	[p2l1798t1401r2147b1459],
18	109/L	CD	NUMBER	109/l	npadvmod	17	SENT_20	[p2l1798t1401r2147b1459],
19	in	IN	O	in	_	0	SENT_20	[p2l8t1493r75b1549],
20	38	CD	NUMBER	38	num	21	SENT_20	[p2l117t1495r199b1550],
21	patients	NNS	O	patient	prep_in	17	SENT_20	[p2l241t1493r544b1565],
22	,	,	O	,	_	0	SENT_20	[p2l241t1493r544b1565],
23	and	CC	O	and	_	0	SENT_20	[p2l589t1493r718b1550],
24	DNA	NN	MISC	dna	nn	25	SENT_20	[p2l759t1493r954b1550],
25	index	NN	O	index	nsubj	29	SENT_20	[p2l993t1493r1188b1550],
26	was	VBD	O	be	cop	29	SENT_20	[p2l1226t1511r1354b1550],
27	greater	JJR	O	greater	mwe	28	SENT_20	[p2l1396t1506r1644b1564],
28	than	IN	O	than	quantmod	29	SENT_20	[p2l1682t1493r1840b1550],
29	1-16	CD	NUMBER	1-16	conj_and	17	SENT_20	[p2l1889t1495r2035b1550],
30	in	IN	O	in	_	0	SENT_20	[p2l2078t1493r2144b1549],
31	26	CD	NUMBER	26	num	32	SENT_20	[p2l10t1587r93b1643],
32	children	NNS	O	child	prep_in	29	SENT_20	[p2l125t1585r435b1643],
33	.	.	O	.	_	0	SENT_20	[p2l125t1585r435b1643],

1	At	IN	O	at	_	0	SENT_21	[p2l91t1679r177b1736],
2	the	DT	O	the	det	3	SENT_21	[p2l206t1678r315b1736],
3	beginning	NN	O	beginning	prep_at	9	SENT_21	[p2l344t1678r700b1750],
4	of	IN	O	of	_	0	SENT_21	[p2l730t1678r805b1736],
5	treatment	NN	O	treatment	prep_of	3	SENT_21	[p2l825t1691r1194b1747],
6	,	,	O	,	_	0	SENT_21	[p2l825t1691r1194b1747],
7	children	NNS	O	child	nsubjpass	9	SENT_21	[p2l1229t1678r1520b1736],
8	were	VBD	O	be	auxpass	9	SENT_21	[p2l1548t1697r1714b1736],
9	assigned	VBN	O	assign	_	0	SENT_21	[p2l1747t1678r2045b1750],
10	to	TO	O	to	_	0	SENT_21	[p2l2075t1691r2142b1736],
11	standard	JJ	O	standard	amod	13	SENT_21	[p2l9t1770r318b1828],
12	(	NN	O	(	nn	13	SENT_21	[p2l373t1770r689b1842],
13	n	NN	O	n	prep_to	9	SENT_21	[p2l373t1770r689b1842],
14	=	JJ	O	=	amod	16	SENT_21	[p2l373t1770r689b1842],
15	115	CD	NUMBER	115	tmod	14	SENT_21	[p2l373t1770r689b1842],
16	)	NN	O	)	dep	13	SENT_21	[p2l373t1770r689b1842],
17	,	,	O	,	_	0	SENT_21	[p2l373t1770r689b1842],
18	high	JJ	O	high	amod	19	SENT_21	[p2l740t1770r895b1842],
19	(	NN	O	(	appos	13	SENT_21	[p2l949t1770r1116b1842],
20	80	CD	NUMBER	80	number	21	SENT_21	[p2l949t1770r1116b1842],
21	)	CD	NUMBER	)	dep	19	SENT_21	[p2l949t1770r1116b1842],
22	,	,	O	,	_	0	SENT_21	[p2l949t1770r1116b1842],
23	and	CC	O	and	_	0	SENT_21	[p2l1171t1770r1300b1828],
24	very	RB	O	very	advmod	25	SENT_21	[p2l1347t1788r1497b1842],
25	high	JJ	O	high	advmod	29	SENT_21	[p2l1543t1770r1698b1842],
26	(	NN	O	(	nn	29	SENT_21	[p2l1752t1770r1847b1842],
27	8	CD	NUMBER	8	num	29	SENT_21	[p2l1752t1770r1847b1842],
28	)	NN	O	)	nn	29	SENT_21	[p2l1752t1770r1847b1842],
29	risk	NN	O	risk	conj_and	21	SENT_21	[p2l1902t1770r2030b1828],
30	of	IN	O	of	_	0	SENT_21	[p2l2078t1769r2153b1828],
31	relapse	NN	O	relapse	prep_of	29	SENT_21	[p2l8t1863r277b1935],
32	,	,	O	,	_	0	SENT_21	[p2l8t1863r277b1935],
33	according	VBG	O	accord	_	0	SENT_21	[p2l314t1863r663b1935],
34	to	TO	O	to	prepc_according_to	9	SENT_21	[p2l693t1876r761b1921],
35	protocol	NN	O	protocol	pobj	9	SENT_21	[p2l794t1863r1112b1935],
36	.	.	O	.	_	0	SENT_21	[p2l794t1863r1112b1935],

1	Methotrexate	NNP	O	Methotrexate	nsubjpass	3	SENT_22	[p2l1150t1863r1632b1921],
2	was	VBD	O	be	auxpass	3	SENT_22	[p2l1664t1882r1793b1921],
3	given	VBN	O	give	_	0	SENT_22	[p2l1827t1863r2014b1935],
4	for	IN	O	for	_	0	SENT_22	[p2l2045t1863r2146b1920],
5	remission	NN	O	remission	nn	6	SENT_22	[p2l8t1955r350b2013],
6	induction	NN	O	induction	prep_for	3	SENT_22	[p2l425t1955r789b2024],
7	,	,	O	,	_	0	SENT_22	[p2l425t1955r789b2024],
8	central-nervous-system	NN	O	central-nervous-system	nn	9	SENT_22	[p2l868t1955r1697b2027],
9	treatment	NN	O	treatment	prep_for	3	SENT_22	[p2l1772t1968r2141b2024],
10	,	,	O	,	_	0	SENT_22	[p2l1772t1968r2141b2024],
11	and	CC	O	and	_	0	SENT_22	[p2l16t2047r145b2105],
12	maintenance	NN	O	maintenance	nn	13	SENT_22	[p2l186t2047r640b2105],
13	therapy	NN	O	therapy	conj_and	6	SENT_22	[p2l683t2047r968b2119],
14	.	.	O	.	_	0	SENT_22	[p2l683t2047r968b2119],

1	We	PRP	O	we	nsubj	2	SENT_23	[p2l1013t2048r1131b2105],
2	enrolled	VBD	O	enrol	_	0	SENT_23	[p2l1175t2047r1463b2105],
3	patients	NNS	O	patient	dobj	2	SENT_23	[p2l1504t2047r1783b2119],
4	receiving	VBG	O	receive	dep	2	SENT_23	[p2l1826t2047r2145b2119],
5	high-dose	JJ	O	high-dose	amod	10	SENT_23	[p2l13t2139r360b2210],
6	methotrexate	NN	O	methotrexate	nn	10	SENT_23	[p2l387t2139r856b2196],
7	(	NN	O	(	nn	10	SENT_23	[p2l888t2139r955b2210],
8	4	CD	NUMBER	4	num	10	SENT_23	[p2l888t2139r955b2210],
9	g/m2	NN	O	g/m2	nn	10	SENT_23	[p2l982t2138r1163b2210],
10	)	NN	O	)	dobj	4	SENT_23	[p2l982t2138r1163b2210],
11	for	IN	O	for	_	0	SENT_23	[p2l1194t2138r1295b2196],
12	induction	NN	O	induction	prep_for	10	SENT_23	[p2l1318t2139r1661b2196],
13	of	IN	O	of	_	0	SENT_23	[p2l1688t2138r1763b2196],
14	remission	NN	O	remission	prep_of	12	SENT_23	[p2l1778t2139r2141b2208],
15	,	,	O	,	_	0	SENT_23	[p2l1778t2139r2141b2208],
16	comprising	VBG	O	comprise	dep	4	SENT_23	[p2l16t2231r411b2303],
17	all	DT	O	all	det	18	SENT_23	[p2l439t2231r518b2288],
18	patients	NNS	O	patient	nsubj	19	SENT_23	[p2l546t2231r825b2303],
19	treated	VBN	O	treat	dep	16	SENT_23	[p2l854t2231r1102b2289],
20	with	IN	O	with	_	0	SENT_23	[p2l1129t2231r1283b2289],
21	DFCI	NN	ORGANIZATION	dfcus	nn	24	SENT_23	[p2l1312t2231r1525b2289],
22	91-01	CD	NUMBER	91-01	num	24	SENT_23	[p2l1556t2233r1754b2289],
23	(	NN	O	(	nn	24	SENT_23	[p2l1796t2231r2038b2302],
24	n	NN	O	n	prep_with	19	SENT_23	[p2l1796t2231r2038b2302],
25	=	JJ	O	=	amod	27	SENT_23	[p2l1796t2231r2038b2302],
26	70	CD	NUMBER	70	tmod	25	SENT_23	[p2l1796t2231r2038b2302],
27	)	NN	O	)	dobj	19	SENT_23	[p2l1796t2231r2038b2302],
28	or	CC	O	or	_	0	SENT_23	[p2l2074t2250r2146b2288],
29	DFCI	NN	O	dfcus	dobj	19	SENT_23	[p2l15t2323r228b2381],
30	95-01	CD	NUMBER	95-01	num	31	SENT_23	[p2l257t2325r455b2381],
31	(	NN	O	(	tmod	2	SENT_23	[p2l496t2323r708b2394],
32	117	CD	NUMBER	117	num	33	SENT_23	[p2l496t2323r708b2394],
33	)	NN	O	)	dep	31	SENT_23	[p2l496t2323r708b2394],
34	,	,	O	,	_	0	SENT_23	[p2l496t2323r708b2394],
35	and	CC	O	and	_	0	SENT_23	[p2l739t2323r867b2381],
36	those	DT	O	those	det	40	SENT_23	[p2l894t2323r1079b2381],
37	randomly	RB	O	randomly	advmod	40	SENT_23	[p2l1106t2323r1448b2395],
38	assigned	VBN	O	assign	amod	40	SENT_23	[p2l1474t2323r1771b2395],
39	high-dose	JJ	O	high-dose	amod	40	SENT_23	[p2l1796t2323r2143b2395],
40	methotrexate	NN	O	methotrexate	tmod	2	SENT_23	[p2l14t2415r483b2472],
41	in	IN	O	in	_	0	SENT_23	[p2l512t2415r578b2471],
42	DFCI	NNP	ORGANIZATION	DFCI	nn	44	SENT_23	[p2l605t2415r819b2472],
43	87-01	CD	NUMBER	87-01	num	44	SENT_23	[p2l850t2417r1046b2472],
44	protocol	NN	O	protocol	prep_in	40	SENT_23	[p2l1082t2415r1379b2487],
45	(	CD	NUMBER	(	num	47	SENT_23	[p2l1413t2415r1578b2486],
46	18	CD	NUMBER	18	num	47	SENT_23	[p2l1413t2415r1578b2486],
47	)	NN	O	)	dep	31	SENT_23	[p2l1413t2415r1578b2486],
48	.	.	O	.	_	0	SENT_23	[p2l1413t2415r1578b2486],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_24	[p2l100t2507r383b2565],
2	were	VBD	O	be	auxpass	3	SENT_24	[p2l427t2526r592b2565],
3	deﬁned	VBN	O	deﬁned	_	0	SENT_24	[p2l638t2507r901b2565],
4	as	IN	O	as	_	0	SENT_24	[p2l947t2526r1012b2565],
5	having	VBG	O	have	prepc_as	3	SENT_24	[p2l1056t2507r1292b2579],
6	an	DT	O	a	det	7	SENT_24	[p2l1336t2526r1417b2564],
7	event	NN	O	event	dobj	5	SENT_24	[p2l1462t2520r1650b2565],
8	if	IN	O	if	mark	15	SENT_24	[p2l1693t2507r1747b2563],
9	relapse	NN	O	relapse	nsubj	15	SENT_24	[p2l1782t2507r2027b2579],
10	or	CC	O	or	_	0	SENT_24	[p2l2074t2526r2146b2564],
11	death	NN	O	death	conj_or	9	SENT_24	[p2l16t2599r211b2657],
12	due	JJ	O	due	_	0	SENT_24	[p2l250t2599r377b2657],
13	to	TO	O	to	_	0	SENT_24	[p2l415t2612r483b2657],
14	disease	NN	O	disease	prep_due_to	9	SENT_24	[p2l524t2599r771b2657],
15	happened	VBD	O	happen	dep	7	SENT_24	[p2l809t2599r1156b2671],
16	during	IN	O	during	_	0	SENT_24	[p2l1196t2599r1429b2671],
17	or	CC	O	or	_	0	SENT_24	[p2l1467t2618r1539b2657],
18	after	IN	O	after	_	0	SENT_24	[p2l1577t2599r1737b2657],
19	treatment	NN	O	treatment	prep_after	15	SENT_24	[p2l1773t2612r2139b2657],
20	.	.	O	.	_	0	SENT_24	[p2l1773t2612r2139b2657],

1	For	IN	O	for	_	0	SENT_25	[p2l15t2692r142b2748],
2	analysis	NN	O	analysis	prep_for	12	SENT_25	[p2l179t2691r450b2762],
3	of	IN	O	of	_	0	SENT_25	[p2l491t2690r566b2748],
4	event	NN	O	event	npadvmod	6	SENT_25	[p2l595t2690r946b2748],
5	—	CD	NUMBER	—	num	4	SENT_25	[p2l595t2690r946b2748],
6	free	JJ	O	free	amod	7	SENT_25	[p2l595t2690r946b2748],
7	survival	NN	O	survival	prep_of	2	SENT_25	[p2l986t2691r1278b2760],
8	,	,	O	,	_	0	SENT_25	[p2l986t2691r1278b2760],
9	survival	NN	O	survival	nn	10	SENT_25	[p2l1320t2691r1590b2748],
10	time	NN	O	time	nsubj	12	SENT_25	[p2l1627t2691r1783b2748],
11	was	VBD	O	be	cop	12	SENT_25	[p2l1820t2709r1949b2748],
12	time	NN	O	time	_	0	SENT_25	[p2l1987t2691r2143b2748],
13	between	IN	O	between	_	0	SENT_25	[p2l13t2783r308b2841],
14	diagnosis	NN	O	diagnosis	prep_between	12	SENT_25	[p2l340t2783r665b2855],
15	and	CC	O	and	_	0	SENT_25	[p2l698t2783r827b2841],
16	event	NN	O	event	prep_between	12	SENT_25	[p2l859t2796r1067b2852],
17	,	,	O	,	_	0	SENT_25	[p2l859t2796r1067b2852],
18	for	IN	O	for	mark	24	SENT_25	[p2l1101t2783r1201b2841],
19	patients	NNS	O	patient	nsubj	24	SENT_25	[p2l1229t2783r1507b2855],
20	without	IN	O	without	_	0	SENT_25	[p2l1538t2783r1812b2841],
21	an	DT	O	a	det	23	SENT_25	[p2l1844t2802r1925b2841],
22	event	NN	O	event	nn	23	SENT_25	[p2l1957t2796r2145b2841],
23	(	NN	O	(	prep_without	19	SENT_25	[p2l20t2875r362b2946],
24	censored	VBD	O	censor	advcl	12	SENT_25	[p2l20t2875r362b2946],
25	cases	NNS	O	case	dobj	24	SENT_25	[p2l422t2875r653b2946],
26	)	RB	O	)	advmod	24	SENT_25	[p2l422t2875r653b2946],
27	,	,	O	,	_	0	SENT_25	[p2l422t2875r653b2946],
28	it	PRP	O	it	nsubj	29	SENT_25	[p2l715t2875r762b2933],
29	corresponded	VBD	O	correspond	dep	24	SENT_25	[p2l821t2875r1305b2947],
30	to	TO	O	to	aux	31	SENT_25	[p2l1363t2888r1430b2933],
31	end	VB	O	end	xcomp	29	SENT_25	[p2l1492t2875r1620b2933],
32	of	IN	O	of	_	0	SENT_25	[p2l1679t2875r1754b2933],
33	follow-up	JJ	O	follow-up	amod	34	SENT_25	[p2l1803t2875r2142b2947],
34	(	NN	O	(	prep_of	31	SENT_25	[p2l20t2967r84b3038],
35	5	CD	DURATION	5	num	36	SENT_25	[p2l20t2967r84b3038],
36	years	NNS	NUMBER	year	tmod	34	SENT_25	[p2l133t2985r311b3038],
37	after	IN	O	after	_	0	SENT_25	[p2l361t2966r521b3024],
38	treatment	NN	O	treatment	prep_after	34	SENT_25	[p2l565t2967r938b3038],
39	)	CD	NUMBER	)	num	38	SENT_25	[p2l565t2967r938b3038],
40	or	CC	O	or	_	0	SENT_25	[p2l992t2985r1064b3024],
41	March	NNP	DATE	March	prep_after	34	SENT_25	[p2l1109t2967r1365b3036],
42	,	,	DATE	,	_	0	SENT_25	[p2l1109t2967r1365b3036],
43	2001	CD	DATE	2001	num	45	SENT_25	[p2l1416t2969r1584b3024],
44	(	CD	NUMBER	(	num	45	SENT_25	[p2l1645t2967r1949b3039],
45	patients	NNS	O	patient	appos	34	SENT_25	[p2l1645t2967r1949b3039],
46	who	WP	O	who	nsubj	49	SENT_25	[p2l1996t2967r2142b3024],
47	were	VBD	O	be	aux	49	SENT_25	[p2l13t3078r178b3117],
48	still	RB	O	still	advmod	49	SENT_25	[p2l240t3059r363b3117],
49	receiving	VBG	O	receive	rcmod	45	SENT_25	[p2l423t3059r742b3131],
50	treatment	NN	O	treatment	dobj	49	SENT_25	[p2l800t3072r1147b3117],
51	or	CC	O	or	_	0	SENT_25	[p2l1207t3078r1279b3116],
52	who	WP	O	who	nsubj	53	SENT_25	[p2l1335t3059r1482b3117],
53	were	VBD	O	be	conj_or	29	SENT_25	[p2l1541t3078r1706b3117],
54	still	RB	O	still	advmod	53	SENT_25	[p2l1768t3059r1891b3117],
55	being	VBG	O	be	cop	57	SENT_25	[p2l1950t3059r2145b3131],
56	followed-up	JJ	O	followed-up	amod	57	SENT_25	[p2l15t3151r493b3223],
57	)	NN	O	)	xcomp	53	SENT_25	[p2l15t3151r493b3223],
58	.	.	O	.	_	0	SENT_25	[p2l15t3151r493b3223],

1	DNA	NN	O	dna	nn	2	SENT_26	[p2l591t3152r786b3209],
2	samples	NNS	O	sample	nsubjpass	18	SENT_26	[p2l878t3151r1155b3223],
3	obtained	VBN	O	obtain	partmod	2	SENT_26	[p2l1251t3151r1560b3209],
4	from	IN	O	from	_	0	SENT_26	[p2l1653t3151r1822b3209],
5	buccal	JJ	O	buccal	amod	7	SENT_26	[p2l1913t3151r2143b3209],
6	epithelial	JJ	O	epithelial	amod	7	SENT_26	[p2l16t3243r339b3315],
7	cells	NNS	O	cell	prep_from	3	SENT_26	[p2l406t3243r578b3312],
8	,	,	O	,	_	0	SENT_26	[p2l406t3243r578b3312],
9	peripheral	JJ	O	peripheral	amod	10	SENT_26	[p2l645t3243r1006b3315],
10	blood	NN	O	blood	prep_from	3	SENT_26	[p2l1071t3243r1295b3312],
11	,	,	O	,	_	0	SENT_26	[p2l1071t3243r1295b3312],
12	or	CC	O	or	_	0	SENT_26	[p2l1365t3261r1437b3300],
13	bone	NN	O	bone	nn	14	SENT_26	[p2l1499t3243r1673b3300],
14	marrow	NN	O	marrow	conj_or	7	SENT_26	[p2l1739t3261r2014b3300],
15	in	IN	O	in	_	0	SENT_26	[p2l2078t3243r2144b3299],
16	remission	NN	O	remission	prep_in	3	SENT_26	[p2l14t3335r355b3393],
17	were	VBD	O	be	auxpass	18	SENT_26	[p2l379t3354r544b3393],
18	analysed	VBN	O	analyse	_	0	SENT_26	[p2l572t3335r875b3407],
19	for	IN	O	for	_	0	SENT_26	[p2l900t3335r1000b3392],
20	the	DT	O	the	det	22	SENT_26	[p2l1023t3335r1132b3393],
21	repeat	NN	O	repeat	nn	22	SENT_26	[p2l1158t3348r1378b3407],
22	polymorphism	NN	O	polymorphism	prep_for	18	SENT_26	[p2l1401t3335r1918b3407],
23	in	IN	O	in	_	0	SENT_26	[p2l1944t3335r2010b3391],
24	the	DT	O	the	det	27	SENT_26	[p2l2035t3335r2143b3393],
25	thymidylate	NN	O	thymidylate	nn	27	SENT_26	[p2l14t3427r433b3499],
26	synthase	NN	O	synthase	nn	27	SENT_26	[p2l473t3427r772b3499],
27	gene	NN	O	gene	prep_in	22	SENT_26	[p2l810t3446r972b3499],
28	by	IN	O	by	_	0	SENT_26	[p2l1009t3427r1094b3499],
29	PCR	NN	O	pcr	nn	30	SENT_26	[p2l1130t3427r1304b3485],
30	ampliﬁcation	NN	O	ampliﬁcation	agent	18	SENT_26	[p2l1340t3427r1828b3499],
31	,	,	O	,	_	0	SENT_26	[p2l1340t3427r1828b3499],
32	then	RB	O	then	advmod	18	SENT_26	[p2l1868t3427r2025b3485],
33	by	IN	O	by	_	0	SENT_26	[p2l2061t3427r2146b3499],
34	agarose	NN	O	agarose	nn	36	SENT_26	[p2l16t3537r278b3590],
35	gel	NN	O	gel	nn	36	SENT_26	[p2l315t3519r413b3590],
36	electrophoresis	NN	O	electrophoresis	agent	18	SENT_26	[p2l450t3519r1032b3591],
37	.	.	O	.	_	0	SENT_26	[p2l450t3519r1032b3591],

1	‘‘	RB	O	‘‘	advmod	2	SENT_27	[p2l450t3519r1032b3591],
2	Written	VBN	O	write	csubjpass	9	SENT_27	[p2l1065t3519r1341b3576],
3	informed	VBN	O	inform	amod	4	SENT_27	[p2l1376t3518r1701b3576],
4	consent	NN	O	consent	dobj	2	SENT_27	[p2l1738t3532r2011b3576],
5	for	IN	O	for	_	0	SENT_27	[p2l2046t3518r2145b3576],
6	study	NN	O	study	nn	7	SENT_27	[p2l16t3611r207b3683],
7	participation	NN	O	participation	prep_for	4	SENT_27	[p2l238t3611r693b3683],
8	was	VBD	O	be	auxpass	9	SENT_27	[p2l725t3630r853b3669],
9	obtained	VBN	O	obtain	_	0	SENT_27	[p2l890t3611r1199b3669],
10	from	IN	O	from	_	0	SENT_27	[p2l1233t3611r1402b3668],
11	all	DT	O	all	det	12	SENT_27	[p2l1437t3611r1517b3668],
12	children	NNS	O	child	prep_from	9	SENT_27	[p2l1552t3611r1842b3669],
13	or	CC	O	or	_	0	SENT_27	[p2l1877t3630r1949b3669],
14	their	PRP$	O	they	poss	15	SENT_27	[p2l1981t3611r2146b3669],
15	parents	NNS	O	parent	conj_or	12	SENT_27	[p2l14t3716r296b3775],
16	,	,	O	,	_	0	SENT_27	[p2l14t3716r296b3775],
17	and	CC	O	and	_	0	SENT_27	[p2l351t3703r479b3761],
18	we	PRP	O	we	nsubj	19	SENT_27	[p2l528t3722r623b3761],
19	obtained	VBD	O	obtain	conj_and	9	SENT_27	[p2l676t3703r985b3761],
20	ethics	NNS	O	ethic	nn	21	SENT_27	[p2l1037t3703r1237b3761],
21	approval	NN	O	approval	dobj	19	SENT_27	[p2l1291t3703r1595b3775],
22	for	IN	O	for	_	0	SENT_27	[p2l1645t3703r1746b3761],
23	the	DT	O	the	det	25	SENT_27	[p2l1794t3703r1902b3761],
24	study	NN	O	study	nn	25	SENT_27	[p2l1954t3703r2146b3775],
25	protocol	NN	O	protocol	prep_for	21	SENT_27	[p3l14t17r331b89],
26	.	.	O	.	_	0	SENT_27	[p3l14t17r331b89],

1	Overall	JJ	O	overall	amod	3	SENT_28	[p3l102t109r356b167],
2	survival	NN	O	survival	nn	3	SENT_28	[p3l419t109r689b167],
3	time	NN	O	time	nsubj	4	SENT_28	[p3l749t109r905b167],
4	ranged	VBD	O	range	_	0	SENT_28	[p3l967t109r1209b181],
5	from	IN	O	from	_	0	SENT_28	[p3l1269t109r1438b166],
6	1	CD	DURATION	1	number	8	SENT_28	[p3l1507t111r1531b165],
7	to	TO	DURATION	to	dep	8	SENT_28	[p3l1601t122r1668b167],
8	84	CD	DURATION	84	num	9	SENT_28	[p3l1733t111r1816b167],
9	months	NNS	NUMBER	month	tmod	10	SENT_28	[p3l1878t109r2142b167],
10	(	RB	O	(	amod	13	SENT_28	[p3l20t201r310b272],
11	median	JJ	O	median	amod	13	SENT_28	[p3l20t201r310b272],
12	46	CD	DURATION	46	num	13	SENT_28	[p3l407t203r491b259],
13	months	NNS	NUMBER	month	prep_from	4	SENT_28	[p3l590t201r877b270],
14	,	,	O	,	_	0	SENT_28	[p3l590t201r877b270],
15	IQR	NN	O	iqr	nn	17	SENT_28	[p3l977t201r1133b273],
16	19-84	CD	DATE	19-84	num	17	SENT_28	[p3l1236t202r1498b272],
17	)	NN	O	)	appos	13	SENT_28	[p3l1236t202r1498b272],
18	.	.	O	.	_	0	SENT_28	[p3l1236t202r1498b272],

1	Genotypes	NNS	O	genotype	nsubj	5	SENT_29	[p3l1601t201r1978b273],
2	of	IN	O	of	_	0	SENT_29	[p3l2079t201r2153b259],
3	thymidylate	NN	O	thymidylate	nn	4	SENT_29	[p3l14t293r433b364],
4	synthase	NN	O	synthase	prep_of	1	SENT_29	[p3l538t293r837b364],
5	differed	VBD	O	differ	conj_and	5	SENT_29	[p3l943t292r1216b350],
6	signiﬁcantly	RB	O	signiﬁcantly	advmod	5	SENT_29	[p3l1320t292r1748b364],
7	between	IN	O	between	_	0	SENT_29	[p3l1849t293r2144b350],
8	children	NNS	O	child	prep_between	5	SENT_29	[p3l16t386r306b444],
9	with	IN	O	with	_	0	SENT_29	[p3l331t386r485b444],
10	and	CC	O	and	_	0	SENT_29	[p3l512t386r641b444],
11	without	IN	O	without	_	0	SENT_29	[p3l665t386r940b444],
12	an	DT	O	a	det	16	SENT_29	[p3l967t405r1049b444],
13	event	NN	O	event	nn	16	SENT_29	[p3l1076t399r1263b444],
14	(	NN	O	(	nn	16	SENT_29	[p3l1294t386r1543b457],
15	table	NN	O	table	nn	16	SENT_29	[p3l1294t386r1543b457],
16	)	NN	O	)	prep_with	5	SENT_29	[p3l1294t386r1543b457],
17	.	.	O	.	_	0	SENT_29	[p3l1294t386r1543b457],

1	Individuals	NNS	O	individual	nsubjpass	13	SENT_30	[p3l1575t386r1969b444],
2	who	WP	O	who	nsubj	4	SENT_30	[p3l1996t386r2142b444],
3	were	VBD	O	be	cop	4	SENT_30	[p3l13t497r178b536],
4	homozygous	JJ	O	homozygous	rcmod	1	SENT_30	[p3l212t478r656b550],
5	for	IN	O	for	_	0	SENT_30	[p3l691t478r791b536],
6	the	DT	O	the	det	8	SENT_30	[p3l823t478r931b536],
7	triple	JJ	O	triple	amod	8	SENT_30	[p3l966t478r1151b550],
8	repeat	NN	O	repeat	prep_for	4	SENT_30	[p3l1186t491r1405b550],
9	(	CD	NUMBER	(	num	11	SENT_30	[p3l1444t478r1725b549],
10	3R/3R	NN	O	3r/3r	nn	11	SENT_30	[p3l1444t478r1725b549],
11	)	NN	O	)	dep	8	SENT_30	[p3l1444t478r1725b549],
12	were	VBD	O	be	auxpass	13	SENT_30	[p3l1763t497r1929b536],
13	overrepresented	VBN	O	overrepresent	_	0	SENT_30	[p3l1965t497r2143b536, p3l14t570r430b642],
14	in	IN	O	in	_	0	SENT_30	[p3l460t570r526b626],
15	the	DT	O	the	det	16	SENT_30	[p3l556t570r665b627],
16	group	NN	O	group	prep_in	13	SENT_30	[p3l696t588r901b642],
17	with	IN	O	with	_	0	SENT_30	[p3l932t570r1087b627],
18	an	DT	O	a	det	19	SENT_30	[p3l1118t588r1200b627],
19	event	NN	O	event	prep_with	16	SENT_30	[p3l1232t583r1438b627],
20	.	.	O	.	_	0	SENT_30	[p3l1232t583r1438b627],

1	As	IN	O	as	_	0	SENT_31	[p3l1472t570r1560b627],
2	a	DT	O	a	det	3	SENT_31	[p3l1594t588r1627b627],
3	result	NN	O	result	prep_as	11	SENT_31	[p3l1658t570r1877b639],
4	,	,	O	,	_	0	SENT_31	[p3l1658t570r1877b639],
5	people	NNS	O	people	appos	3	SENT_31	[p3l1909t570r2143b641],
6	who	WP	O	who	nsubjpass	8	SENT_31	[p3l13t662r160b720],
7	were	VBD	O	be	auxpass	8	SENT_31	[p3l187t681r352b720],
8	genotyped	VBN	O	genotype	rcmod	5	SENT_31	[p3l381t662r749b734],
9	as	IN	O	as	_	0	SENT_31	[p3l778t681r843b720],
10	3R/3R	NN	O	3r/3r	prep_as	8	SENT_31	[p3l874t662r1105b720],
11	had	VBD	O	have	_	0	SENT_31	[p3l1127t662r1258b720],
12	a	DT	O	a	det	14	SENT_31	[p3l1287t681r1320b719],
13	higher	JJR	O	higher	amod	14	SENT_31	[p3l1347t662r1573b734],
14	risk	NN	O	risk	dobj	11	SENT_31	[p3l1598t662r1726b719],
15	of	IN	O	of	_	0	SENT_31	[p3l1752t662r1827b719],
16	an	DT	O	a	det	17	SENT_31	[p3l1847t681r1929b719],
17	event	NN	O	event	prep_of	14	SENT_31	[p3l1957t675r2145b720],
18	than	IN	O	than	mark	19	SENT_31	[p3l14t754r172b812],
19	did	VBD	O	do	advcl	11	SENT_31	[p3l210t754r322b812],
20	those	DT	O	those	nsubj	26	SENT_31	[p3l359t754r545b812],
21	with	IN	O	with	_	0	SENT_31	[p3l582t754r736b812],
22	other	JJ	O	other	amod	25	SENT_31	[p3l775t754r960b812],
23	thymidylate	NN	O	thymidylate	nn	25	SENT_31	[p3l995t754r1414b826],
24	synthase	NN	O	synthase	nn	25	SENT_31	[p3l1453t754r1752b826],
25	genotypes	NNS	O	genotype	prep_with	20	SENT_31	[p3l1791t767r2143b826],
26	(	VBP	O	(	ccomp	19	SENT_31	[p3l20t846r213b917],
27	odds	NNS	O	odds	dobj	26	SENT_31	[p3l20t846r213b917],
28	ratio	NN	O	ratio	nsubj	11	SENT_31	[p3l245t846r405b903],
29	4-1	CD	NUMBER	4-1	num	28	SENT_31	[p3l438t848r570b914],
30	,	,	O	,	_	0	SENT_31	[p3l438t848r570b914],
31	95	CD	PERCENT	95	num	34	SENT_31	[p3l605t846r760b905],
32	%	NN	PERCENT	%	nn	34	SENT_31	[p3l605t846r760b905],
33	CI	NN	O	ci	nn	34	SENT_31	[p3l797t846r885b903],
34	1-9-9-O	NN	O	1-9-9-o	appos	28	SENT_31	[p3l924t848r1205b915],
35	,	,	O	,	_	0	SENT_31	[p3l924t848r1205b915],
36	p	NN	O	p	appos	34	SENT_31	[p3l1237t846r1593b918],
37	=	JJ	O	=	amod	39	SENT_31	[p3l1237t846r1593b918],
38	0-001	CD	NUMBER	0-001	tmod	37	SENT_31	[p3l1237t846r1593b918],
39	)	NN	O	)	dep	36	SENT_31	[p3l1237t846r1593b918],
40	.	.	O	.	_	0	SENT_31	[p3l1237t846r1593b918],

1	Risk	NN	O	risk	nsubj	3	SENT_32	[p3l1629t846r1783b903],
2	remained	VBD	O	remain	cop	3	SENT_32	[p3l1811t846r2144b903],
3	unchanged	JJ	O	unchanged	_	0	SENT_32	[p3l14t938r404b1010],
4	after	IN	O	after	mark	11	SENT_32	[p3l460t938r621b995],
5	inclusion	NN	O	inclusion	nsubj	11	SENT_32	[p3l674t938r996b996],
6	of	IN	O	of	_	0	SENT_32	[p3l1052t938r1126b995],
7	known	JJ	O	known	amod	10	SENT_32	[p3l1172t938r1410b996],
8	clinical	JJ	O	clinical	amod	10	SENT_32	[p3l1465t938r1715b995],
9	prognostic	JJ	O	prognostic	amod	10	SENT_32	[p3l1769t938r2143b1010],
10	factors	NNS	O	factor	prep_of	5	SENT_32	[p3l15t1030r250b1088],
11	(	VBP	O	(	advcl	3	SENT_32	[p3l315t1030r472b1101],
12	sex	NN	O	sex	dobj	11	SENT_32	[p3l315t1030r472b1101],
13	,	,	O	,	_	0	SENT_32	[p3l315t1030r472b1101],
14	age	NN	O	age	conj_and	12	SENT_32	[p3l534t1049r669b1102],
15	,	,	O	,	_	0	SENT_32	[p3l534t1049r669b1102],
16	WBC	NN	ORGANIZATION	wbc	nn	17	SENT_32	[p3l728t1030r924b1088],
17	count	NN	O	count	conj_and	12	SENT_32	[p3l986t1043r1208b1099],
18	,	,	O	,	_	0	SENT_32	[p3l986t1043r1208b1099],
19	cell	NN	O	cell	nn	20	SENT_32	[p3l1270t1030r1387b1088],
20	type	NN	O	type	conj_and	12	SENT_32	[p3l1444t1043r1615b1102],
21	,	,	O	,	_	0	SENT_32	[p3l1444t1043r1615b1102],
22	DNA	NN	MISC	dna	nn	23	SENT_32	[p3l1676t1031r1870b1088],
23	index	NN	O	index	conj_and	12	SENT_32	[p3l1926t1030r2141b1099],
24	,	,	O	,	_	0	SENT_32	[p3l1926t1030r2141b1099],
25	treatment	NN	O	treatment	nn	26	SENT_32	[p3l14t1135r361b1179],
26	protocol	NN	O	protocol	conj_and	12	SENT_32	[p3l406t1122r726b1194],
27	,	,	O	,	_	0	SENT_32	[p3l406t1122r726b1194],
28	and	CC	O	and	_	0	SENT_32	[p3l776t1122r905b1179],
29	risk	NN	O	risk	nn	30	SENT_32	[p3l951t1122r1079b1179],
30	class	NN	O	class	conj_and	12	SENT_32	[p3l1125t1122r1284b1179],
31	[	CD	NUMBER	[	dep	30	SENT_32	[p3l1342t1122r1448b1193],
32	by	IN	O	by	_	0	SENT_32	[p3l1342t1122r1448b1193],
33	the	DT	O	the	det	34	SENT_32	[p3l1492t1122r1600b1179],
34	categorisation	NN	O	categorisation	prep_by	11	SENT_32	[p3l1650t1122r2144b1193],
35	given	VBN	O	give	prep	34	SENT_32	[p3l15t1214r201b1286],
36	within	IN	O	within	pcomp	35	SENT_32	[p3l231t1214r455b1272],
37	patients	NNS	O	patient	dep	46	SENT_32	[p3l485t1214r787b1286],
38	’	CD	NUMBER	’	num	41	SENT_32	[p3l485t1214r787b1286],
39	description	NN	O	description	nn	41	SENT_32	[p3l824t1214r1276b1286],
40	]	NN	O	]	nn	41	SENT_32	[p3l824t1214r1276b1286],
41	)	NN	O	)	dep	37	SENT_32	[p3l824t1214r1276b1286],
42	in	IN	O	in	_	0	SENT_32	[p3l1314t1214r1380b1271],
43	multivariate	JJ	O	multivariate	amod	44	SENT_32	[p3l1411t1214r1837b1272],
44	analysis	NN	O	analysis	prep_in	41	SENT_32	[p3l1872t1214r2142b1286],
45	(	CD	NUMBER	(	dep	46	SENT_32	[p3l20t1306r180b1377],
46	4-6	CD	NUMBER	4-6	dep	53	SENT_32	[p3l20t1306r180b1377],
47	,	,	O	,	_	0	SENT_32	[p3l20t1306r180b1377],
48	1-6-12-8	CD	DATE	1-6-12-8	appos	46	SENT_32	[p3l225t1308r551b1375],
49	,	,	O	,	_	0	SENT_32	[p3l225t1308r551b1375],
50	p	NN	O	p	appos	46	SENT_32	[p3l587t1306r943b1378],
51	=	JJ	O	=	amod	53	SENT_32	[p3l587t1306r943b1378],
52	O-O04	NN	O	o-o04	nn	53	SENT_32	[p3l587t1306r943b1378],
53	)	NN	O	)	dep	36	SENT_32	[p3l587t1306r943b1378],
54	.	.	O	.	_	0	SENT_32	[p3l587t1306r943b1378],

1	Closely	RB	O	closely	advmod	2	SENT_33	[p3l985t1306r1245b1378],
2	similar	JJ	O	similar	amod	3	SENT_33	[p3l1278t1306r1518b1364],
3	odds	NNS	O	odds	nn	4	SENT_33	[p3l1551t1306r1716b1364],
4	ratios	NNS	O	ratio	nsubjpass	6	SENT_33	[p3l1750t1306r1944b1364],
5	were	VBD	O	be	auxpass	6	SENT_33	[p3l1978t1325r2143b1364],
6	obtained	VBN	O	obtain	_	0	SENT_33	[p3l16t1398r325b1455],
7	if	IN	O	if	mark	13	SENT_33	[p3l375t1397r429b1454],
8	the	DT	O	the	det	12	SENT_33	[p3l470t1398r578b1455],
9	non	JJ	O	non	amod	12	SENT_33	[p3l628t1411r988b1455],
10	—	CD	NUMBER	—	tmod	9	SENT_33	[p3l628t1411r988b1455],
11	eVent	NN	O	event	nn	12	SENT_33	[p3l628t1411r988b1455],
12	group	NN	O	group	nsubj	13	SENT_33	[p3l1037t1416r1242b1470],
13	included	VBD	O	include	dep	51	SENT_33	[p3l1294t1398r1602b1455],
14	only	RB	O	only	advmod	15	SENT_33	[p3l1654t1398r1804b1469],
15	children	NNS	O	child	nsubjpass	24	SENT_33	[p3l1854t1398r2144b1455],
16	whose	WP$	O	whose	dep	20	SENT_33	[p3l13t1490r232b1548],
17	5-year	JJ	DURATION	5-year	amod	19	SENT_33	[p3l265t1492r485b1562],
18	post	NN	O	post	nn	19	SENT_33	[p3l510t1503r660b1562],
19	treatment	NN	O	treatment	nsubj	20	SENT_33	[p3l688t1503r1035b1547],
20	follow	VBP	O	follow	dep	15	SENT_33	[p3l1063t1490r1402b1562],
21	—	CD	NUMBER	—	dobj	20	SENT_33	[p3l1063t1490r1402b1562],
22	up	RP	O	up	prt	20	SENT_33	[p3l1063t1490r1402b1562],
23	was	VBD	O	be	auxpass	24	SENT_33	[p3l1431t1509r1559b1548],
24	ﬁnished	VBN	O	ﬁnished	ccomp	13	SENT_33	[p3l1590t1490r1870b1548],
25	(	NN	O	(	nn	26	SENT_33	[p3l1904t1490r2141b1561],
26	n	NN	O	n	dobj	24	SENT_33	[p3l1904t1490r2141b1561],
27	=	JJ	O	=	amod	26	SENT_33	[p3l1904t1490r2141b1561],
28	45	CD	NUMBER	45	tmod	27	SENT_33	[p3l1904t1490r2141b1561],
29	,	,	O	,	_	0	SENT_33	[p3l1904t1490r2141b1561],
30	crude	JJ	O	crude	amod	31	SENT_33	[p3l16t1582r213b1640],
31	odds	NNS	O	odds	dep	44	SENT_33	[p3l257t1582r422b1640],
32	ratio	NN	O	ratio	dep	31	SENT_33	[p3l465t1582r626b1640],
33	2-8	CD	NUMBER	2-8	num	32	SENT_33	[p3l671t1584r803b1651],
34	,	,	O	,	_	0	SENT_33	[p3l671t1584r803b1651],
35	1-1-7-2	CD	NUMBER	1-1-7-2	appos	32	SENT_33	[p3l856t1584r1138b1651],
36	,	,	O	,	_	0	SENT_33	[p3l856t1584r1138b1651],
37	p	NN	O	p	appos	32	SENT_33	[p3l1181t1584r1462b1654],
38	=	JJ	O	=	amod	37	SENT_33	[p3l1181t1584r1462b1654],
39	0-05	CD	NUMBER	0-05	tmod	38	SENT_33	[p3l1181t1584r1462b1654],
40	,	,	O	,	_	0	SENT_33	[p3l1181t1584r1462b1654],
41	multivariate	JJ	O	multivariate	amod	42	SENT_33	[p3l1507t1582r1933b1640],
42	odds	NNS	O	odds	appos	32	SENT_33	[p3l1978t1582r2142b1640],
43	ratio	NN	O	ratio	dep	44	SENT_33	[p3l14t1674r175b1731],
44	4-8	CD	NUMBER	4-8	dep	51	SENT_33	[p3l205t1676r337b1743],
45	,	,	O	,	_	0	SENT_33	[p3l205t1676r337b1743],
46	1-1-20-3	CD	DATE	1-1-20-3	appos	44	SENT_33	[p3l376t1676r703b1743],
47	,	,	O	,	_	0	SENT_33	[p3l376t1676r703b1743],
48	p	NN	O	p	nn	50	SENT_33	[p3l732t1674r1043b1746],
49	=	JJ	O	=	amod	50	SENT_33	[p3l732t1674r1043b1746],
50	O-O4	NN	O	o-o4	appos	44	SENT_33	[p3l732t1674r1043b1746],
51	)	NN	O	)	dep	6	SENT_33	[p3l732t1674r1043b1746],
52	.	.	O	.	_	0	SENT_33	[p3l732t1674r1043b1746],

1	We	PRP	O	we	nsubj	3	SENT_34	[p3l97t1767r215b1824],
2	further	RB	O	further	advmod	3	SENT_34	[p3l259t1766r506b1823],
3	estimated	VBD	O	estimate	_	0	SENT_34	[p3l550t1766r891b1824],
4	patients	NNS	O	patient	dep	9	SENT_34	[p3l933t1766r1235b1838],
5	’	CD	NUMBER	’	dep	4	SENT_34	[p3l933t1766r1235b1838],
6	event	NN	O	event	dep	9	SENT_34	[p3l1284t1766r1635b1824],
7	—	CD	NUMBER	—	num	6	SENT_34	[p3l1284t1766r1635b1824],
8	free	JJ	O	free	amod	9	SENT_34	[p3l1284t1766r1635b1824],
9	survival	NN	O	survival	dep	3	SENT_34	[p3l1681t1766r1951b1824],
10	as	IN	O	as	_	0	SENT_34	[p3l1997t1785r2063b1823],
11	a	DT	O	a	det	12	SENT_34	[p3l2110t1785r2144b1823],
12	function	NN	O	function	prep_as	9	SENT_34	[p3l15t1858r313b1916],
13	of	IN	O	of	_	0	SENT_34	[p3l375t1858r449b1916],
14	3R/3R	NN	O	3r/3r	nn	15	SENT_34	[p3l502t1858r733b1916],
15	genotype	NN	O	genotype	prep_of	12	SENT_34	[p3l790t1871r1109b1930],
16	(	CD	NUMBER	(	num	18	SENT_34	[p3l1177t1858r1433b1930],
17	ﬁgure	NN	O	ﬁgure	nn	18	SENT_34	[p3l1177t1858r1433b1930],
18	)	NN	O	)	dobj	3	SENT_34	[p3l1177t1858r1433b1930],
19	by	IN	O	by	_	0	SENT_34	[p3l1498t1858r1583b1930],
20	Kaplan-Meier	NN	PERSON	kaplan-meier	nn	21	SENT_34	[p3l1643t1858r2146b1930],
21	analysis	NN	O	analysis	prep_by	18	SENT_34	[p3l16t1950r307b2021],
22	.	.	O	.	_	0	SENT_34	[p3l16t1950r307b2021],

1	Individuals	NNS	O	individual	npadvmod	2	SENT_35	[p3l349t1950r744b2007],
2	homozygous	JJ	O	homozygous	dep	5	SENT_35	[p3l780t1950r1224b2021],
3	for	IN	O	for	_	0	SENT_35	[p3l1260t1949r1361b2007],
4	3R/3R	NN	O	3r/3r	prep_for	2	SENT_35	[p3l1397t1949r1626b2007],
5	had	VBD	O	have	_	0	SENT_35	[p3l1657t1950r1788b2007],
6	a	DT	O	a	det	8	SENT_35	[p3l1825t1968r1859b2007],
7	shorter	JJR	O	shorter	amod	8	SENT_35	[p3l1896t1950r2146b2007],
8	eVent	NN	O	event	dobj	5	SENT_35	[p3l16t2042r367b2100],
9	—	CD	NUMBER	—	num	11	SENT_35	[p3l16t2042r367b2100],
10	free	JJ	O	free	amod	11	SENT_35	[p3l16t2042r367b2100],
11	survival	NN	O	survival	nsubj	5	SENT_35	[p3l411t2042r681b2100],
12	than	IN	O	than	mark	13	SENT_35	[p3l722t2042r880b2100],
13	did	VBD	O	do	dep	5	SENT_35	[p3l923t2042r1035b2100],
14	those	DT	O	those	nsubj	20	SENT_35	[p3l1076t2042r1262b2100],
15	with	IN	O	with	_	0	SENT_35	[p3l1303t2042r1457b2100],
16	other	JJ	O	other	amod	19	SENT_35	[p3l1500t2042r1685b2099],
17	thymidylate	NN	O	thymidylate	nn	19	SENT_35	[p3l1724t2042r2143b2114],
18	synthase	NN	O	synthase	nn	19	SENT_35	[p3l16t2134r315b2206],
19	genotypes	NNS	O	genotype	prep_with	14	SENT_35	[p3l411t2147r763b2206],
20	(	VBP	O	(	ccomp	13	SENT_35	[p3l866t2134r1147b2206],
21	ﬁgure	NN	O	ﬁgure	nn	22	SENT_35	[p3l866t2134r1147b2206],
22	)	NN	O	)	dobj	20	SENT_35	[p3l866t2134r1147b2206],
23	.	.	O	.	_	0	SENT_35	[p3l866t2134r1147b2206],

1	The	DT	O	the	det	2	SENT_36	[p3l1247t2134r1390b2192],
2	results	NNS	O	result	nsubj	4	SENT_36	[p3l1486t2134r1714b2192],
3	remained	VBD	O	remain	cop	4	SENT_36	[p3l1811t2134r2144b2192],
4	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_36	[p3l16t2225r381b2297],
5	if	IN	O	if	mark	11	SENT_36	[p3l424t2225r478b2282],
6	leukaemia	NN	O	leukaemia	nsubjpass	11	SENT_36	[p3l512t2225r1035b2283],
7	—	CD	NUMBER	—	num	9	SENT_36	[p3l512t2225r1035b2283],
8	free	JJ	O	free	amod	9	SENT_36	[p3l512t2225r1035b2283],
9	survival	NN	O	survival	dep	6	SENT_36	[p3l1081t2226r1351b2283],
10	was	VBD	O	be	auxpass	11	SENT_36	[p3l1394t2244r1522b2283],
11	regarded	VBN	O	regard	advcl	4	SENT_36	[p3l1567t2226r1879b2297],
12	as	IN	O	as	_	0	SENT_36	[p3l1924t2244r1990b2283],
13	the	DT	O	the	prep_as	11	SENT_36	[p3l2035t2226r2143b2283],

1	Number	NN	O	number	dep	13	SENT_37	[p3l367t2450r589b2497],
2	with	IN	O	with	_	0	SENT_37	[p3l609t2449r732b2497],
3	Number	NN	O	number	prep_with	1	SENT_37	[p3l886t2450r1108b2497],
4	with	IN	O	with	_	0	SENT_37	[p3l1128t2449r1252b2497],
5	Crude	JJ	O	crude	amod	7	SENT_37	[p3l1430t2449r1599b2497],
6	odds	NNS	O	odds	nn	7	SENT_37	[p3l1621t2450r1757b2497],
7	ratio	NN	O	ratio	prep_with	3	SENT_37	[p3l1783t2449r1913b2497],
8	p	NN	O	p	dep	13	SENT_37	[p3l1954t2450r2019b2507],
9	*	CD	NUMBER	*	num	8	SENT_37	[p3l1954t2450r2019b2507],
10	an	DT	O	a	det	13	SENT_37	[p3l365t2540r431b2576],
11	event	NN	O	event	nn	13	SENT_37	[p3l455t2530r615b2576],
12	(	NN	O	(	nn	13	SENT_37	[p3l639t2528r836b2586],
13	n	NN	O	n	dep	21	SENT_37	[p3l639t2528r836b2586],
14	=	JJ	O	=	quantmod	16	SENT_37	[p3l639t2528r836b2586],
15	32	CD	NUMBER	32	number	16	SENT_37	[p3l639t2528r836b2586],
16	)	CD	NUMBER	)	dep	13	SENT_37	[p3l639t2528r836b2586],
17	no	DT	O	no	det	20	SENT_37	[p3l885t2540r952b2576],
18	event	NN	O	event	nn	20	SENT_37	[p3l974t2530r1134b2576],
19	(	NN	O	(	nn	20	SENT_37	[p3l1158t2528r1395b2586],
20	n	NN	O	n	dep	16	SENT_37	[p3l1158t2528r1395b2586],
21	=	JJ	O	=	dep	27	SENT_37	[p3l1158t2528r1395b2586],
22	173	CD	NUMBER	173	number	23	SENT_37	[p3l1158t2528r1395b2586],
23	)	CD	NUMBER	)	num	24	SENT_37	[p3l1158t2528r1395b2586],
24	(	NN	O	(	dep	21	SENT_37	[p3l1430t2528r1577b2586],
25	95	CD	PERCENT	95	number	26	SENT_37	[p3l1430t2528r1577b2586],
26	%	NN	PERCENT	%	amod	24	SENT_37	[p3l1430t2528r1577b2586],
27	Cl	NN	O	cl	_	0	SENT_37	[p3l1599t2528r1681b2586],
28	)	CD	NUMBER	)	num	27	SENT_37	[p3l1599t2528r1681b2586],

1	Genotype	NN	O	genotype	nn	2	SENT_38	[p3l11t2648r285b2706],
2	2R/2R	NN	O	2r/2r	_	0	SENT_38	[p3l12t2727r201b2785],
3	4	CD	PERCENT	4	number	4	SENT_38	[p3l417t2727r453b2774],
4	(	CD	PERCENT	(	dep	2	SENT_38	[p3l477t2727r636b2785],
5	13	CD	PERCENT	13	num	6	SENT_38	[p3l477t2727r636b2785],
6	%	NN	PERCENT	%	dep	4	SENT_38	[p3l477t2727r636b2785],
7	)	CD	NUMBER	)	number	8	SENT_38	[p3l477t2727r636b2785],
8	44	CD	NUMBER	44	dep	2	SENT_38	[p3l884t2727r959b2774],
9	(	NN	O	(	dep	8	SENT_38	[p3l984t2727r1142b2785],
10	25	CD	PERCENT	25	num	11	SENT_38	[p3l984t2727r1142b2785],
11	%	NN	PERCENT	%	dep	2	SENT_38	[p3l984t2727r1142b2785],
12	)	CD	NUMBER	)	num	13	SENT_38	[p3l984t2727r1142b2785],
13	1-0	CD	NUMBER	1-0	dep	11	SENT_38	[p3l1432t2727r1524b2774],
14	.	.	O	.	_	0	SENT_38	[p3l1956t2765r1984b2774],

1	.	.	O	.	_	0	SENT_39	[p3l1956t2765r1984b2774],

1	2R/3R	NN	O	2r/3r	dep	21	SENT_40	[p3l12t2806r201b2864],
2	12	CD	PERCENT	12	num	1	SENT_40	[p3l380t2806r451b2853],
3	(	CD	PERCENT	(	num	5	SENT_40	[p3l477t2806r636b2864],
4	38	CD	PERCENT	38	num	5	SENT_40	[p3l477t2806r636b2864],
5	%	NN	PERCENT	%	dep	1	SENT_40	[p3l477t2806r636b2864],
6	)	CD	NUMBER	)	number	7	SENT_40	[p3l477t2806r636b2864],
7	95	CD	NUMBER	95	num	8	SENT_40	[p3l885t2806r958b2853],
8	(	NN	O	(	dep	5	SENT_40	[p3l984t2806r1142b2864],
9	55	CD	PERCENT	55	number	10	SENT_40	[p3l984t2806r1142b2864],
10	%	NN	PERCENT	%	amod	8	SENT_40	[p3l984t2806r1142b2864],
11	)	CD	NUMBER	)	number	12	SENT_40	[p3l984t2806r1142b2864],
12	1-4	CD	NUMBER	1-4	num	16	SENT_40	[p3l1432t2806r1525b2853],
13	(	NN	O	(	nn	16	SENT_40	[p3l1549t2806r1813b2864],
14	O-4-4-6	NN	O	o-4-4-6	nn	16	SENT_40	[p3l1549t2806r1813b2864],
15	)	CD	NUMBER	)	num	16	SENT_40	[p3l1549t2806r1813b2864],
16	O-8	NN	O	o-8	dep	5	SENT_40	[p3l1953t2806r2047b2853],
17	3R/3R	NN	O	3r/3r	dep	21	SENT_40	[p3l11t2885r201b2943],
18	16	CD	PERCENT	16	num	17	SENT_40	[p3l380t2885r452b2932],
19	(	CD	PERCENT	(	num	21	SENT_40	[p3l477t2885r636b2943],
20	50	CD	PERCENT	50	num	21	SENT_40	[p3l477t2885r636b2943],
21	%	NN	PERCENT	%	dep	29	SENT_40	[p3l477t2885r636b2943],
22	)	CD	NUMBER	)	number	23	SENT_40	[p3l477t2885r636b2943],
23	34	CD	NUMBER	34	num	24	SENT_40	[p3l884t2885r959b2932],
24	(	NN	O	(	dep	21	SENT_40	[p3l984t2885r1142b2943],
25	20	CD	PERCENT	20	number	26	SENT_40	[p3l984t2885r1142b2943],
26	%	NN	PERCENT	%	amod	24	SENT_40	[p3l984t2885r1142b2943],
27	)	CD	NUMBER	)	num	28	SENT_40	[p3l984t2885r1142b2943],
28	5-2	CD	NUMBER	5-2	dep	24	SENT_40	[p3l1431t2885r1523b2932],
29	(	NN	O	(	dep	32	SENT_40	[p3l1549t2885r1853b2943],
30	1-6-16-9	CD	DATE	1-6-16-9	num	29	SENT_40	[p3l1549t2885r1853b2943],
31	)	CD	NUMBER	)	num	32	SENT_40	[p3l1549t2885r1853b2943],
32	O-O05	NN	O	o-o05	_	0	SENT_40	[p3l1953t2885r2125b2932],

1	2R	NN	O	2r	nsubj	2	SENT_41	[p3l12t2998r297b3041],
2	=	JJ	O	=	_	0	SENT_41	[p3l12t2998r297b3041],
3	doub	NN	O	doub	nn	4	SENT_41	[p3l12t2998r297b3041],
4	|	NN	O	|	dobj	2	SENT_41	[p3l12t2998r297b3041],
5	e	SYM	O	e	dep	6	SENT_41	[p3l12t2998r297b3041],
6	repeat	NN	O	repeat	rcmod	4	SENT_41	[p3l323t3001r503b3051],
7	;	:	O	;	_	0	SENT_41	[p3l323t3001r503b3051],
8	3R	NN	O	3r	nn	10	SENT_41	[p3l528t2998r769b3051],
9	=	JJ	O	=	amod	10	SENT_41	[p3l528t2998r769b3051],
10	trip	NN	O	trip	dep	4	SENT_41	[p3l528t2998r769b3051],
11	|	RB	O	|	advmod	10	SENT_41	[p3l528t2998r769b3051],
12	e	SYM	O	e	dep	13	SENT_41	[p3l528t2998r769b3051],
13	repeat	NN	O	repeat	dep	4	SENT_41	[p3l794t3001r974b3051],
14	.	.	O	.	_	0	SENT_41	[p3l794t3001r974b3051],

1	*	NNP	O	*	nn	2	SENT_42	[p3l1004t2998r1244b3041],
2	Fisher	NNP	PERSON	Fisher	poss	5	SENT_42	[p3l1004t2998r1244b3041],
3	’s	POS	O	’s	_	0	SENT_42	[p3l1004t2998r1244b3041],
4	exact	JJ	O	exact	amod	5	SENT_42	[p3l1266t3000r1406b3041],
5	test	NN	O	test	nsubjpass	14	SENT_42	[p3l1424t3001r1528b3041],
6	(	CD	NUMBER	(	number	7	SENT_42	[p3l1549t2998r1835b3051],
7	two	CD	NUMBER	two	num	5	SENT_42	[p3l1549t2998r1835b3051],
8	—	CD	NUMBER	—	num	9	SENT_42	[p3l1549t2998r1835b3051],
9	tai	NNS	O	taus	nsubj	10	SENT_42	[p3l1549t2998r1835b3051],
10	|	VBP	O	|	rcmod	5	SENT_42	[p3l1549t2998r1835b3051],
11	ed	VBN	O	ed	dep	10	SENT_42	[p3l1549t2998r1835b3051],
12	)	NN	O	)	dobj	11	SENT_42	[p3l1549t2998r1835b3051],
13	was	VBD	O	be	auxpass	14	SENT_42	[p3l1856t3008r1959b3041],
14	used	VBN	O	use	_	0	SENT_42	[p3l1983t2998r2107b3041],
15	to	TO	O	to	aux	16	SENT_42	[p3l9t3070r59b3111],
16	test	VB	O	test	xcomp	14	SENT_42	[p3l80t3070r184b3111],
17	the	DT	O	the	det	18	SENT_42	[p3l202t3068r285b3111],
18	difference	NN	O	difference	dobj	16	SENT_42	[p3l308t3067r569b3111],
19	between	IN	O	between	_	0	SENT_42	[p3l593t3068r811b3111],
20	children	NNS	O	child	prep_between	18	SENT_42	[p3l835t3068r1039b3111],
21	with	IN	O	with	_	0	SENT_42	[p3l1062t3068r1165b3111],
22	and	CC	O	and	_	0	SENT_42	[p3l1189t3068r1282b3111],
23	without	IN	O	without	_	0	SENT_42	[p3l1305t3068r1498b3111],
24	an	DT	O	a	det	25	SENT_42	[p3l1518t3078r1578b3111],
25	event	NN	O	event	prep_without	16	SENT_42	[p3l1602t3070r1759b3111],
26	.	.	O	.	_	0	SENT_42	[p3l1602t3070r1759b3111],

1	Distribution	NN	O	distribution	_	0	SENT_43	[p3l13t3165r397b3219],
2	of	IN	O	of	_	0	SENT_43	[p3l424t3165r488b3219],
3	thymidylate	NN	O	thymidylate	nn	5	SENT_43	[p3l509t3165r900b3231],
4	synthase	NN	O	synthase	nn	5	SENT_43	[p3l924t3165r1224b3231],
5	genotypes	NNS	O	genotype	prep_of	1	SENT_43	[p3l1249t3167r1594b3231],
6	in	IN	O	in	_	0	SENT_43	[p3l1623t3165r1676b3218],
7	patients	NNS	O	patient	prep_in	1	SENT_43	[p3l1705t3165r1976b3231],
8	with	IN	O	with	dep	1	SENT_43	[p3l9t3252r150b3306],
9	acute	JJ	O	acute	amod	11	SENT_43	[p3l178t3254r365b3306],
10	lymphoblastic	JJ	O	lymphoblastic	amod	11	SENT_43	[p3l394t3252r853b3319],
11	leukaemia	NN	O	leukaemia	pobj	8	SENT_43	[p3l882t3252r1222b3306],
12	with	IN	O	with	dep	1	SENT_43	[p3l1248t3252r1388b3306],
13	and	CC	O	and	_	0	SENT_43	[p3l1416t3253r1533b3306],
14	without	IN	O	without	conj_and	12	SENT_43	[p3l1559t3252r1811b3306],
15	an	DT	O	a	det	16	SENT_43	[p3l1837t3265r1913b3306],
16	event	NN	O	event	pobj	14	SENT_43	[p3l1941t3254r2124b3306],

1	THE	DT	O	the	det	2	SENT_44	[p3l47t3418r113b3439],
2	LANCET	NN	O	lancet	_	0	SENT_44	[p3l122t3418r252b3439],
3	-	:	O	-	_	0	SENT_44	[p3l261t3425r269b3433],
4	Vol	NN	O	vol	nn	6	SENT_44	[p3l278t3418r322b3439],
5	359	CD	NUMBER	359	num	6	SENT_44	[p3l332t3419r377b3439],
6	~	NN	O	~	dep	2	SENT_44	[p3l388t3425r396b3433],
7	March	NNP	DATE	March	tmod	6	SENT_44	[p3l406t3418r489b3439],
8	23	CD	DATE	23	num	7	SENT_44	[p3l499t3419r537b3443],
9	,	,	DATE	,	_	0	SENT_44	[p3l499t3419r537b3443],
10	2002	CD	DATE	2002	num	7	SENT_44	[p3l548t3419r610b3439],
11	°	CD	NUMBER	°	num	12	SENT_44	[p3l620t3425r628b3433],
12	www.thelancet.com	NNP	O	www.thelancet.com	dep	6	SENT_44	[p3l637t3418r888b3439],
13	1033	CD	DATE	1033	num	12	SENT_44	[p3l1941t3413r2016b3439],

1	For	IN	O	for	_	0	SENT_45	[p3l107t3519r175b3554],
2	personal	JJ	O	personal	amod	3	SENT_45	[p3l200t3519r388b3562],
3	use	NN	O	use	pobj	1	SENT_45	[p3l415t3527r504b3554],
4	.	.	O	.	_	0	SENT_45	[p3l415t3527r504b3554],

1	Only	RB	O	only	advmod	2	SENT_46	[p3l552t3518r648b3562],
2	reproduce	VB	O	reproduce	_	0	SENT_46	[p3l674t3519r896b3562],
3	with	IN	O	with	_	0	SENT_46	[p3l920t3518r1015b3554],
4	permission	NN	O	permission	prep_with	2	SENT_46	[p3l1042t3518r1283b3562],
5	from	IN	O	from	_	0	SENT_46	[p3l1308t3518r1406b3554],
6	The	DT	O	the	det	9	SENT_46	[p3l1431t3519r1511b3554],
7	Lancet	NNP	ORGANIZATION	Lancet	nn	9	SENT_46	[p3l1537t3519r1687b3554],
8	Publishing	NNP	ORGANIZATION	Publishing	nn	9	SENT_46	[p3l1714t3518r1947b3562],
9	Group	NNP	ORGANIZATION	Group	prep_from	2	SENT_46	[p3l1970t3518r2113b3562],
10	.	.	O	.	_	0	SENT_46	[p3l1970t3518r2113b3562],

1	RESEARCH	NN	O	research	nn	2	SENT_47	[p3l92t3637r258b3658],
2	LETTERS	NNS	O	letter	_	0	SENT_47	[p3l267t3637r408b3658],

1	O-9	NN	O	o-9	_	0	SENT_48	[p4l401t82r509b135],

1	0	CD	NUMBER	0	_	0	SENT_49	[p4l401t318r509b373],
2	'	''	O	'	_	0	SENT_49	[p4l401t318r509b373],
3	9	CD	NUMBER	9	dep	1	SENT_49	[p4l401t318r509b373],
4	2R/2R	NN	O	2r/2r	dep	1	SENT_49	[p4l1427t370r1617b428],
5	or	CC	O	or	_	0	SENT_49	[p4l1642t382r1697b418],
6	2R/3R	NN	O	2r/3r	dep	1	SENT_49	[p4l1719t370r1909b428],

1	To	TO	O	to	dep	12	SENT_50	[p4l251t532r305b631],
2	0-8	CD	NUMBER	0-8	pobj	1	SENT_50	[p4l401t550r509b604],
3	3	CD	NUMBER	3	number	4	SENT_50	[p4l264t636r304b689],
4	3	CD	NUMBER	3	num	6	SENT_50	[p4l265t699r305b729],
5	(	NN	O	(	nn	6	SENT_50	[p4l264t737r305b770],
6	D	NN	O	d	npadvmod	2	SENT_50	[p4l264t737r305b770],
7	as	IN	O	as	_	0	SENT_50	[p4l264t799r305b835],
8	0-7	CD	NUMBER	0-7	num	9	SENT_50	[p4l401t778r507b831],
9	2	CD	NUMBER	2	prep_as	2	SENT_50	[p4l264t840r305b897],
10	E	NN	O	e	nn	12	SENT_50	[p4l255t925r305b1001],
11	’	NN	O	’	nn	12	SENT_50	[p4l255t925r305b1001],
12	o	NN	O	o	_	0	SENT_50	[p4l264t1009r305b1080],
13	;	:	O	;	_	0	SENT_50	[p4l264t1009r305b1080],
14	O-6	NN	O	o-6	nn	15	SENT_50	[p4l401t1011r509b1065],
15	LIJ	NN	O	lij	dep	12	SENT_50	[p4l252t1082r304b1116],

1	Number	NN	O	number	dep	4	SENT_51	[p4l6t1814r229b1860],
2	of	IN	O	of	_	0	SENT_51	[p4l250t1813r306b1860],
3	patients	NNS	O	patient	prep_of	1	SENT_51	[p4l328t1813r565b1871],
4	Tlme	VBP	O	tlme	_	0	SENT_51	[p4l1103t1769r1258b1822],
5	(	CD	NUMBER	(	num	6	SENT_51	[p4l1287t1769r1573b1835],
6	months	NNS	NUMBER	month	dobj	4	SENT_51	[p4l1287t1769r1573b1835],
7	)	RB	O	)	advmod	8	SENT_51	[p4l1287t1769r1573b1835],
8	remaining	VBG	O	remain	partmod	6	SENT_51	[p4l6t1879r294b1938],
9	3R/3R	NN	O	3r/3r	dobj	8	SENT_51	[p4l10t1958r200b2016],
10	50	CD	NUMBER	50	num	9	SENT_51	[p4l556t1958r629b2005],
11	35	CD	NUMBER	35	num	12	SENT_51	[p4l851t1958r926b2005],
12	26	CD	NUMBER	26	dep	9	SENT_51	[p4l1149t1958r1223b2005],
13	16	CD	NUMBER	16	number	14	SENT_51	[p4l1449t1958r1520b2005],
14	12	CD	NUMBER	12	num	16	SENT_51	[p4l1746t1958r1817b2004],
15	O	NN	O	o	nn	16	SENT_51	[p4l2061t1958r2095b2005],
16	2R/2R	NN	O	2r/2r	dep	12	SENT_51	[p4l11t2051r200b2109],
17	or	CC	O	or	_	0	SENT_51	[p4l225t2062r280b2098],
18	2R/3R	NN	O	2r/3r	dobj	8	SENT_51	[p4l303t2051r492b2109],
19	155	CD	NUMBER	155	number	20	SENT_51	[p4l537t2051r648b2098],
20	114	CD	NUMBER	114	num	22	SENT_51	[p4l834t2051r947b2098],
21	80	CD	NUMBER	80	number	22	SENT_51	[p4l1149t2051r1224b2098],
22	51	CD	NUMBER	51	dep	18	SENT_51	[p4l1447t2051r1521b2098],
23	31	CD	NUMBER	31	num	24	SENT_51	[p4l1743t2051r1818b2098],
24	O	NN	O	o	nsubj	4	SENT_51	[p4l2061t2051r2095b2098],

1	Kaplan-Meier	JJR	O	kaplan-meier	amod	2	SENT_52	[p4l11t2179r464b2245],
2	estimates	NNS	O	estimate	nsubjpass	40	SENT_52	[p4l491t2179r834b2233],
3	of	IN	O	of	_	0	SENT_52	[p4l864t2179r928b2233],
4	event-free	RB	O	event-free	advmod	5	SENT_52	[p4l953t2179r1297b2233],
5	survival	NN	O	survival	prep_of	2	SENT_52	[p4l1325t2179r1586b2233],
6	for	IN	O	for	_	0	SENT_52	[p4l1616t2179r1707b2233],
7	patients	NNS	O	patient	conj_and	7	SENT_52	[p4l1736t2179r2017b2245],
8	with	IN	O	with	_	0	SENT_52	[p4l7t2272r152b2326],
9	and	CC	O	and	_	0	SENT_52	[p4l183t2273r303b2326],
10	without	IN	O	without	_	0	SENT_52	[p4l332t2272r592b2326],
11	thymidylate	NN	O	thymidylate	nn	14	SENT_52	[p4l620t2272r1025b2339],
12	synthase	NN	O	synthase	nn	14	SENT_52	[p4l1053t2273r1363b2339],
13	3R/3R	NN	O	3r/3r	nn	14	SENT_52	[p4l1392t2272r1629b2338],
14	genotype	NN	O	genotype	nn	18	SENT_52	[p4l1657t2274r1975b2339],
15	dependent	JJ	O	dependent	amod	16	SENT_52	[p4l10t2421r386b2493],
16	Variable	JJ	O	variable	amod	18	SENT_52	[p4l454t2421r733b2479],
17	(	NN	O	(	nn	18	SENT_52	[p4l810t2421r1167b2493],
18	p	NN	O	p	prep_without	7	SENT_52	[p4l810t2421r1167b2493],
19	=	JJ	O	=	amod	21	SENT_52	[p4l810t2421r1167b2493],
20	0-002	CD	NUMBER	0-002	num	21	SENT_52	[p4l810t2421r1167b2493],
21	)	CD	NUMBER	)	prep_with	7	SENT_52	[p4l810t2421r1167b2493],
22	or	CC	O	or	_	0	SENT_52	[p4l1245t2440r1318b2478],
23	when	WRB	O	when	advmod	36	SENT_52	[p4l1385t2421r1576b2479],
24	patients	NNS	O	patient	nsubj	36	SENT_52	[p4l1645t2421r1924b2493],
25	who	WP	O	who	nsubj	26	SENT_52	[p4l1995t2421r2143b2479],
26	received	VBD	O	receive	rcmod	24	SENT_52	[p4l8t2513r302b2571],
27	low-dose	JJ	O	low-dose	amod	28	SENT_52	[p4l377t2513r695b2571],
28	methotrexate	NN	O	methotrexate	dobj	26	SENT_52	[p4l771t2513r1241b2571],
29	in	IN	O	in	_	0	SENT_52	[p4l1318t2513r1384b2570],
30	the	DT	O	the	det	35	SENT_52	[p4l1459t2513r1568b2571],
31	DFCI	NNP	ORGANIZATION	DFCI	nn	35	SENT_52	[p4l1645t2513r1859b2571],
32	87-O1	NN	O	87-o1	nn	35	SENT_52	[p4l1938t2515r2135b2571],
33	protocol	NN	O	protocol	nn	35	SENT_52	[p4l7t2606r306b2678],
34	(	CD	NUMBER	(	num	35	SENT_52	[p4l363t2606r606b2677],
35	n	NN	O	n	prep_in	26	SENT_52	[p4l363t2606r606b2677],
36	=	JJ	O	=	prep_of	2	SENT_52	[p4l363t2606r606b2677],
37	22	CD	NUMBER	22	num	38	SENT_52	[p4l363t2606r606b2677],
38	)	NN	O	)	dobj	36	SENT_52	[p4l363t2606r606b2677],
39	were	VBD	O	be	auxpass	40	SENT_52	[p4l661t2624r827b2663],
40	added	VBN	O	add	_	0	SENT_52	[p4l880t2606r1095b2663],
41	to	TO	O	to	_	0	SENT_52	[p4l1145t2619r1213b2663],
42	the	DT	O	the	det	48	SENT_52	[p4l1265t2606r1374b2663],
43	analysis	NN	O	analysis	nn	48	SENT_52	[p4l1427t2606r1698b2677],
44	(	NN	O	(	nn	48	SENT_52	[p4l1757t2606r2139b2678],
45	p	NN	O	p	nn	48	SENT_52	[p4l1757t2606r2139b2678],
46	=	JJ	O	=	amod	48	SENT_52	[p4l1757t2606r2139b2678],
47	0-O03	NN	O	0-o03	nn	48	SENT_52	[p4l1757t2606r2139b2678],
48	)	NN	O	)	prep_to	40	SENT_52	[p4l1757t2606r2139b2678],
49	.	.	O	.	_	0	SENT_52	[p4l1757t2606r2139b2678],

1	Hazard	NN	MISC	hazard	nn	2	SENT_53	[p4l9t2698r269b2756],
2	ratio	NN	O	ratio	nsubjpass	4	SENT_53	[p4l306t2698r467b2756],
3	was	VBD	O	be	auxpass	4	SENT_53	[p4l504t2717r632b2756],
4	estimated	VBN	O	estimate	ccomp	50	SENT_53	[p4l672t2698r1014b2756],
5	with	IN	O	with	_	0	SENT_53	[p4l1050t2698r1205b2756],
6	Cox	NN	ORGANIZATION	cox	nn	9	SENT_53	[p4l1244t2698r1388b2756],
7	proportional	JJ	O	proportional	amod	9	SENT_53	[p4l1423t2698r1870b2770],
8	hazard	NN	O	hazard	nn	9	SENT_53	[p4l1906t2698r2144b2756],
9	model	NN	O	model	prep_with	4	SENT_53	[p4l8t2790r229b2848],
10	in	IN	O	in	_	0	SENT_53	[p4l258t2790r325b2847],
11	the	DT	O	the	det	12	SENT_53	[p4l353t2790r461b2848],
12	presence	NN	O	presence	prep_in	4	SENT_53	[p4l489t2809r799b2862],
13	of	IN	O	of	_	0	SENT_53	[p4l831t2790r906b2848],
14	clinical	JJ	O	clinical	amod	19	SENT_53	[p4l926t2790r1176b2848],
15	prognostic	JJ	O	prognostic	amod	19	SENT_53	[p4l1204t2790r1579b2862],
16	factors	NNS	O	factor	nn	19	SENT_53	[p4l1608t2790r1845b2848],
17	(	NN	O	(	nn	19	SENT_53	[p4l1881t2790r2144b2861],
18	hazard	NN	O	hazard	nn	19	SENT_53	[p4l1881t2790r2144b2861],
19	ratio	NN	O	ratio	prep_of	12	SENT_53	[p4l8t2882r364b2951],
20	=	JJ	O	=	amod	12	SENT_53	[p4l8t2882r364b2951],
21	3-3	CD	NUMBER	3-3	tmod	20	SENT_53	[p4l8t2882r364b2951],
22	,	,	O	,	_	0	SENT_53	[p4l8t2882r364b2951],
23	95	CD	PERCENT	95	number	24	SENT_53	[p4l461t2882r616b2941],
24	%	NN	PERCENT	%	amod	25	SENT_53	[p4l461t2882r616b2941],
25	CI	NN	O	ci	appos	12	SENT_53	[p4l715t2882r804b2939],
26	14-78	CD	NUMBER	14-78	dep	25	SENT_53	[p4l904t2884r1187b2951],
27	,	,	O	,	_	0	SENT_53	[p4l904t2884r1187b2951],
28	p	NN	O	p	nn	30	SENT_53	[p4l1280t2882r1612b2954],
29	=	JJ	O	=	amod	30	SENT_53	[p4l1280t2882r1612b2954],
30	O-O06	NN	O	o-o06	appos	12	SENT_53	[p4l1280t2882r1612b2954],
31	)	CD	NUMBER	)	npadvmod	32	SENT_53	[p4l1280t2882r1612b2954],
32	Further	JJ	O	further	amod	30	SENT_53	[p4l1710t2882r1986b2939],
33	to	TO	O	to	aux	34	SENT_53	[p4l2075t2894r2143b2939],
34	thymidylate	VB	O	thymidylate	xcomp	4	SENT_53	[p4l8t2974r428b3046],
35	synthase	NN	O	synthase	nn	36	SENT_53	[p4l512t2974r812b3046],
36	genotype	NN	O	genotype	dobj	34	SENT_53	[p4l894t2987r1236b3046],
37	,	,	O	,	_	0	SENT_53	[p4l894t2987r1236b3046],
38	which	WDT	O	which	nsubj	42	SENT_53	[p4l1320t2974r1532b3032],
39	was	VBD	O	be	cop	42	SENT_53	[p4l1611t2993r1740b3032],
40	a	DT	O	a	det	42	SENT_53	[p4l1824t2993r1858b3031],
41	major	JJ	O	major	amod	42	SENT_53	[p4l1939t2974r2146b3046],
42	contributor	NN	O	contributor	rcmod	36	SENT_53	[p4l10t3067r418b3125],
43	to	TO	O	to	aux	44	SENT_53	[p4l451t3080r518b3125],
44	risk	VB	O	risk	infmod	42	SENT_53	[p4l555t3067r682b3125],
45	of	IN	O	of	_	0	SENT_53	[p4l717t3067r792b3125],
46	event	NN	O	event	prep_of	44	SENT_53	[p4l819t3080r1028b3136],
47	,	,	O	,	_	0	SENT_53	[p4l819t3080r1028b3136],
48	we	PRP	O	we	nsubj	50	SENT_53	[p4l1065t3086r1161b3125],
49	also	RB	O	also	advmod	50	SENT_53	[p4l1199t3067r1331b3125],
50	saw	VBD	O	see	_	0	SENT_53	[p4l1370t3086r1498b3125],
51	an	DT	O	a	det	52	SENT_53	[p4l1534t3086r1616b3125],
52	association	NN	O	association	dobj	50	SENT_53	[p4l1652t3067r2042b3125],
53	of	IN	O	of	_	0	SENT_53	[p4l2079t3067r2154b3125],
54	WBC	NN	ORGANIZATION	wbc	nn	55	SENT_53	[p4l7t3159r204b3217],
55	count	NN	O	count	prep_of	52	SENT_53	[p4l240t3172r442b3217],
56	greater	JJR	O	greater	quantmod	57	SENT_53	[p4l472t3172r719b3231],
57	than	IN	O	than	num	59	SENT_53	[p4l748t3159r906b3217],
58	5O	NN	O	5o	dep	57	SENT_53	[p4l940t3158r1289b3217],
59	>	JJR	O	>	npadvmod	60	SENT_53	[p4l940t3158r1289b3217],
60	<	JJR	O	<	amod	55	SENT_53	[p4l940t3158r1289b3217],
61	109/L	CD	NUMBER	109/l	dep	60	SENT_53	[p4l940t3158r1289b3217],
62	with	IN	O	with	dep	61	SENT_53	[p4l1315t3159r1471b3217],
63	worse	JJR	O	worse	amod	64	SENT_53	[p4l1500t3178r1705b3217],
64	outcome	NN	O	outcome	pobj	62	SENT_53	[p4l1738t3172r2045b3217],
65	of	IN	O	of	_	0	SENT_53	[p4l2079t3158r2154b3217],
66	acute	JJ	O	acute	amod	70	SENT_53	[p4l10t3265r196b3310],
67	lymphoblastic	JJ	O	lymphoblastic	amod	70	SENT_53	[p4l259t3252r757b3324],
68	leukaemia	NN	O	leukaemia	nn	70	SENT_53	[p4l820t3252r1179b3310],
69	(	NN	O	(	nn	70	SENT_53	[p4l1247t3252r1584b3324],
70	p	NN	O	p	prep_of	64	SENT_53	[p4l1247t3252r1584b3324],
71	=	JJ	O	=	amod	55	SENT_53	[p4l1247t3252r1584b3324],
72	0	CD	NUMBER	0	tmod	71	SENT_53	[p4l1247t3252r1584b3324],
73	'	''	O	'	_	0	SENT_53	[p4l1247t3252r1584b3324],
74	O2	CD	NUMBER	o2	num	75	SENT_53	[p4l1247t3252r1584b3324],
75	)	NN	O	)	dep	52	SENT_53	[p4l1247t3252r1584b3324],
76	.	.	O	.	_	0	SENT_53	[p4l1247t3252r1584b3324],

1	No	DT	O	no	det	2	SENT_54	[p4l1649t3253r1759b3310],
2	effect	NN	O	effect	nsubjpass	11	SENT_54	[p4l1824t3252r2016b3309],
3	of	IN	O	of	_	0	SENT_54	[p4l2079t3252r2154b3309],
4	genotype	NN	O	genotype	prep_of	2	SENT_54	[p4l9t3357r329b3416],
5	on	IN	O	on	_	0	SENT_54	[p4l381t3363r468b3402],
6	any	DT	O	any	det	9	SENT_54	[p4l519t3363r641b3416],
7	clinical	JJ	O	clinical	amod	9	SENT_54	[p4l691t3344r941b3402],
8	prognostic	JJ	O	prognostic	amod	9	SENT_54	[p4l989t3344r1365b3416],
9	factors	NNS	O	factor	prep_on	4	SENT_54	[p4l1415t3344r1651b3402],
10	was	VBD	O	be	auxpass	11	SENT_54	[p4l1700t3363r1829b3402],
11	noticed	VBN	O	notice	_	0	SENT_54	[p4l1879t3344r2144b3402],
12	(	RB	O	(	advmod	11	SENT_54	[p4l14t3437r191b3508],
13	data	NNS	O	datum	npadvmod	14	SENT_54	[p4l14t3437r191b3508],
14	not	RB	O	not	neg	11	SENT_54	[p4l218t3449r336b3494],
15	shown	VBN	O	show	dep	11	SENT_54	[p4l364t3437r641b3508],
16	)	NN	O	)	dobj	11	SENT_54	[p4l364t3437r641b3508],
17	.	.	O	.	_	0	SENT_54	[p4l364t3437r641b3508],

1	Acute	JJ	O	acute	amod	3	SENT_55	[p5l92t18r301b75],
2	lymphoblastic	JJ	O	lymphoblastic	amod	3	SENT_55	[p5l360t17r858b89],
3	leukaemia	NN	O	leukaemia	nsubj	8	SENT_55	[p5l918t17r1277b75],
4	is	VBZ	O	be	cop	8	SENT_55	[p5l1335t17r1386b75],
5	the	DT	O	the	det	8	SENT_55	[p5l1445t17r1553b75],
6	most	RBS	O	most	advmod	7	SENT_55	[p5l1613t30r1786b75],
7	frequent	JJ	O	frequent	amod	8	SENT_55	[p5l1844t17r2145b89],
8	malignancy	NN	O	malignancy	_	0	SENT_55	[p5l8t109r417b181],
9	that	WDT	O	that	nsubj	10	SENT_55	[p5l448t109r587b167],
10	affects	VBZ	O	affect	rcmod	8	SENT_55	[p5l620t109r844b167],
11	children	NNS	O	child	dobj	10	SENT_55	[p5l880t109r1189b167],
12	.	.	O	.	_	0	SENT_55	[p5l880t109r1189b167],

1	Resistant	JJ	O	resistant	amod	2	SENT_56	[p5l1228t109r1554b167],
2	cases	NNS	O	case	nsubj	10	SENT_56	[p5l1587t128r1764b167],
3	and	CC	O	and	_	0	SENT_56	[p5l1800t109r1929b167],
4	longterm	JJ	O	longterm	amod	5	SENT_56	[p5l1961t109r2144b181, p5l8t214r174b259],
5	effects	NNS	O	effect	nsubj	10	SENT_56	[p5l219t200r442b259],
6	caused	VBN	O	cause	partmod	5	SENT_56	[p5l488t201r728b259],
7	by	IN	O	by	_	0	SENT_56	[p5l770t201r855b273],
8	intensive	JJ	O	intensive	amod	9	SENT_56	[p5l897t201r1211b259],
9	chemotherapy	NN	O	chemotherapy	agent	6	SENT_56	[p5l1257t201r1764b274],
10	suggest	VBP	O	suggest	_	0	SENT_56	[p5l1807t214r2066b273],
11	a	DT	O	a	det	12	SENT_56	[p5l2110t220r2144b259],
12	need	NN	O	need	dobj	10	SENT_56	[p5l8t294r177b352],
13	for	IN	O	for	_	0	SENT_56	[p5l238t294r339b351],
14	alternative	JJ	O	alternative	amod	15	SENT_56	[p5l400t294r770b352],
15	treatments	NNS	O	treatment	prep_for	12	SENT_56	[p5l833t307r1232b352],
16	.	.	O	.	_	0	SENT_56	[p5l833t307r1232b352],

1	The	DT	O	the	det	3	SENT_57	[p5l1298t294r1442b351],
2	key	JJ	O	key	amod	3	SENT_57	[p5l1504t294r1623b366],
3	drug	NN	O	drug	nsubj	11	SENT_57	[p5l1684t294r1847b366],
4	in	IN	O	in	_	0	SENT_57	[p5l1907t294r1974b350],
5	the	DT	O	the	det	6	SENT_57	[p5l2035t294r2143b352],
6	treatment	NN	O	treatment	prep_in	3	SENT_57	[p5l8t399r357b444],
7	of	IN	O	of	_	0	SENT_57	[p5l409t386r484b444],
8	this	DT	O	this	det	9	SENT_57	[p5l525t386r650b444],
9	leukaemia	NN	O	leukaemia	prep_of	6	SENT_57	[p5l704t386r1063b444],
10	is	VBZ	O	be	cop	11	SENT_57	[p5l1115t386r1165b444],
11	methotrexate	NN	O	methotrexate	_	0	SENT_57	[p5l1218t386r1711b455],
12	,	,	O	,	_	0	SENT_57	[p5l1218t386r1711b455],
13	which	WDT	O	which	nsubj	20	SENT_57	[p5l1764t386r2146b458],
14	—	RB	O	—	advmod	20	SENT_57	[p5l1764t386r2146b458],
15	by	IN	O	by	_	0	SENT_57	[p5l1764t386r2146b458],
16	synthesis	NN	O	synthesis	prep_by	20	SENT_57	[p5l10t478r325b550],
17	of	IN	O	of	_	0	SENT_57	[p5l363t477r439b536],
18	methotrexate	NN	O	methotrexate	nn	19	SENT_57	[p5l464t478r934b536],
19	glutamates	NNS	O	glutamate	prep_of	16	SENT_57	[p5l971t478r1576b550],
20	—	VBP	O	—	rcmod	11	SENT_57	[p5l971t478r1576b550],
21	acts	VBZ	O	act	ccomp	20	SENT_57	[p5l971t478r1576b550],
22	as	IN	O	as	_	0	SENT_57	[p5l1615t496r1680b536],
23	an	DT	O	a	det	24	SENT_57	[p5l1719t496r1801b536],
24	inhibitor	NN	O	inhibitor	prep_as	21	SENT_57	[p5l1836t478r2146b536],
25	of	IN	O	of	_	0	SENT_57	[p5l10t571r85b629],
26	thymidylate	NN	O	thymidylate	nn	27	SENT_57	[p5l155t571r575b643],
27	synthase	NN	O	synthase	prep_of	24	SENT_57	[p5l657t571r1005b643],
28	?	.	O	?	_	0	SENT_57	[p5l657t571r1005b643],

1	Interindividual	JJ	O	interindividual	amod	2	SENT_58	[p5l1085t571r1618b629],
2	diversity	NN	O	diversity	nsubjpass	18	SENT_58	[p5l1700t571r2000b643],
3	in	IN	O	in	_	0	SENT_58	[p5l2078t571r2145b627],
4	response	NN	O	response	prep_in	2	SENT_58	[p5l8t682r317b735],
5	to	TO	O	to	_	0	SENT_58	[p5l401t676r468b721],
6	methotrexate	NN	O	methotrexate	prep_to	4	SENT_58	[p5l553t663r1046b732],
7	,	,	O	,	_	0	SENT_58	[p5l553t663r1046b732],
8	along	IN	O	along	_	0	SENT_58	[p5l1133t663r1326b735],
9	with	IN	O	with	_	0	SENT_58	[p5l1406t663r1561b721],
10	variability	NN	O	variability	prep_along_with	18	SENT_58	[p5l1641t663r1997b735],
11	in	IN	O	in	_	0	SENT_58	[p5l2078t663r2145b720],
12	thymidylate	NN	O	thymidylate	nn	15	SENT_58	[p5l8t755r428b826],
13	synthase	NN	O	synthase	nn	15	SENT_58	[p5l473t755r773b826],
14	mRNA	NN	O	mrna	nn	15	SENT_58	[p5l816t755r1073b812],
15	expression	NN	O	expression	prep_in	10	SENT_58	[p5l1116t755r1510b827],
16	,	,	O	,	_	0	SENT_58	[p5l1116t755r1510b827],
17	is	VBZ	O	be	auxpass	18	SENT_58	[p5l1556t755r1606b812],
18	documented	VBN	O	document	_	0	SENT_58	[p5l1652t755r2144b812],
19	?	.	O	?	_	0	SENT_58	[p5l1652t755r2144b812],

1	This	DT	O	this	det	2	SENT_59	[p5l8t847r168b905],
2	variation	NN	O	variation	nsubj	4	SENT_59	[p5l226t847r540b905],
3	could	MD	O	could	aux	4	SENT_59	[p5l600t847r796b905],
4	interfere	VB	O	interfere	_	0	SENT_59	[p5l854t847r1153b905],
5	with	IN	O	with	_	0	SENT_59	[p5l1211t847r1366b905],
6	drug	NN	O	drug	nn	7	SENT_59	[p5l1425t847r1588b919],
7	response	NN	O	response	prep_with	4	SENT_59	[p5l1645t866r1954b919],
8	and	CC	O	and	_	0	SENT_59	[p5l2015t847r2144b905],
9	treatment	NN	O	treatment	nn	10	SENT_59	[p5l8t952r356b997],
10	efﬁcacy	NN	O	efﬁcacy	prep_with	4	SENT_59	[p5l384t939r670b1011],
11	.	.	O	.	_	0	SENT_59	[p5l384t939r670b1011],

1	We	PRP	O	we	nsubj	2	SENT_60	[p5l92t1031r210b1089],
2	report	VBP	O	report	_	0	SENT_60	[p5l287t1044r505b1104],
3	that	IN	O	that	complm	25	SENT_60	[p5l581t1031r720b1089],
4	homozygosity	NN	O	homozygosity	nsubjpass	25	SENT_60	[p5l795t1031r1287b1103],
5	for	IN	O	for	_	0	SENT_60	[p5l1362t1030r1463b1089],
6	the	DT	O	the	det	10	SENT_60	[p5l1537t1031r1646b1089],
7	thymidylate	NN	O	thymidylate	nn	10	SENT_60	[p5l1724t1031r2143b1103],
8	synthase	NN	O	synthase	nn	10	SENT_60	[p5l10t1124r310b1196],
9	triple	JJ	O	triple	amod	10	SENT_60	[p5l357t1124r542b1196],
10	repeat	NN	O	repeat	prep_for	4	SENT_60	[p5l590t1137r830b1196],
11	,	,	O	,	_	0	SENT_60	[p5l590t1137r830b1196],
12	which	WDT	O	which	nsubjpass	14	SENT_60	[p5l878t1124r1090b1182],
13	is	VBZ	O	be	auxpass	14	SENT_60	[p5l1137t1124r1187b1182],
14	known	VBN	O	know	rcmod	10	SENT_60	[p5l1235t1124r1473b1182],
15	to	TO	O	to	aux	16	SENT_60	[p5l1519t1137r1586b1181],
16	correlate	VB	O	correlate	xcomp	14	SENT_60	[p5l1636t1124r1944b1182],
17	with	IN	O	with	_	0	SENT_60	[p5l1990t1124r2145b1182],
18	raised	VBN	O	raise	amod	21	SENT_60	[p5l8t1216r218b1274],
19	thymidylate	NN	O	thymidylate	nn	21	SENT_60	[p5l254t1216r673b1288],
20	synthase	NN	O	synthase	nn	21	SENT_60	[p5l711t1216r1011b1288],
21	expression	NN	O	expression	prep_with	16	SENT_60	[p5l1049t1216r1470b1288],
22	,	,	O	,	_	0	SENT_60	[p5l1049t1216r1470b1288],
23	“	NN	O	“	appos	21	SENT_60	[p5l1049t1216r1470b1288],
24	is	VBZ	O	be	auxpass	25	SENT_60	[p5l1505t1216r1555b1274],
25	associated	VBN	O	associate	ccomp	2	SENT_60	[p5l1595t1216r1955b1274],
26	with	IN	O	with	_	0	SENT_60	[p5l1990t1216r2145b1274],
27	poorer	JJR	O	poorer	amod	28	SENT_60	[p5l7t1326r244b1380],
28	outlook	NN	O	outlook	prep_with	25	SENT_60	[p5l316t1308r587b1365],
29	in	IN	O	in	_	0	SENT_60	[p5l657t1308r724b1364],
30	children	NNS	O	child	prep_in	28	SENT_60	[p5l797t1308r1088b1365],
31	with	IN	O	with	_	0	SENT_60	[p5l1158t1308r1313b1365],
32	acute	JJ	O	acute	amod	34	SENT_60	[p5l1386t1321r1572b1365],
33	lymphoblastic	JJ	O	lymphoblastic	amod	34	SENT_60	[p5l1646t1308r2143b1380],
34	leukaemia	NN	O	leukaemia	prep_with	30	SENT_60	[p5l9t1400r368b1458],
35	than	IN	O	than	dep	25	SENT_60	[p5l413t1400r572b1458],
36	in	IN	O	in	_	0	SENT_60	[p5l617t1400r684b1456],
37	those	DT	O	those	prep_in	25	SENT_60	[p5l729t1400r915b1458],
38	with	IN	O	with	_	0	SENT_60	[p5l960t1400r1115b1458],
39	at	IN	O	at	quantmod	41	SENT_60	[p5l1162t1413r1225b1457],
40	least	JJS	O	least	mwe	39	SENT_60	[p5l1270t1400r1429b1458],
41	one	CD	NUMBER	one	prep_with	37	SENT_60	[p5l1475t1419r1600b1458],
42	double	JJ	O	double	amod	45	SENT_60	[p5l1648t1400r2145b1472],
43	—	JJ	O	—	amod	45	SENT_60	[p5l1648t1400r2145b1472],
44	repeat	NN	O	repeat	nn	45	SENT_60	[p5l1648t1400r2145b1472],
45	allele	NN	O	allele	dep	41	SENT_60	[p5l10t1492r210b1550],
46	.	.	O	.	_	0	SENT_60	[p5l10t1492r210b1550],

1	A	DT	O	a	det	4	SENT_61	[p5l271t1493r330b1549],
2	closely	RB	O	closely	advmod	3	SENT_61	[p5l387t1492r625b1564],
3	similar	JJ	O	similar	amod	4	SENT_61	[p5l682t1492r922b1550],
4	ﬁnding	NN	O	ﬁnding	nsubjpass	7	SENT_61	[p5l978t1492r1231b1564],
5	has	VBZ	O	have	aux	7	SENT_61	[p5l1286t1492r1400b1550],
6	been	VBN	O	be	auxpass	7	SENT_61	[p5l1458t1492r1628b1550],
7	reported	VBN	O	report	_	0	SENT_61	[p5l1685t1492r1988b1564],
8	for	IN	O	for	_	0	SENT_61	[p5l2045t1492r2146b1550],
9	patients	NNS	O	patient	prep_for	7	SENT_61	[p5l7t1584r287b1656],
10	with	IN	O	with	_	0	SENT_61	[p5l334t1584r489b1641],
11	colon	NN	O	colon	nn	12	SENT_61	[p5l538t1584r731b1641],
12	cancer	NN	O	cancer	prep_with	7	SENT_61	[p5l779t1602r1011b1641],
13	who	WP	O	who	nsubj	14	SENT_61	[p5l1054t1584r1201b1641],
14	received	VBD	O	receive	rcmod	12	SENT_61	[p5l1250t1584r1543b1641],
15	chemotherapy	NN	O	chemotherapy	dobj	14	SENT_61	[p5l1591t1584r2143b1656],
16	?	.	O	?	_	0	SENT_61	[p5l1591t1584r2143b1656],

1	Overexpression	NN	O	overexpression	nsubj	8	SENT_62	[p5l11t1676r560b1748],
2	of	IN	O	of	_	0	SENT_62	[p5l640t1676r715b1734],
3	thymidylate	NN	O	thymidylate	nn	4	SENT_62	[p5l783t1676r1204b1748],
4	synthase	NN	O	synthase	prep_of	1	SENT_62	[p5l1285t1676r1584b1748],
5	might	MD	O	might	aux	8	SENT_62	[p5l1664t1676r1870b1748],
6	be	VB	O	be	cop	8	SENT_62	[p5l1947t1676r2029b1733],
7	a	DT	O	a	det	8	SENT_62	[p5l2110t1695r2144b1734],
8	mechanism	NN	O	mechanism	_	0	SENT_62	[p5l8t1768r414b1826],
9	by	IN	O	by	_	0	SENT_62	[p5l446t1768r531b1840],
10	which	WDT	O	which	rel	16	SENT_62	[p5l562t1768r775b1826],
11	individuals	NNS	O	individual	nsubj	16	SENT_62	[p5l807t1768r1195b1826],
12	with	IN	O	with	_	0	SENT_62	[p5l1229t1768r1384b1826],
13	the	DT	O	the	det	15	SENT_62	[p5l1417t1768r1525b1826],
14	3R/3R	NN	O	3r/3r	nn	15	SENT_62	[p5l1562t1768r1793b1826],
15	genotype	NN	O	genotype	prep_with	11	SENT_62	[p5l1823t1781r2143b1840],
16	develop	VBP	O	develop	rcmod	8	SENT_62	[p5l10t1860r282b1933],
17	resistance	NN	O	resistance	dobj	16	SENT_62	[p5l341t1860r708b1918],
18	.	.	O	.	_	0	SENT_62	[p5l341t1860r708b1918],

1	This	DT	O	this	det	2	SENT_63	[p5l770t1860r930b1918],
2	ﬁnding	NN	O	ﬁnding	nsubj	3	SENT_63	[p5l989t1859r1242b1932],
3	is	VBZ	O	be	_	0	SENT_63	[p5l1298t1860r1348b1918],
4	in	IN	O	in	_	0	SENT_63	[p5l1408t1860r1474b1917],
5	accordance	NN	O	accordance	prep_in	3	SENT_63	[p5l1533t1860r1932b1918],
6	with	IN	O	with	_	0	SENT_63	[p5l1990t1860r2144b1918],
7	observations	NNS	O	observation	prep_with	3	SENT_63	[p5l10t1953r453b2011],
8	that	WDT	O	that	nsubj	9	SENT_63	[p5l520t1953r659b2011],
9	raised	VBD	O	raise	rcmod	7	SENT_63	[p5l723t1953r933b2011],
10	concentrations	NNS	O	concentration	nsubj	14	SENT_63	[p5l1000t1953r1524b2011],
11	of	IN	O	of	_	0	SENT_63	[p5l1593t1953r1668b2011],
12	thymidylate	NN	O	thymidylate	nn	13	SENT_63	[p5l1723t1953r2143b2025],
13	synthase	NN	O	synthase	prep_of	10	SENT_63	[p5l10t2045r310b2117],
14	predict	VBP	O	predict	ccomp	9	SENT_63	[p5l395t2045r647b2117],
15	a	DT	O	a	det	17	SENT_63	[p5l733t2064r767b2103],
16	poor	JJ	O	poor	amod	17	SENT_63	[p5l851t2064r1018b2117],
17	response	NN	O	response	dobj	14	SENT_63	[p5l1100t2064r1410b2117],
18	to	TO	O	to	_	0	SENT_63	[p5l1495t2058r1563b2103],
19	inhibitors	NNS	O	inhibitor	prep_to	14	SENT_63	[p5l1650t2045r1990b2103],
20	of	IN	O	of	_	0	SENT_63	[p5l2079t2045r2154b2103],
21	thymidylate	NN	O	thymidylate	nn	22	SENT_63	[p5l8t2137r428b2208],
22	synthase	NN	O	synthase	prep_of	19	SENT_63	[p5l462t2137r761b2208],
23	in	IN	O	in	_	0	SENT_63	[p5l794t2137r861b2193],
24	various	JJ	O	various	amod	25	SENT_63	[p5l890t2137r1145b2194],
25	carcinomas	NNS	O	carcinoma	prep_in	22	SENT_63	[p5l1179t2137r1626b2194],
26	.	.	O	.	_	0	SENT_63	[p5l1179t2137r1626b2194],

1	‘	NN	O	‘	nsubjpass	27	SENT_64	[p5l1179t2137r1626b2194],
2	Furthermore	RB	O	furthermore	advmod	1	SENT_64	[p5l1660t2137r2141b2206],
3	,	,	O	,	_	0	SENT_64	[p5l1660t2137r2141b2206],
4	in	IN	O	in	_	0	SENT_64	[p5l9t2229r75b2285],
5	myeloid	JJ	O	myeloid	prep_in	27	SENT_64	[p5l105t2229r390b2301],
6	or	CC	O	or	_	0	SENT_64	[p5l421t2248r494b2286],
7	T	NN	O	t	prep_in	27	SENT_64	[p5l522t2230r582b2286],
8	lymphoblastic	JJ	O	lymphoblastic	amod	10	SENT_64	[p5l612t2229r1111b2301],
9	leukaemic	JJ	O	leukaemic	amod	10	SENT_64	[p5l1142t2229r1500b2287],
10	cells	NNS	O	cell	nsubjpass	27	SENT_64	[p5l1534t2229r1683b2287],
11	that	WDT	O	that	nsubj	14	SENT_64	[p5l1715t2229r1854b2287],
12	are	VBP	O	be	cop	14	SENT_64	[p5l1886t2248r1989b2287],
13	less	RBR	O	less	advmod	14	SENT_64	[p5l2021t2229r2143b2287],
14	sensitive	JJ	O	sensitive	rcmod	10	SENT_64	[p5l10t2321r308b2379],
15	to	TO	O	to	_	0	SENT_64	[p5l337t2334r405b2379],
16	methotrexate	NN	O	methotrexate	prep_to	14	SENT_64	[p5l435t2321r906b2379],
17	than	IN	O	than	_	0	SENT_64	[p5l934t2321r1093b2379],
18	B	NN	O	b	nn	19	SENT_64	[p5l1121t2322r1171b2378],
19	cells	NNS	O	cell	prep_than	16	SENT_64	[p5l1203t2321r1376b2390],
20	,	,	O	,	_	0	SENT_64	[p5l1203t2321r1376b2390],
21	increased	VBN	O	increase	amod	22	SENT_64	[p5l1407t2321r1742b2379],
22	expression	NN	O	expression	appos	19	SENT_64	[p5l1772t2321r2145b2393],
23	of	IN	O	of	_	0	SENT_64	[p5l10t2412r85b2471],
24	thymidylate	NN	O	thymidylate	nn	25	SENT_64	[p5l102t2413r522b2485],
25	synthase	NN	O	synthase	prep_of	22	SENT_64	[p5l552t2413r852b2485],
26	was	VBD	O	be	auxpass	27	SENT_64	[p5l879t2432r1008b2471],
27	reported	VBN	O	report	_	0	SENT_64	[p5l1037t2413r1387b2486],
28	?	.	O	?	_	0	SENT_64	[p5l1037t2413r1387b2486],

1	In	IN	O	in	_	0	SENT_65	[p5l94t2507r169b2563],
2	conclusion	NN	O	conclusion	prep_in	7	SENT_65	[p5l232t2506r637b2575],
3	,	,	O	,	_	0	SENT_65	[p5l232t2506r637b2575],
4	thymidylate	NN	O	thymidylate	nn	6	SENT_65	[p5l702t2506r1121b2578],
5	synthase	NN	O	synthase	nn	6	SENT_65	[p5l1186t2506r1486b2578],
6	genotype	NN	O	genotype	nsubj	7	SENT_65	[p5l1549t2519r1870b2578],
7	seems	VBZ	O	seem	_	0	SENT_65	[p5l1934t2525r2142b2564],
8	to	TO	O	to	aux	12	SENT_65	[p5l8t2611r75b2656],
9	be	VB	O	be	cop	12	SENT_65	[p5l133t2598r215b2656],
10	a	DT	O	a	det	12	SENT_65	[p5l275t2617r308b2656],
11	signiﬁcant	JJ	O	signiﬁcant	amod	12	SENT_65	[p5l367t2598r733b2670],
12	predictor	NN	O	predictor	xcomp	7	SENT_65	[p5l788t2598r1117b2670],
13	of	IN	O	of	_	0	SENT_65	[p5l1174t2598r1249b2656],
14	outcome	NN	O	outcome	prep_of	12	SENT_65	[p5l1297t2611r1605b2656],
15	in	IN	O	in	_	0	SENT_65	[p5l1663t2598r1730b2655],
16	childhood	NN	O	childhood	nn	19	SENT_65	[p5l1788t2598r2144b2656],
17	acute	JJ	O	acute	amod	19	SENT_65	[p5l10t2703r196b2748],
18	lymphoblastic	JJ	O	lymphoblastic	amod	19	SENT_65	[p5l249t2690r747b2763],
19	leukaemia	NN	O	leukaemia	prep_in	14	SENT_65	[p5l799t2690r1179b2748],
20	.	.	O	.	_	0	SENT_65	[p5l799t2690r1179b2748],

1	This	DT	O	this	det	2	SENT_66	[p5l1234t2690r1394b2748],
2	ﬁnding	NN	O	ﬁnding	nsubj	4	SENT_66	[p5l1447t2689r1700b2762],
3	could	MD	O	could	aux	4	SENT_66	[p5l1752t2690r1948b2748],
4	lead	VB	O	lead	_	0	SENT_66	[p5l2000t2690r2144b2748],
5	to	TO	O	to	_	0	SENT_66	[p5l8t2796r75b2841],
6	individualisation	NN	O	individualisation	prep_to	4	SENT_66	[p5l135t2783r730b2841],
7	of	IN	O	of	_	0	SENT_66	[p5l788t2783r863b2841],
8	treatment	NN	O	treatment	prep_of	6	SENT_66	[p5l910t2796r1259b2841],
9	for	IN	O	for	_	0	SENT_66	[p5l1315t2783r1415b2841],
10	patients	NNS	O	patient	prep_for	4	SENT_66	[p5l1469t2783r1749b2855],
11	with	IN	O	with	_	0	SENT_66	[p5l1806t2783r1962b2841],
12	this	DT	O	this	det	13	SENT_66	[p5l2018t2783r2143b2841],
13	disease	NN	O	disease	prep_with	10	SENT_66	[p5l10t2875r278b2933],
14	.	.	O	.	_	0	SENT_66	[p5l10t2875r278b2933],

1	Contributors	NNS	O	contributor	nsubj	8	SENT_67	[p5l12t2955r410b3008],
2	I	PRP	O	I	dep	1	SENT_67	[p5l9t3037r31b3083],
3	Costea	NNP	O	Costea	dep	1	SENT_67	[p5l53t3036r243b3084],
4	and	CC	O	and	_	0	SENT_67	[p5l264t3036r367b3083],
5	S	NNP	O	S	nn	6	SENT_67	[p5l388t3036r420b3084],
6	Chiasson	NNP	PERSON	Chiasson	dep	1	SENT_67	[p5l444t3036r699b3084],
7	were	VBD	O	be	cop	8	SENT_67	[p5l717t3052r848b3084],
8	responsible	JJ	O	responsible	_	0	SENT_67	[p5l868t3036r1181b3095],
9	for	IN	O	for	_	0	SENT_67	[p5l1201t3036r1280b3083],
10	genotyping	NN	O	genotyping	prep_for	8	SENT_67	[p5l1298t3036r1608b3095],
11	of	IN	O	of	_	0	SENT_67	[p5l1627t3036r1687b3083],
12	thymidylate	NN	O	thymidylate	nn	14	SENT_67	[p5l1699t3036r2027b3095],
13	synthase	NN	O	synthase	nn	14	SENT_67	[p5l10t3111r245b3170],
14	polymorphisms	NNS	O	polymorphism	prep_of	10	SENT_67	[p5l264t3111r695b3170],
15	and	CC	O	and	_	0	SENT_67	[p5l717t3111r819b3158],
16	retrieval	NN	O	retrieval	prep_for	8	SENT_67	[p5l839t3111r1063b3158],
17	of	IN	O	of	_	0	SENT_67	[p5l1084t3110r1144b3158],
18	clinical	JJ	O	clinical	amod	19	SENT_67	[p5l1157t3111r1351b3158],
19	data	NNS	O	datum	prep_of	16	SENT_67	[p5l1372t3111r1504b3158],
20	.	.	O	.	_	0	SENT_67	[p5l1372t3111r1504b3158],

1	Maja	NNP	PERSON	Maja	nn	2	SENT_68	[p5l1527t3111r1670b3169],
2	Krajinovic	NNP	PERSON	Krajinovic	nsubj	4	SENT_68	[p5l1690t3111r1979b3170],
3	was	VBD	O	be	cop	4	SENT_68	[p5l1998t3126r2100b3158],
4	responsible	JJ	O	responsible	_	0	SENT_68	[p5l9t3186r322b3245],
5	for	IN	O	for	_	0	SENT_68	[p5l342t3186r421b3234],
6	study	NN	O	study	nn	7	SENT_68	[p5l440t3186r591b3245],
7	design	NN	O	design	prep_for	4	SENT_68	[p5l610t3186r803b3245],
8	,	,	O	,	_	0	SENT_68	[p5l610t3186r803b3245],
9	data	NN	O	datum	nn	10	SENT_68	[p5l825t3186r943b3234],
10	analysis	NN	O	analysis	prep_for	4	SENT_68	[p5l964t3186r1193b3245],
11	,	,	O	,	_	0	SENT_68	[p5l964t3186r1193b3245],
12	and	CC	O	and	_	0	SENT_68	[p5l1216t3186r1318b3234],
13	the	DT	O	the	det	14	SENT_68	[p5l1337t3186r1423b3234],
14	writing	NN	O	writing	prep_for	4	SENT_68	[p5l1442t3186r1639b3245],
15	of	IN	O	of	_	0	SENT_68	[p5l1659t3186r1719b3234],
16	the	DT	O	the	det	17	SENT_68	[p5l1730t3186r1816b3234],
17	report	NN	O	report	prep_of	14	SENT_68	[p5l1836t3197r2020b3245],
18	.	.	O	.	_	0	SENT_68	[p5l1836t3197r2020b3245],

1	Conflict	NN	O	conflict	nsubj	6	SENT_69	[p5l12t3330r255b3383],
2	of	IN	O	of	_	0	SENT_69	[p5l281t3330r348b3383],
3	interest	NN	O	interest	nn	5	SENT_69	[p5l368t3331r617b3383],
4	statement	NN	O	statement	nn	5	SENT_69	[p5l639t3335r974b3383],
5	None	NN	O	none	prep_of	1	SENT_69	[p5l8t3412r169b3458],
6	declared	VBD	O	declare	_	0	SENT_69	[p5l193t3411r454b3458],
7	.	.	O	.	_	0	SENT_69	[p5l193t3411r454b3458],

1	Acknowledgments	NNS	O	acknowledgment	nsubj	3	SENT_70	[p6l6t56r601b121],
2	We	PRP	O	we	nsubj	3	SENT_70	[p6l7t137r104b184],
3	thank	VBP	O	thank	_	0	SENT_70	[p6l126t136r292b184],
4	Daniel	NNP	PERSON	Daniel	nn	5	SENT_70	[p6l312t136r505b184],
5	Sinnett	NNP	PERSON	Sinnett	dobj	3	SENT_70	[p6l530t137r739b184],
6	and	CC	O	and	_	0	SENT_70	[p6l762t136r867b184],
7	Damian	NNP	PERSON	Damian	nn	8	SENT_70	[p6l890t137r1123b184],
8	Labuda	NNP	PERSON	Labuda	conj_and	5	SENT_70	[p6l1145t136r1367b184],
9	for	IN	O	for	_	0	SENT_70	[p6l1390t136r1472b184],
10	biological	JJ	O	biological	amod	11	SENT_70	[p6l1491t136r1773b196],
11	material	NN	O	material	prep_for	8	SENT_70	[p6l1795t136r2032b184],
12	and	CC	O	and	_	0	SENT_70	[p6l10t211r116b259],
13	discussion	NN	O	discussion	prep_for	8	SENT_70	[p6l139t211r455b268],
14	;	:	O	;	_	0	SENT_70	[p6l139t211r455b268],
15	and	CC	O	and	_	0	SENT_70	[p6l481t211r586b259],
16	Albert	NNP	PERSON	Albert	nn	17	SENT_70	[p6l607t211r791b259],
17	Moghrabi	NNP	PERSON	Moghrabi	conj_and	5	SENT_70	[p6l813t211r1100b270],
18	and	CC	O	and	_	0	SENT_70	[p6l1123t211r1228b259],
19	Mark	NNP	PERSON	Mark	nn	20	SENT_70	[p6l1251t211r1409b259],
20	Bernstein	NNP	PERSON	Bernstein	conj_and	5	SENT_70	[p6l1430t211r1708b259],
21	for	IN	O	for	_	0	SENT_70	[p6l1730t211r1812b259],
22	access	NN	O	access	prep_for	17	SENT_70	[p6l1834t227r2010b259],
23	to	TO	O	to	_	0	SENT_70	[p6l2033t222r2088b259],
24	clinical	JJ	O	clinical	amod	25	SENT_70	[p6l10t286r215b333],
25	data	NNS	O	datum	prep_to	3	SENT_70	[p6l238t286r376b333],
26	.	.	O	.	_	0	SENT_70	[p6l238t286r376b333],

1	The	DT	O	the	det	2	SENT_71	[p6l402t286r520b333],
2	equipment	NN	O	equipment	nsubjpass	6	SENT_71	[p6l544t286r856b345],
3	and	CC	O	and	_	0	SENT_71	[p6l879t286r984b333],
4	reagents	NNS	O	reagent	conj_and	2	SENT_71	[p6l1007t297r1246b345],
5	were	VBD	O	be	auxpass	6	SENT_71	[p6l1268t301r1404b333],
6	purchased	VBN	O	purchase	_	0	SENT_71	[p6l1426t286r1725b345],
7	by	IN	O	by	_	0	SENT_71	[p6l1746t286r1816b345],
8	funds	NNS	O	fund	agent	6	SENT_71	[p6l1836t286r1996b333],
9	provided	VBN	O	provide	partmod	8	SENT_71	[p6l8t361r266b421],
10	by	IN	O	by	_	0	SENT_71	[p6l287t361r357b420],
11	the	DT	O	the	det	14	SENT_71	[p6l377t361r467b409],
12	Leukemia	NNP	ORGANIZATION	Leukemia	nn	14	SENT_71	[p6l489t361r777b409],
13	Research	NNP	ORGANIZATION	Research	nn	14	SENT_71	[p6l800t361r1063b409],
14	Fund	NNP	ORGANIZATION	Fund	agent	9	SENT_71	[p6l1085t361r1242b409],
15	of	IN	ORGANIZATION	of	_	0	SENT_71	[p6l1266t361r1327b409],
16	Canada	NNP	ORGANIZATION	Canada	nn	20	SENT_71	[p6l1344t361r1565b409],
17	and	CC	ORGANIZATION	and	_	0	SENT_71	[p6l1589t361r1694b409],
18	Centre	NNP	ORGANIZATION	Centre	nn	20	SENT_71	[p6l1719t362r1916b409],
19	de	IN	ORGANIZATION	de	amod	20	SENT_71	[p6l1939t361r2005b409],
20	Recherche	NNP	ORGANIZATION	Recherche	prep_of	14	SENT_71	[p6l10t436r332b493],
21	,	,	O	,	_	0	SENT_71	[p6l10t436r332b493],
22	Hopital	NNP	PERSON	Hopital	nn	23	SENT_71	[p6l357t436r577b495],
23	Ste-Justine	NNP	PERSON	Ste-Justine	appos	20	SENT_71	[p6l602t436r933b494],
24	.	.	O	.	_	0	SENT_71	[p6l602t436r933b494],

1	The	DT	O	the	det	3	SENT_72	[p6l960t436r1077b484],
2	funding	NN	O	funding	nn	3	SENT_72	[p6l1100t436r1327b495],
3	sources	NNS	O	source	nsubj	4	SENT_72	[p6l1348t452r1561b484],
4	had	VBD	O	have	_	0	SENT_72	[p6l1584t436r1691b484],
5	no	DT	O	no	det	6	SENT_72	[p6l1712t452r1784b484],
6	role	NN	O	role	dobj	4	SENT_72	[p6l1807t436r1916b484],
7	in	IN	O	in	_	0	SENT_72	[p6l1939t436r1993b483],
8	study	NN	O	study	nn	9	SENT_72	[p6l10t511r167b570],
9	design	NN	O	design	prep_in	6	SENT_72	[p6l189t511r391b570],
10	,	,	O	,	_	0	SENT_72	[p6l189t511r391b570],
11	data	NNS	O	datum	nn	12	SENT_72	[p6l417t511r538b558],
12	collection	NN	O	collection	prep_in	6	SENT_72	[p6l562t511r861b568],
13	,	,	O	,	_	0	SENT_72	[p6l562t511r861b568],
14	data	NN	O	datum	nn	15	SENT_72	[p6l887t511r1008b558],
15	analysis	NN	O	analysis	prep_in	6	SENT_72	[p6l1033t511r1273b570],
16	,	,	O	,	_	0	SENT_72	[p6l1033t511r1273b570],
17	data	NNS	O	datum	nn	18	SENT_72	[p6l1298t511r1420b558],
18	interpretation	NN	O	interpretation	prep_in	6	SENT_72	[p6l1443t511r1862b570],
19	,	,	O	,	_	0	SENT_72	[p6l1443t511r1862b570],
20	or	CC	O	or	_	0	SENT_72	[p6l1888t526r1947b558],
21	writing	NN	O	writing	prep_in	6	SENT_72	[p6l8t586r214b645],
22	of	IN	O	of	_	0	SENT_72	[p6l237t585r298b633],
23	the	DT	O	the	det	24	SENT_72	[p6l312t586r401b633],
24	report	NN	O	report	prep_of	21	SENT_72	[p6l423t596r617b645],
25	.	.	O	.	_	0	SENT_72	[p6l423t596r617b645],

1	MK	NN	O	mk	nsubj	4	SENT_73	[p6l643t586r764b632],
2	is	VBZ	O	be	cop	4	SENT_73	[p6l784t586r825b633],
3	a	DT	O	a	det	4	SENT_73	[p6l850t601r877b633],
4	scholar	NN	O	scholar	_	0	SENT_73	[p6l901t586r1108b633],
5	of	IN	O	of	_	0	SENT_73	[p6l1130t585r1191b633],
6	the	DT	O	the	det	10	SENT_73	[p6l1205t586r1294b633],
7	Fonds	NNP	O	Fonds	nn	10	SENT_73	[p6l1318t586r1498b633],
8	de	NNP	O	de	nn	10	SENT_73	[p6l1523t586r1588b633],
9	la	NNP	O	la	nn	10	SENT_73	[p6l1611t586r1658b633],
10	Recherche	NNP	O	Recherche	prep_of	4	SENT_73	[p6l1682t586r1985b633],
11	en	IN	O	en	_	0	SENT_73	[p6l2010t601r2076b633],
12	Santé	NNP	O	Santé	nn	14	SENT_73	[p6l11t661r171b709],
13	du	NNP	O	du	nn	14	SENT_73	[p6l195t661r268b709],
14	Québec	NNP	O	Québec	prep_en	4	SENT_73	[p6l292t661r529b720],
15	.	.	O	.	_	0	SENT_73	[p6l292t661r529b720],

1	1	CD	NUMBER	1	num	4	SENT_74	[p6l16t812r36b857],
2	Welsh	NNP	O	Welsh	nn	4	SENT_74	[p6l111t810r292b858],
3	S	NN	O	s	nn	4	SENT_74	[p6l317t810r393b868],
4	]	NN	O	]	_	0	SENT_74	[p6l317t810r393b868],
5	,	,	O	,	_	0	SENT_74	[p6l317t810r393b868],
6	Titley	NNP	PERSON	Titley	nn	7	SENT_74	[p6l417t810r592b869],
7	J	NNP	PERSON	J	appos	4	SENT_74	[p6l608t811r651b868],
8	,	,	O	,	_	0	SENT_74	[p6l608t811r651b868],
9	Brunton	NNP	PERSON	Brunton	nn	10	SENT_74	[p6l676t811r920b858],
10	L	NNP	O	L	appos	4	SENT_74	[p6l941t811r1002b867],
11	,	,	O	,	_	0	SENT_74	[p6l941t811r1002b867],
12	et	FW	O	et	nn	13	SENT_74	[p6l1028t821r1079b858],
13	al.	FW	O	al.	appos	4	SENT_74	[p6l1101t810r1164b858],
14	.	.	O	.	_	0	SENT_74	[p6l1101t810r1164b858],

1	Comparison	NN	O	comparison	nsubj	7	SENT_75	[p6l1193t810r1551b869],
2	of	IN	O	of	_	0	SENT_75	[p6l1574t810r1636b858],
3	thymidylate	NN	O	thymidylate	nn	4	SENT_75	[p6l1650t810r1993b869],
4	synthase	NN	O	synthase	prep_of	1	SENT_75	[p6l114t885r359b944],
5	(	CD	NUMBER	(	num	7	SENT_75	[p6l387t885r518b943],
6	TS	NN	O	t	nn	7	SENT_75	[p6l387t885r518b943],
7	)	NN	O	)	_	0	SENT_75	[p6l387t885r518b943],
8	protein	NN	O	protein	nn	9	SENT_75	[p6l544t885r754b944],
9	up-regulation	NN	O	up-regulation	dobj	7	SENT_75	[p6l775t885r1172b944],
10	after	IN	O	after	_	0	SENT_75	[p6l1195t885r1326b932],
11	exposure	NN	O	exposure	prep_after	9	SENT_75	[p6l1348t900r1606b944],
12	to	TO	O	to	_	0	SENT_75	[p6l1628t896r1683b932],
13	TS	NN	O	t	nn	14	SENT_75	[p6l1707t885r1793b932],
14	inhibitors	NNS	O	inhibitor	prep_to	7	SENT_75	[p6l1817t885r2095b932],
15	in	IN	O	in	_	0	SENT_75	[p6l113t959r167b1005],
16	normal	JJ	O	normal	amod	20	SENT_75	[p6l189t958r396b1006],
17	and	CC	O	and	_	0	SENT_75	[p6l420t958r525b1006],
18	tumor	NN	O	tumor	conj_and	16	SENT_75	[p6l547t969r727b1006],
19	cell	NN	O	cell	nn	20	SENT_75	[p6l749t958r845b1006],
20	lines	NNS	O	line	prep_in	14	SENT_75	[p6l868t958r998b1006],
21	and	CC	O	and	_	0	SENT_75	[p6l1023t958r1128b1006],
22	tissues	NNS	O	tissue	prep_in	14	SENT_75	[p6l1151t959r1356b1006],
23	.	.	O	.	_	0	SENT_75	[p6l1151t959r1356b1006],

1	Clin	NNP	O	Clin	nn	3	SENT_76	[p6l1385t959r1498b1006],
2	Cancer	NNP	O	Cancer	nn	3	SENT_76	[p6l1522t959r1716b1006],
3	Res	NNP	O	Res	_	0	SENT_76	[p6l1733t959r1827b1006],
4	2000	CD	DATE	2000	num	3	SENT_76	[p6l1850t960r2012b1015],
5	;	:	O	;	_	0	SENT_76	[p6l1850t960r2012b1015],
6	6	CD	NUMBER	6	num	8	SENT_76	[p6l2037t961r2088b1006],
7	:	:	O	:	_	0	SENT_76	[p6l2037t961r2088b1006],
8	2538-46	CD	NUMBER	2538-46	dep	3	SENT_76	[p6l115t1035r383b1080],
9	.	.	O	.	_	0	SENT_76	[p6l115t1035r383b1080],

1	2	CD	NUMBER	2	nsubj	2	SENT_77	[p6l11t1119r41b1164],
2	Rots	VBZ	O	rot	_	0	SENT_77	[p6l114t1118r243b1165],
3	MG	NN	O	mg	dobj	2	SENT_77	[p6l267t1117r404b1174],
4	,	,	O	,	_	0	SENT_77	[p6l267t1117r404b1174],
5	Willey	NNP	PERSON	Willey	nn	6	SENT_77	[p6l428t1117r615b1176],
6	JC	NNP	O	JC	appos	3	SENT_77	[p6l632t1117r727b1175],
7	,	,	O	,	_	0	SENT_77	[p6l632t1117r727b1175],
8	Jansen	NNP	PERSON	Jansen	nn	9	SENT_77	[p6l747t1118r941b1175],
9	G	NNP	PERSON	G	appos	6	SENT_77	[p6l965t1117r1033b1174],
10	,	,	O	,	_	0	SENT_77	[p6l965t1117r1033b1174],
11	et	FW	O	et	nn	14	SENT_77	[p6l1059t1128r1110b1165],
12	al.	FW	O	al.	nn	14	SENT_77	[p6l1133t1117r1195b1165],
13	mRNA	NN	O	mrna	nn	14	SENT_77	[p6l1222t1118r1431b1165],
14	expression	NN	O	expression	appos	6	SENT_77	[p6l1454t1117r1758b1176],
15	levels	NNS	O	level	npadvmod	23	SENT_77	[p6l1780t1117r1935b1165],
16	of	IN	O	of	_	0	SENT_77	[p6l1960t1117r2022b1165],
17	methotrexate	NN	O	methotrexate	nn	19	SENT_77	[p6l113t1192r497b1239],
18	resistance-related	JJ	O	resistance-related	amod	19	SENT_77	[p6l520t1192r1031b1239],
19	proteins	NNS	O	protein	prep_of	15	SENT_77	[p6l1052t1192r1287b1251],
20	in	IN	O	in	_	0	SENT_77	[p6l1311t1192r1365b1239],
21	childhood	NN	O	childhood	nn	22	SENT_77	[p6l1388t1192r1679b1239],
22	leukemia	NN	O	leukemia	prep_in	19	SENT_77	[p6l1701t1192r1962b1239],
23	as	IN	O	as	advmod	24	SENT_77	[p6l1986t1207r2040b1239],
24	determined	VBN	O	determine	partmod	14	SENT_77	[p6l114t1266r446b1314],
25	by	IN	O	by	_	0	SENT_77	[p6l468t1266r537b1325],
26	a	DT	O	a	det	31	SENT_77	[p6l559t1282r587b1314],
27	standardized	JJ	O	standardized	amod	31	SENT_77	[p6l611t1266r981b1314],
28	competitive	JJ	O	competitive	amod	31	SENT_77	[p6l1004t1267r1342b1326],
29	template-based	JJ	O	template-based	amod	31	SENT_77	[p6l1365t1266r1810b1326],
30	RT-PCR	NN	O	rt-pcr	nn	31	SENT_77	[p6l1834t1267r2100b1314],
31	method	NN	O	method	agent	24	SENT_77	[p6l113t1340r351b1388],
32	.	.	O	.	_	0	SENT_77	[p6l113t1340r351b1388],

1	Leukemia	NN	O	leukemia	_	0	SENT_78	[p6l377t1340r647b1388],
2	2000	CD	DATE	2000	num	1	SENT_78	[p6l671t1342r833b1397],
3	;	:	O	;	_	0	SENT_78	[p6l671t1342r833b1397],
4	14	CD	NUMBER	14	num	6	SENT_78	[p6l862t1342r944b1388],
5	:	:	O	:	_	0	SENT_78	[p6l862t1342r944b1388],
6	2166-75	CD	NUMBER	2166-75	dep	1	SENT_78	[p6l972t1342r1241b1388],
7	.	.	O	.	_	0	SENT_78	[p6l972t1342r1241b1388],

1	3	CD	NUMBER	3	num	3	SENT_79	[p6l11t1427r40b1473],
2	Horie	NN	ORGANIZATION	horie	nn	3	SENT_79	[p6l114t1425r279b1473],
3	N	NN	ORGANIZATION	n	_	0	SENT_79	[p6l301t1426r373b1482],
4	,	,	O	,	_	0	SENT_79	[p6l301t1426r373b1482],
5	Aiba	NNP	ORGANIZATION	Aiba	nn	6	SENT_79	[p6l396t1425r532b1473],
6	H	NNP	O	H	conj_and	3	SENT_79	[p6l554t1426r626b1482],
7	,	,	O	,	_	0	SENT_79	[p6l554t1426r626b1482],
8	Oguro	NNP	LOCATION	Oguro	nn	9	SENT_79	[p6l653t1425r835b1484],
9	K	NNP	LOCATION	K	conj_and	3	SENT_79	[p6l859t1426r927b1482],
10	,	,	O	,	_	0	SENT_79	[p6l859t1426r927b1482],
11	Hojo	NNP	PERSON	Hojo	nn	12	SENT_79	[p6l952t1425r1096b1484],
12	H	NNP	PERSON	H	conj_and	3	SENT_79	[p6l1119t1426r1191b1482],
13	,	,	O	,	_	0	SENT_79	[p6l1119t1426r1191b1482],
14	Takeishi	NNP	PERSON	Takeishi	nn	17	SENT_79	[p6l1215t1425r1464b1473],
15	K.	NNP	PERSON	K.	nn	17	SENT_79	[p6l1487t1426r1553b1473],
16	Functional	JJ	PERSON	functional	amod	17	SENT_79	[p6l1580t1425r1897b1473],
17	analysis	NN	O	analysis	conj_and	3	SENT_79	[p6l115t1500r336b1559],
18	and	CC	O	and	_	0	SENT_79	[p6l361t1500r466b1547],
19	DNA	NN	O	dna	nn	20	SENT_79	[p6l488t1501r647b1547],
20	polymorphism	NN	O	polymorphism	conj_and	3	SENT_79	[p6l668t1500r1091b1559],
21	of	IN	O	of	_	0	SENT_79	[p6l1114t1500r1175b1547],
22	the	DT	O	the	det	25	SENT_79	[p6l1189t1500r1278b1547],
23	tandemly	RB	O	tandemly	advmod	24	SENT_79	[p6l1301t1500r1573b1559],
24	repeated	VBN	O	repeat	amod	25	SENT_79	[p6l1593t1500r1843b1559],
25	sequences	NNS	O	sequence	prep_of	3	SENT_79	[p6l114t1590r405b1634],
26	in	IN	O	in	_	0	SENT_79	[p6l428t1575r483b1621],
27	the	DT	O	the	det	28	SENT_79	[p6l504t1574r593b1622],
28	5	CD	NUMBER	5	prep_in	25	SENT_79	[p6l619t1574r944b1622],
29	’	SYM	O	’	dep	25	SENT_79	[p6l619t1574r944b1622],
30	-	:	O	-	_	0	SENT_79	[p6l619t1574r944b1622],
31	terminal	JJ	O	terminal	amod	33	SENT_79	[p6l619t1574r944b1622],
32	regulatory	JJ	O	regulatory	amod	33	SENT_79	[p6l966t1575r1263b1634],
33	region	NN	O	region	dep	3	SENT_79	[p6l1284t1575r1466b1634],
34	of	IN	O	of	_	0	SENT_79	[p6l1489t1574r1551b1622],
35	the	DT	O	the	det	37	SENT_79	[p6l1565t1574r1654b1622],
36	human	JJ	O	human	amod	37	SENT_79	[p6l1675t1574r1880b1622],
37	gene	NN	O	gene	prep_of	33	SENT_79	[p6l1901t1590r2033b1634],
38	for	IN	O	for	_	0	SENT_79	[p6l113t1649r195b1697],
39	thymidylate	NN	O	thymidylate	nn	40	SENT_79	[p6l216t1649r558b1708],
40	synthase	NN	O	synthase	prep_for	37	SENT_79	[p6l582t1649r844b1708],
41	.	.	O	.	_	0	SENT_79	[p6l582t1649r844b1708],

1	Cell	NN	O	cell	nn	3	SENT_80	[p6l872t1649r979b1697],
2	Struct	NNP	O	Struct	nn	3	SENT_80	[p6l996t1649r1163b1697],
3	Funct	NNP	O	Funct	_	0	SENT_80	[p6l1180t1650r1342b1697],
4	1995	CD	DATE	1995	num	3	SENT_80	[p6l1368t1651r1503b1697],
5	5	CD	NUMBER	5	number	6	SENT_80	[p6l1511t1665r1524b1706],
6	20	CD	NUMBER	20	dep	3	SENT_80	[p6l1550t1651r1636b1697],
7	:	:	O	:	_	0	SENT_80	[p6l1550t1651r1636b1697],
8	191-97	CD	NUMBER	191-97	dep	3	SENT_80	[p6l1669t1651r1895b1697],
9	.	.	O	.	_	0	SENT_80	[p6l1669t1651r1895b1697],

1	4	CD	NUMBER	4	num	15	SENT_81	[p6l10t1735r42b1780],
2	Kawakami	NNP	ORGANIZATION	Kawakami	nn	15	SENT_81	[p6l114t1733r421b1781],
3	K	NNP	ORGANIZATION	K	nn	15	SENT_81	[p6l444t1734r511b1790],
4	,	,	O	,	_	0	SENT_81	[p6l444t1734r511b1790],
5	Omura	NNP	PERSON	Omura	appos	15	SENT_81	[p6l538t1733r742b1781],
6	K	NNP	PERSON	K	nn	15	SENT_81	[p6l765t1734r833b1790],
7	,	,	O	,	_	0	SENT_81	[p6l765t1734r833b1790],
8	Kanehira	NNP	O	Kanehira	appos	15	SENT_81	[p6l858t1733r1125b1781],
9	E	NNP	O	E	nn	15	SENT_81	[p6l1148t1734r1208b1790],
10	,	,	O	,	_	0	SENT_81	[p6l1148t1734r1208b1790],
11	Watanbe	NNP	O	Watanbe	appos	15	SENT_81	[p6l1231t1733r1491b1781],
12	Y.	NNP	O	Y.	nn	15	SENT_81	[p6l1513t1734r1575b1781],
13	Polymorphic	JJ	O	polymorphic	amod	15	SENT_81	[p6l1602t1733r1975b1792],
14	tandem	JJ	O	tandem	amod	15	SENT_81	[p6l113t1808r332b1855],
15	repeats	NNS	O	repeat	nsubjpass	22	SENT_81	[p6l354t1819r559b1867],
16	in	IN	O	in	_	0	SENT_81	[p6l583t1808r637b1855],
17	the	DT	O	the	det	20	SENT_81	[p6l658t1808r747b1855],
18	thymidylate	NN	O	thymidylate	nn	20	SENT_81	[p6l770t1808r1113b1867],
19	synthase	NN	O	synthase	nn	20	SENT_81	[p6l1137t1808r1382b1867],
20	gene	NN	O	gene	prep_in	15	SENT_81	[p6l1405t1823r1537b1867],
21	is	VBZ	O	be	auxpass	22	SENT_81	[p6l1560t1808r1601b1855],
22	associated	VBN	O	associate	_	0	SENT_81	[p6l1626t1808r1920b1855],
23	with	IN	O	with	_	0	SENT_81	[p6l1942t1808r2068b1855],
24	its	PRP$	O	its	poss	26	SENT_81	[p6l113t1883r177b1930],
25	protein	NN	O	protein	nn	26	SENT_81	[p6l200t1883r410b1942],
26	expression	NN	O	expression	prep_with	22	SENT_81	[p6l433t1883r737b1942],
27	in	IN	O	in	_	0	SENT_81	[p6l759t1883r814b1929],
28	human	JJ	O	human	amod	30	SENT_81	[p6l834t1883r1038b1930],
29	gastrointestinal	JJ	O	gastrointestinal	amod	30	SENT_81	[p6l1060t1883r1504b1942],
30	cancers	NNS	O	cancer	prep_in	22	SENT_81	[p6l1529t1898r1759b1930],
31	.	.	O	.	_	0	SENT_81	[p6l1529t1898r1759b1930],

1	Anticancer	JJ	O	anticancer	amod	2	SENT_82	[p6l1781t1883r2084b1930],
2	Res	NNP	O	Res	_	0	SENT_82	[p6l112t1957r207b2004],
3	1999	CD	DATE	1999	dep	2	SENT_82	[p6l235t1958r392b2013],
4	;	:	O	;	_	0	SENT_82	[p6l235t1958r392b2013],
5	19	CD	NUMBER	19	num	7	SENT_82	[p6l421t1958r503b2004],
6	:	:	O	:	_	0	SENT_82	[p6l421t1958r503b2004],
7	3249-52	CD	NUMBER	3249-52	dep	2	SENT_82	[p6l531t1958r799b2004],
8	.	.	O	.	_	0	SENT_82	[p6l531t1958r799b2004],

1	5	CD	NUMBER	5	num	3	SENT_83	[p6l12t2043r40b2089],
2	Iacopetta	NN	O	iacopetta	nn	3	SENT_83	[p6l113t2042r384b2100],
3	B	NN	O	b	nsubj	24	SENT_83	[p6l406t2042r467b2098],
4	,	,	O	,	_	0	SENT_83	[p6l406t2042r467b2098],
5	Grieu	NNP	O	Grieu	nn	6	SENT_83	[p6l493t2041r659b2089],
6	F	NN	O	f	appos	3	SENT_83	[p6l681t2042r739b2098],
7	,	,	O	,	_	0	SENT_83	[p6l681t2042r739b2098],
8	Joseph	NNP	PERSON	Joseph	nn	9	SENT_83	[p6l761t2041r957b2100],
9	D	NNP	PERSON	D	appos	3	SENT_83	[p6l979t2042r1050b2098],
10	,	,	O	,	_	0	SENT_83	[p6l979t2042r1050b2098],
11	Elsaleh	NNP	O	Elsaleh	nn	14	SENT_83	[p6l1075t2041r1284b2089],
12	H.	NNP	O	H.	nn	14	SENT_83	[p6l1305t2042r1375b2089],
13	A	NNP	O	A	nn	14	SENT_83	[p6l1400t2042r1448b2088],
14	polymorphism	NN	O	polymorphism	appos	3	SENT_83	[p6l1468t2041r1891b2100],
15	in	IN	O	in	_	0	SENT_83	[p6l1913t2041r1968b2088],
16	the	DT	O	the	det	18	SENT_83	[p6l1989t2041r2078b2089],
17	enhancer	NN	O	enhancer	nn	18	SENT_83	[p6l114t2116r380b2163],
18	region	NN	O	region	prep_in	14	SENT_83	[p6l401t2116r583b2175],
19	of	IN	O	of	_	0	SENT_83	[p6l606t2116r668b2163],
20	the	DT	O	the	det	23	SENT_83	[p6l681t2116r770b2163],
21	thymidylate	NN	O	thymidylate	nn	23	SENT_83	[p6l793t2116r1135b2175],
22	synthase	NN	O	synthase	nn	23	SENT_83	[p6l1160t2116r1404b2175],
23	promoter	NN	O	promoter	prep_of	18	SENT_83	[p6l1427t2127r1700b2175],
24	inﬂuences	VBZ	O	inﬂuences	_	0	SENT_83	[p6l1722t2116r2014b2163],
25	the	DT	O	the	det	26	SENT_83	[p6l2037t2116r2126b2163],
26	survival	NN	O	survival	dobj	24	SENT_83	[p6l114t2191r335b2238],
27	of	IN	O	of	_	0	SENT_83	[p6l359t2190r420b2238],
28	colorectal	JJ	O	colorectal	amod	30	SENT_83	[p6l436t2191r718b2238],
29	cancer	NN	O	cancer	nn	30	SENT_83	[p6l742t2206r931b2238],
30	patients	NNS	O	patient	prep_of	26	SENT_83	[p6l950t2191r1179b2250],
31	treated	VBN	O	treat	partmod	30	SENT_83	[p6l1202t2191r1405b2238],
32	with	IN	O	with	_	0	SENT_83	[p6l1426t2191r1553b2238],
33	5-ﬂuorouracil	NN	O	5-ﬂuorouracil	prep_with	31	SENT_83	[p6l1577t2190r1992b2238],
34	.	.	O	.	_	0	SENT_83	[p6l1577t2190r1992b2238],

1	Br	NN	O	br	_	0	SENT_84	[p6l111t2265r238b2324],
2	}	CD	NUMBER	}	num	1	SENT_84	[p6l111t2265r238b2324],
3	Cancer	NN	O	cancer	dep	1	SENT_84	[p6l256t2265r450b2313],
4	2001	CD	DATE	2001	num	3	SENT_84	[p6l469t2267r631b2322],
5	;	:	O	;	_	0	SENT_84	[p6l469t2267r631b2322],
6	85	CD	NUMBER	85	num	8	SENT_84	[p6l657t2267r743b2313],
7	:	:	O	:	_	0	SENT_84	[p6l657t2267r743b2313],
8	827-30	CD	NUMBER	827-30	dep	1	SENT_84	[p6l771t2267r1001b2313],
9	.	.	O	.	_	0	SENT_84	[p6l771t2267r1001b2313],

1	Serviced	VBN	O	service	partmod	29	SENT_85	[p6l8t2344r1086b2409],
2	’	NN	O	’	nn	3	SENT_85	[p6l8t2344r1086b2409],
3	Hématologie-Oncologie	NN	O	hématologie-oncologie	dobj	1	SENT_85	[p6l8t2344r1086b2409],
4	,	,	O	,	_	0	SENT_85	[p6l8t2344r1086b2409],
5	Centre	NNP	O	Centre	nn	7	SENT_85	[p6l1116t2346r1329b2397],
6	de	IN	O	de	amod	7	SENT_85	[p6l1355t2346r1429b2397],
7	Recherche	NNP	O	Recherche	appos	3	SENT_85	[p6l1458t2346r1817b2408],
8	,	,	O	,	_	0	SENT_85	[p6l1458t2346r1817b2408],
9	H6pitaI	NNP	O	H6pitaI	nn	10	SENT_85	[p6l1849t2344r2072b2408],
10	Sainte-Justine	NNP	O	Sainte-Justine	appos	3	SENT_85	[p6l8t2431r480b2493],
11	,	,	O	,	_	0	SENT_85	[p6l8t2431r480b2493],
12	3175	CD	NUMBER	3175	num	14	SENT_85	[p6l509t2431r678b2482],
13	C6te	NN	O	c6te	nn	14	SENT_85	[p6l705t2429r855b2482],
14	Ste-Catherine	NN	ORGANIZATION	ste-catherine	appos	3	SENT_85	[p6l879t2431r1339b2493],
15	,	,	O	,	_	0	SENT_85	[p6l879t2431r1339b2493],
16	Montreal	NNP	LOCATION	Montreal	appos	3	SENT_85	[p6l1371t2432r1675b2493],
17	,	,	O	,	_	0	SENT_85	[p6l1371t2432r1675b2493],
18	Quebec	NNP	LOCATION	Quebec	nn	20	SENT_85	[p6l1705t2431r1943b2492],
19	H3T	NN	O	h3t	nn	20	SENT_85	[p6l1972t2431r2096b2482],
20	1C5	NN	O	1c5	appos	3	SENT_85	[p6l10t2516r159b2577],
21	,	,	O	,	_	0	SENT_85	[p6l10t2516r159b2577],
22	Canada	NNP	LOCATION	Canada	nn	24	SENT_85	[p6l188t2516r427b2567],
23	(	CD	NUMBER	(	num	24	SENT_85	[p6l455t2517r527b2578],
24	M	NN	O	m	appos	3	SENT_85	[p6l455t2517r527b2578],
25	Krajinovic	JJ	O	krajinovic	amod	26	SENT_85	[p6l561t2517r857b2578],
26	MD	NN	O	md	dep	24	SENT_85	[p6l885t2533r969b2575],
27	,	,	O	,	_	0	SENT_85	[p6l885t2533r969b2575],
28	I	PRP	O	I	nsubj	29	SENT_85	[p6l1003t2517r1010b2566],
29	Costea	VBP	O	costea	_	0	SENT_85	[p6l1042t2516r1258b2567],
30	MD	NN	O	md	dobj	29	SENT_85	[p6l1288t2533r1371b2575],
31	,	,	O	,	_	0	SENT_85	[p6l1288t2533r1371b2575],
32	8	CD	NUMBER	8	num	35	SENT_85	[p6l1403t2516r1441b2566],
33	Chiasson	NNP	ORGANIZATION	Chiasson	nn	35	SENT_85	[p6l1470t2516r1756b2567],
34	Msc	NNP	ORGANIZATION	Msc	nn	35	SENT_85	[p6l1787t2517r1915b2578],
35	)	NN	O	)	appos	30	SENT_85	[p6l1787t2517r1915b2578],
36	;	:	O	;	_	0	SENT_85	[p6l1787t2517r1915b2578],
37	and	CC	O	and	_	0	SENT_85	[p6l1944t2517r2056b2567],
38	Département	NNP	O	Département	nn	40	SENT_85	[p6l12t2599r427b2663],
39	de	IN	O	de	amod	40	SENT_85	[p6l454t2601r527b2652],
40	Pédiatrie	NNP	O	Pédiatrie	conj_and	30	SENT_85	[p6l556t2599r862b2662],
41	,	,	O	,	_	0	SENT_85	[p6l556t2599r862b2662],
42	Université	NNP	ORGANIZATION	Université	nn	44	SENT_85	[p6l892t2599r1214b2652],
43	de	IN	ORGANIZATION	de	amod	44	SENT_85	[p6l1241t2601r1314b2652],
44	Montréal	NNP	ORGANIZATION	Montréal	appos	40	SENT_85	[p6l1343t2599r1647b2662],
45	,	,	O	,	_	0	SENT_85	[p6l1343t2599r1647b2662],
46	Montréal	NNP	PERSON	Montréal	appos	40	SENT_85	[p6l1680t2599r1963b2652],
47	(	CD	NUMBER	(	num	46	SENT_85	[p6l11t2686r83b2747],
48	M	NN	O	m	dep	46	SENT_85	[p6l11t2686r83b2747],
49	Krajinovic	JJ	O	krajinovic	amod	51	SENT_85	[p6l117t2686r434b2748],
50	)	NN	O	)	nn	51	SENT_85	[p6l117t2686r434b2748],
51	Correspondence	NN	O	correspondence	dobj	48	SENT_85	[p6l10t2770r530b2832],
52	to	TO	O	to	prep	48	SENT_85	[p6l555t2771r639b2821],
53	:	:	O	:	_	0	SENT_85	[p6l555t2771r639b2821],
54	Dr	NN	O	dr	dep	46	SENT_85	[p6l672t2770r737b2820],
55	M	NN	O	m	prep	54	SENT_85	[p6l765t2770r813b2820],
56	Krajinovic	JJ	O	krajinovic	amod	57	SENT_85	[p6l847t2770r1142b2833],
57	(	NN	O	(	dep	55	SENT_85	[p6l11t2854r234b2915],
58	e	SYM	O	e	dep	59	SENT_85	[p6l11t2854r234b2915],
59	—	CD	NUMBER	—	dep	54	SENT_85	[p6l11t2854r234b2915],
60	mai	FW	O	mai	nn	61	SENT_85	[p6l11t2854r234b2915],
61	|	FW	O	|	dep	54	SENT_85	[p6l11t2854r234b2915],
62	:	:	O	:	_	0	SENT_85	[p6l11t2854r234b2915],
63	maja.krajinovic@umontrea	FW	O	maja.krajinovic@umontrea	nn	64	SENT_85	[p6l268t2854r1227b2916],
64	|	FW	O	|	amod	40	SENT_85	[p6l268t2854r1227b2916],
65	.	.	O	.	_	0	SENT_85	[p6l268t2854r1227b2916],

1	ca	MD	O	can	aux	2	SENT_86	[p6l268t2854r1227b2916],
2	)	VB	O	)	_	0	SENT_86	[p6l268t2854r1227b2916],

1	Antibodies	NNS	O	antibody	_	0	SENT_87	[p6l8t3164r617b3258],
2	to	TO	O	to	_	0	SENT_87	[p6l657t3168r774b3258],
3	varicella-zoster	NN	O	varicella-zoster	nn	4	SENT_87	[p6l815t3164r1679b3258],
4	virus	NN	O	virus	prep_to	1	SENT_87	[p6l1717t3164r1989b3258],
5	in	IN	O	in	_	0	SENT_87	[p6l2036t3164r2127b3257],
6	blood	NN	O	blood	nn	7	SENT_87	[p6l15t3325r316b3418],
7	donors	NNS	O	donor	prep_in	4	SENT_87	[p6l362t3325r745b3418],
8	with	IN	O	with	_	0	SENT_87	[p6l786t3324r1029b3418],
9	genetic	JJ	O	genetic	amod	10	SENT_87	[p6l1072t3324r1503b3440],
10	variance	NN	O	variance	prep_with	7	SENT_87	[p6l1544t3324r2029b3418],
11	in	IN	O	in	_	0	SENT_87	[p6l15t3485r106b3577],
12	CC	NN	O	cc	nn	14	SENT_87	[p6l152t3485r316b3579],
13	chemokine	NN	O	chemokine	nn	14	SENT_87	[p6l362t3485r988b3579],
14	receptor	NN	O	receptor	prep_in	10	SENT_87	[p6l1035t3488r1514b3600],
15	5	CD	NUMBER	5	dep	1	SENT_87	[p6l1554t3486r1625b3579],

1	Mingdong	NNP	PERSON	Mingdong	nn	2	SENT_88	[p7l10t53r331b119],
2	Zhang	NNP	PERSON	Zhang	_	0	SENT_88	[p7l350t53r567b119],
3	,	,	O	,	_	0	SENT_88	[p7l350t53r567b119],
4	Scott	NNP	PERSON	Scott	nn	5	SENT_88	[p7l597t52r764b106],
5	Schmid	NNP	PERSON	Schmid	appos	2	SENT_88	[p7l786t52r1041b116],
6	,	,	O	,	_	0	SENT_88	[p7l786t52r1041b116],
7	Mary	NNP	PERSON	Mary	nn	8	SENT_88	[p7l1074t53r1235b118],
8	Carrington	NNP	PERSON	Carrington	appos	2	SENT_88	[p7l1259t52r1607b119],
9	,	,	O	,	_	0	SENT_88	[p7l1259t52r1607b119],
10	Thomas	NNP	PERSON	Thomas	nn	12	SENT_88	[p7l13t137r261b189],
11	R	NNP	PERSON	R	nn	12	SENT_88	[p7l290t137r333b188],
12	O'Brien	NNP	PERSON	O'Brien	appos	2	SENT_88	[p7l362t136r593b189],

1	Carriers	NNS	O	carrier	dep	10	SENT_89	[p7l10t255r275b310],
2	of	IN	O	of	_	0	SENT_89	[p7l305t255r369b310],
3	a	DT	O	a	det	6	SENT_89	[p7l396t269r432b310],
4	32	CD	NUMBER	32	num	6	SENT_89	[p7l463t255r550b310],
5	bp	NN	O	bp	nn	6	SENT_89	[p7l582t256r660b322],
6	deletion	NN	O	deletion	prep_of	1	SENT_89	[p7l689t255r959b310],
7	(	CD	NUMBER	(	num	8	SENT_89	[p7l992t254r1182b322],
8	A32	NN	O	a32	dep	10	SENT_89	[p7l992t254r1182b322],
9	)	CD	NUMBER	)	num	10	SENT_89	[p7l992t254r1182b322],
10	allele	NN	O	allele	dep	15	SENT_89	[p7l1216t256r1396b310],
11	of	IN	O	of	_	0	SENT_89	[p7l1426t255r1490b310],
12	the	DT	O	the	det	14	SENT_89	[p7l1515t256r1624b310],
13	CC	NN	O	cc	nn	14	SENT_89	[p7l1655t255r1750b310],
14	chemokine	NN	O	chemokine	prep_of	10	SENT_89	[p7l1782t255r2150b310],
15	receptor	NN	O	receptor	dep	22	SENT_89	[p7l12t351r295b415],
16	5	CD	NUMBER	5	num	15	SENT_89	[p7l323t349r364b403],
17	(	CD	NUMBER	(	num	20	SENT_89	[p7l395t349r634b415],
18	CCR5	NN	O	ccr5	nn	20	SENT_89	[p7l395t349r634b415],
19	)	NN	O	)	nn	20	SENT_89	[p7l395t349r634b415],
20	gene	NN	O	gene	nsubjpass	22	SENT_89	[p7l666t356r830b415],
21	are	VBP	O	be	auxpass	22	SENT_89	[p7l860t362r964b403],
22	reported	VBN	O	report	_	0	SENT_89	[p7l996t349r1276b415],
23	to	TO	O	to	aux	26	SENT_89	[p7l1305t351r1373b403],
24	be	VB	O	be	cop	26	SENT_89	[p7l1405t349r1481b403],
25	more	RBR	O	more	advmod	26	SENT_89	[p7l1512t362r1678b403],
26	likely	JJ	O	likely	xcomp	22	SENT_89	[p7l1709t349r1885b415],
27	to	TO	O	to	aux	28	SENT_89	[p7l1911t351r1980b403],
28	lack	VB	O	lack	xcomp	26	SENT_89	[p7l2011t349r2152b403],
29	antibodies	NNS	O	antibody	dobj	28	SENT_89	[p7l10t441r360b495],
30	to	TO	O	to	_	0	SENT_89	[p7l429t443r497b495],
31	varicella-zoster	NN	O	varicella-zoster	nn	32	SENT_89	[p7l566t441r1080b495],
32	virus	NN	O	virus	prep_to	28	SENT_89	[p7l1147t441r1307b495],
33	than	IN	O	than	_	0	SENT_89	[p7l1375t442r1524b495],
34	CCR5	NN	O	ccr5	nn	36	SENT_89	[p7l1597t442r1784b495],
35	wild-type	JJ	O	wild-type	amod	36	SENT_89	[p7l1848t441r2151b508],
36	individuals	NNS	O	individual	prep_than	28	SENT_89	[p7l12t534r387b589],
37	.	.	O	.	_	0	SENT_89	[p7l12t534r387b589],

1	To	TO	O	to	aux	2	SENT_90	[p7l423t535r503b589],
2	find	VB	O	find	purpcl	17	SENT_90	[p7l535t534r656b589],
3	out	RP	O	out	prt	2	SENT_90	[p7l691t537r799b589],
4	whether	IN	O	whether	complm	7	SENT_90	[p7l831t535r1107b589],
5	CCR5-A32	NN	O	ccr5-a32	nsubjpass	7	SENT_90	[p7l1140t533r1484b589],
6	is	VBZ	O	be	auxpass	7	SENT_90	[p7l1519t534r1571b589],
7	associated	VBN	O	associate	ccomp	2	SENT_90	[p7l1605t534r1973b589],
8	with	IN	O	with	_	0	SENT_90	[p7l2006t534r2149b589],
9	the	DT	O	the	det	10	SENT_90	[p7l8t629r117b683],
10	seroprevalence	NN	O	seroprevalence	prep_with	7	SENT_90	[p7l179t629r695b695],
11	of	IN	O	of	_	0	SENT_90	[p7l757t629r822b683],
12	varicella-zoster	NN	O	varicella-zoster	nn	14	SENT_90	[p7l880t629r1394b683],
13	virus	NN	O	virus	nn	14	SENT_90	[p7l1454t629r1613b683],
14	infection	NN	O	infection	prep_of	10	SENT_90	[p7l1678t629r1991b694],
15	,	,	O	,	_	0	SENT_90	[p7l1678t629r1991b694],
16	we	PRP	O	we	nsubj	17	SENT_90	[p7l2055t642r2150b683],
17	tested	VBD	O	test	_	0	SENT_90	[p7l8t722r224b775],
18	blood	NN	O	blood	nn	19	SENT_90	[p7l272t722r450b775],
19	donors	NNS	O	donor	dobj	17	SENT_90	[p7l496t722r721b775],
20	with	IN	O	with	_	0	SENT_90	[p7l765t721r907b775],
21	different	JJ	O	different	amod	23	SENT_90	[p7l954t721r1236b775],
22	CCR5-A32	NN	O	ccr5-a32	nn	23	SENT_90	[p7l1282t719r1627b776],
23	genotypes	NNS	O	genotype	prep_with	17	SENT_90	[p7l1668t723r2019b788],
24	for	IN	O	for	_	0	SENT_90	[p7l2062t721r2152b775],
25	varicella-zoster	NN	O	varicella-zoster	nn	27	SENT_90	[p7l8t814r523b869],
26	virus	NN	O	virus	nn	27	SENT_90	[p7l570t814r730b869],
27	lgG	NN	O	lgg	prep_for	17	SENT_90	[p7l783t814r913b881],
28	.	.	O	.	_	0	SENT_90	[p7l783t814r913b881],

1	Antibody	NN	O	antibody	nsubj	6	SENT_91	[p7l965t814r1264b881],
2	to	TO	O	to	_	0	SENT_91	[p7l1311t816r1379b869],
3	varicella-zoster	NN	O	varicella-zoster	nn	4	SENT_91	[p7l1429t814r1943b869],
4	virus	NN	O	virus	prep_to	1	SENT_91	[p7l1991t814r2150b869],
5	was	VBD	O	be	cop	6	SENT_91	[p7l8t921r141b962],
6	present	JJ	DATE	present	dep	26	SENT_91	[p7l186t910r439b974],
7	in	IN	O	in	_	0	SENT_91	[p7l483t908r536b961],
8	209	CD	PERCENT	209	number	9	SENT_91	[p7l581t908r713b962],
9	(	CD	PERCENT	(	prep_in	6	SENT_91	[p7l757t908r1020b974],
10	99-5	CD	PERCENT	99-5	num	11	SENT_91	[p7l757t908r1020b974],
11	%	NN	PERCENT	%	dep	9	SENT_91	[p7l757t908r1020b974],
12	)	CD	NUMBER	)	dep	9	SENT_91	[p7l757t908r1020b974],
13	of	IN	O	of	_	0	SENT_91	[p7l1067t908r1131b962],
14	210	CD	NUMBER	210	num	16	SENT_91	[p7l1170t908r1302b962],
15	CCR5-A32	NN	O	ccr5-a32	nn	16	SENT_91	[p7l1346t906r1690b962],
16	carriers	NNS	O	carrier	prep_of	12	SENT_91	[p7l1732t908r1988b962],
17	and	CC	O	and	_	0	SENT_91	[p7l2031t908r2149b962],
18	exactly	RB	O	exactly	advmod	21	SENT_91	[p7l9t1001r258b1067],
19	the	DT	O	the	det	21	SENT_91	[p7l306t1001r415b1054],
20	same	JJ	O	same	amod	21	SENT_91	[p7l465t1013r645b1054],
21	proportion	NN	O	proportion	prep_in	6	SENT_91	[p7l698t1000r1040b1066],
22	of	IN	O	of	_	0	SENT_91	[p7l1093t1000r1157b1054],
23	CCR5	NN	O	ccr5	prep_of	21	SENT_91	[p7l1205t1001r1392b1054],
24	wild-type	JJ	O	wild-type	amod	25	SENT_91	[p7l1439t1000r1741b1067],
25	individuals	NNS	O	individual	nsubj	26	SENT_91	[p7l1794t1000r2150b1054],
26	(	VBP	O	(	_	0	SENT_91	[p7l10t1093r172b1160],
27	209	CD	NUMBER	209	dobj	26	SENT_91	[p7l10t1093r172b1160],
28	of	IN	O	of	_	0	SENT_91	[p7l208t1093r272b1148],
29	210	CD	NUMBER	210	num	30	SENT_91	[p7l304t1093r486b1160],
30	)	NN	O	)	prep_of	27	SENT_91	[p7l304t1093r486b1160],
31	.	.	O	.	_	0	SENT_91	[p7l304t1093r486b1160],

1	We	PRP	O	we	nsubj	4	SENT_92	[p7l523t1094r630b1148],
2	have	VBP	O	have	aux	4	SENT_92	[p7l668t1094r822b1148],
3	therefore	RB	O	therefore	advmod	4	SENT_92	[p7l856t1093r1165b1148],
4	found	VBN	O	find	_	0	SENT_92	[p7l1199t1093r1383b1148],
5	no	DT	O	no	det	6	SENT_92	[p7l1422t1107r1499b1148],
6	evidence	NN	O	evidence	dobj	4	SENT_92	[p7l1534t1093r1834b1148],
7	that	IN	O	that	complm	12	SENT_92	[p7l1868t1094r2007b1148],
8	the	DT	O	the	det	10	SENT_92	[p7l2041t1094r2150b1148],
9	CCR5-A32	NN	O	ccr5-a32	nn	10	SENT_92	[p7l11t1185r355b1241],
10	allele	NN	O	allele	nsubjpass	12	SENT_92	[p7l385t1187r565b1241],
11	is	VBZ	O	be	auxpass	12	SENT_92	[p7l598t1187r650b1241],
12	associated	VBN	O	associate	ccomp	4	SENT_92	[p7l681t1187r1049b1241],
13	with	IN	O	with	_	0	SENT_92	[p7l1080t1187r1223b1241],
14	decreased	VBN	O	decrease	amod	15	SENT_92	[p7l1255t1187r1603b1241],
15	seroprevalence	NN	O	seroprevalence	prep_with	12	SENT_92	[p7l1634t1187r2150b1253],
16	of	IN	O	of	_	0	SENT_92	[p7l9t1278r74b1331],
17	varicella-zoster	NN	O	varicella-zoster	nn	19	SENT_92	[p7l96t1278r610b1331],
18	virus	NN	O	virus	nn	19	SENT_92	[p7l635t1278r794b1331],
19	infection	NN	O	infection	prep_of	15	SENT_92	[p7l823t1278r1136b1331],
20	.	.	O	.	_	0	SENT_92	[p7l823t1278r1136b1331],

1	Lancet	NNP	O	Lancet	_	0	SENT_93	[p7l11t1428r243b1483],
2	2002	CD	DATE	2002	num	1	SENT_93	[p7l270t1426r479b1483],
3	:	:	O	:	_	0	SENT_93	[p7l270t1426r479b1483],
4	359	CD	NUMBER	359	num	6	SENT_93	[p7l512t1426r676b1483],
5	:	:	O	:	_	0	SENT_93	[p7l512t1426r676b1483],
6	1034-36	CD	NUMBER	1034-36	dep	1	SENT_93	[p7l712t1426r1035b1483],

1	Chemokines	NNS	MISC	chemokine	nsubj	5	SENT_94	[p7l13t1606r451b1664],
2	and	CC	O	and	_	0	SENT_94	[p7l501t1606r629b1664],
3	chemokine	NN	O	chemokine	nn	4	SENT_94	[p7l677t1606r1059b1664],
4	receptors	NNS	O	receptor	conj_and	1	SENT_94	[p7l1107t1619r1430b1679],
5	play	VBP	O	play	_	0	SENT_94	[p7l1477t1606r1624b1679],
6	an	DT	O	a	det	8	SENT_94	[p7l1670t1624r1752b1664],
7	important	JJ	O	important	amod	8	SENT_94	[p7l1798t1606r2152b1679],
8	part	NN	O	part	dobj	5	SENT_94	[p7l8t1713r150b1773],
9	in	IN	O	in	_	0	SENT_94	[p7l180t1700r246b1757],
10	the	DT	O	the	det	12	SENT_94	[p7l275t1700r383b1758],
11	inﬂammatory	JJ	O	inﬂammatory	amod	12	SENT_94	[p7l414t1700r893b1773],
12	response	NN	O	response	prep_in	8	SENT_94	[p7l920t1719r1227b1773],
13	by	IN	O	by	_	0	SENT_94	[p7l1257t1700r1342b1773],
14	mediating	VBG	O	mediate	prepc_by	5	SENT_94	[p7l1370t1700r1724b1773],
15	chemotaxis	NN	O	chemotaxi	nn	18	SENT_94	[p7l1754t1700r2149b1758],
16	and	CC	O	and	_	0	SENT_94	[p7l11t1794r139b1852],
17	leucocyte	NN	O	leucocyte	nn	18	SENT_94	[p7l165t1794r495b1867],
18	activation	NN	O	activation	dobj	14	SENT_94	[p7l523t1794r885b1852],
19	.	.	O	.	_	0	SENT_94	[p7l523t1794r885b1852],

1	CC	NN	O	cc	nn	3	SENT_95	[p7l918t1794r1037b1852],
2	chemokine	NN	O	chemokine	nn	3	SENT_95	[p7l1066t1794r1449b1852],
3	receptor	NN	O	receptor	_	0	SENT_95	[p7l1474t1808r1769b1867],
4	5	CD	NUMBER	5	number	5	SENT_95	[p7l1795t1796r1829b1852],
5	(	CD	NUMBER	(	num	7	SENT_95	[p7l1865t1794r2145b1866],
6	CCR5	NN	O	ccr5	nn	7	SENT_95	[p7l1865t1794r2145b1866],
7	)	NN	O	)	nsubj	9	SENT_95	[p7l1865t1794r2145b1866],
8	also	RB	O	also	advmod	9	SENT_95	[p7l11t1887r143b1945],
9	serves	VBZ	O	serve	rcmod	3	SENT_95	[p7l185t1905r391b1945],
10	as	IN	O	as	_	0	SENT_95	[p7l433t1906r498b1945],
11	the	DT	O	the	det	13	SENT_95	[p7l538t1887r646b1945],
12	major	JJ	O	major	amod	13	SENT_95	[p7l685t1887r891b1959],
13	coreceptor	NN	O	coreceptor	prep_as	9	SENT_95	[p7l929t1900r1304b1960],
14	for	IN	O	for	_	0	SENT_95	[p7l1341t1886r1441b1945],
15	HIV-1	NN	MISC	hiv-1	nn	16	SENT_95	[p7l1478t1888r1699b1945],
16	strains	NNS	O	strain	prep_for	13	SENT_95	[p7l1748t1887r1974b1945],
17	that	WDT	O	that	nsubj	18	SENT_95	[p7l2013t1887r2152b1945],
18	predominate	VBP	O	predominate	rcmod	13	SENT_95	[p7l8t1981r458b2054],
19	in	IN	O	in	_	0	SENT_95	[p7l485t1981r551b2038],
20	the	DT	O	the	det	22	SENT_95	[p7l575t1981r684b2039],
21	early	JJ	O	early	amod	22	SENT_95	[p7l712t1981r879b2054],
22	phase	NN	O	phase	prep_in	18	SENT_95	[p7l902t1981r1101b2054],
23	of	IN	O	of	_	0	SENT_95	[p7l1129t1981r1204b2039],
24	infection	NN	O	infection	prep_of	22	SENT_95	[p7l1220t1981r1574b2039],
25	}	CD	NUMBER	}	num	24	SENT_95	[p7l1220t1981r1574b2039],
26	An	DT	O	a	det	27	SENT_95	[p7l1601t1982r1706b2038],
27	allele	NN	O	allele	dep	35	SENT_95	[p7l1733t1981r1910b2039],
28	with	IN	O	with	_	0	SENT_95	[p7l1936t1981r2090b2039],
29	a	DT	O	a	det	31	SENT_95	[p7l2117t2000r2150b2039],
30	32	CD	NUMBER	32	num	31	SENT_95	[p7l11t2077r94b2132],
31	bp	NN	O	bp	prep_with	27	SENT_95	[p7l132t2074r220b2147],
32	deletion	NN	O	deletion	dep	35	SENT_95	[p7l260t2074r544b2132],
33	(	CD	NUMBER	(	num	32	SENT_95	[p7l587t2072r775b2146],
34	A32	NN	O	a32	nn	35	SENT_95	[p7l587t2072r775b2146],
35	)	NN	O	)	dep	39	SENT_95	[p7l587t2072r775b2146],
36	in	IN	O	in	_	0	SENT_95	[p7l818t2074r884b2132],
37	the	DT	O	the	det	38	SENT_95	[p7l920t2074r1029b2132],
38	CCR5	NN	O	ccr5	prep_in	35	SENT_95	[p7l1068t2074r1281b2132],
39	gene	NN	O	gene	dep	3	SENT_95	[p7l1316t2093r1477b2147],
40	confers	VBZ	O	confer	rcmod	39	SENT_95	[p7l1516t2074r1767b2132],
41	resistance	NN	O	resistance	dobj	40	SENT_95	[p7l1806t2074r2150b2132],

1	1034	CD	DATE	1034	_	0	SENT_96	[p7l49t2239r125b2265],
2	THE	DT	O	the	det	5	SENT_96	[p7l1176t2244r1242b2265],
3	LANCET	NN	O	lancet	nn	5	SENT_96	[p7l1251t2244r1381b2265],
4	°	CD	NUMBER	°	num	5	SENT_96	[p7l1390t2251r1398b2259],
5	Vol	NN	O	vol	dep	1	SENT_96	[p7l1407t2244r1451b2265],
6	359	CD	NUMBER	359	dep	5	SENT_96	[p7l1461t2245r1507b2265],
7	-	:	O	-	_	0	SENT_96	[p7l1518t2251r1525b2259],
8	March	NNP	DATE	March	dep	5	SENT_96	[p7l1535t2244r1619b2265],
9	23	CD	DATE	23	num	8	SENT_96	[p7l1628t2245r1666b2269],
10	,	,	DATE	,	_	0	SENT_96	[p7l1628t2245r1666b2269],
11	2002	CD	DATE	2002	num	8	SENT_96	[p7l1677t2245r1739b2265],
12	-	:	O	-	_	0	SENT_96	[p7l1750t2251r1757b2259],
13	wWw.thelancet.com	NNP	O	wWw.thelancet.com	dep	8	SENT_96	[p7l1767t2244r2017b2265],

1	For	IN	O	for	_	0	SENT_97	[p7l108t2345r177b2380],
2	personal	JJ	O	personal	amod	3	SENT_97	[p7l202t2345r389b2388],
3	use	NN	O	use	pobj	1	SENT_97	[p7l417t2353r506b2380],
4	.	.	O	.	_	0	SENT_97	[p7l417t2353r506b2380],

1	Only	RB	O	only	advmod	2	SENT_98	[p7l554t2344r650b2388],
2	reproduce	VB	O	reproduce	_	0	SENT_98	[p7l675t2345r898b2388],
3	with	IN	O	with	_	0	SENT_98	[p7l922t2344r1016b2380],
4	permission	NN	O	permission	prep_with	2	SENT_98	[p7l1044t2344r1285b2388],
5	from	IN	O	from	_	0	SENT_98	[p7l1310t2344r1408b2380],
6	The	DT	O	the	det	9	SENT_98	[p7l1433t2345r1513b2380],
7	Lancet	NNP	ORGANIZATION	Lancet	nn	9	SENT_98	[p7l1539t2345r1689b2380],
8	Publishing	NNP	ORGANIZATION	Publishing	nn	9	SENT_98	[p7l1716t2344r1948b2388],
9	Group	NNP	ORGANIZATION	Group	prep_from	2	SENT_98	[p7l1972t2344r2115b2388],
10	.	.	O	.	_	0	SENT_98	[p7l1972t2344r2115b2388],

